CPO-PIEMONTE ELENCO PUBBLICAZIONI DAL 1993 AD APRILE 2005
1.
AA.VV. Carcinoma del polmone linee guida clinico-organizzative per la Regione Piemonte, Regione Piemonte, Torino, febbraio, 2004.
2.
AA.VV. Sarcomi dei tessuti molli nell’adulto linee guida clinico-organizzative per la Regione Piemonte, Regione Piemonte, Torino, ottobre, 2004.
3.
AA.VV. Tumore della mammella: linee guida clinico-organizzative per la Regione Piemonte, Regione Piemonte, Torino, 2002.
4.
AA.VV. Tumori del colon-retto. Linee guida clinico organizzative per la Regione Piemonte. Regione Piemonte, Torino, 2001.
5.
ABAITUA BORDA I, PHILEN RM, POSADA DE LA PAZ M, GÓMEZ DE LA CÁMARA A, DÍEZ RUIZ NAVARRO M, GIMÉNEZ RIBOTA O, ALVARGONZÁLEZ SOLDEVILLA J, TERRACINI B, SEVERIANO PEÑA S, FUENTES LEAL C, KILBOURNE E.M. Toxic oil syndrome mortality: the first 13 years. Int J Epidemiol 1998; 27: 105763.
6.
AGABITI N, MALLONE S, FORASTIERE F, CORBO GM, FERRO S, RENZONI E, SESTINI P, RUSCONI F, CICCONE G, VIEGI G, CHELLINI E, PIFFER S. AND SIDRIA COLLABORATIVE GROUP. The impact of parental smoking on asthma and wheezing. Epidemiology 1999; 10: 692-8.
7.
AGUDO A, AHRENS W, BENHAMOU E, BENHAMOU S, BOFFETTA P, DARBY SC, FORASTIERE F, FORTES C, GABORIEAU V, GONZALES CA, JÖCKEL K-H, KREUZER M, MERLETTI F, POHLABELN H, RICHIARDI L, WHITLEY E, WICHMANN H-E, ZAMBON P, SIMONATO L. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int J Cancer 2000; 88: 820-7.
8.
AGUDO A, SLIMANI N, OCKE MC, NASKA A, MILLER AB, KROKE A, BAMIA C, KARALIS D, VINEIS P, PALLI D, BUENO-DE-MESQUITA HB, PEETERS PH, ENGESET D, HJARTAKER A, NAVARRO C, MARTINEZ GARCIA C, WALLSTROM P, ZHANG JX, WELCH AA, SPENCER E, STRIPP C, OVERVAD K, CLAVEL-CHAPELON F, CASAGRANDE C, RIBOLI E. Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr 2002; 5: 1179-96.
9.
AHRENS W, MERLETTI F. A standard tool for the analysis of occupational lung cancer in epidemiologic studies. Int J Occup Environ Health 1998; 4: 236-40.
10. AIROLDI L, ORSI F, MAGAGNOTTI C, CODA R, RANDONE D, CASETTA G, PELUSO M, HAUTEFEUILLE A, MALAVEILLE C, VINEIS P. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 2002; 23: 861-6.
11. ALBANESE MC, GUBIANI M, CUZZATO AL, OPPENHEIM R, CASINI M, MIANI D, ROZBOWSZKY P, MAURO K,
GREGORI D, TRENTIN M, GREMESE E, FIORETTI PM. [Management of chronic heart failure: clinical features and resource utilization among patients managed by the general practitioner. Pilot project in the province of Udine (Italy)] Monaldi Arch Chest Dis 2002; 58: 95-100.
12. ALBIN M, MAGNANI C, KRSTEV S, RAPITI E, SHEFER I. Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 1999; 107: 289-98.
13. ALBIN M, SHEFER I, MAGNANI C, KRSTEV S. Asbestos and cancer. Tenth International Symposium: Epidemiology in occupational health. Como, 20-24 September 1994. Med Lav 1994; 86: 259-62.
1
14. ALEXANDER FE, BOYLE P, CARLI PM, COEBERGH JW, DRAPER GJ, EKBOM A, LEVI F, MCKINNEY PA, MCWHIRTER W, MICHAELIS J, PERIS-BONET R, PETRIDOU E, POMPE-KIRN V, PLESKO I, PUKKALA E, RAHU M, STORM H, TERRACINI B, VATTEN L, WRAY N. Spatial clustering of childhood leukaemia: summary results from the EUROCLUS project. Br J Cancer 1998; 77: 818-24.
15. ALEXANDER FE, BOYLE P, CARLI PM, COEBERGH JW, DRAPER GJ, EKBOM A, LEVI F, MCKINNEY PA, MCWHIRTER W, MAGNANI C, MICHAELIS J, OLSEN JH, PERIS-BONET R, PETRIDOU E, PUKKALA E, VATTEN L. Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. Br J Cancer 1998; 77: 812-7.
16. ALEXANDER FE, BOYLE P, CARLI PM, COEBERGH JW, EKBOM A, LEVI F, MCKINNEY PA, MCWHIRTER W, MICHAELIS J, PERIS-BONET R, PETRIDOU E, POMPE-KIRN V, PLESKO I, PUKKALA E, RAHU M, STILLER CA, STORM H, TERRACINI B, VATTEN L, WRAY N. Population density and childhood leukaemia: results of the EUROCLUS Study. Eur J Cancer 1999; 35: 439-44.
17. ALEXANDER FE, WRAY N, BOYLE P, BRING J, COEBERGH JW., DRAPER G, LEVI F, MCKINNEY PA, MICHAELIS
J, PERIS-BONET R, PETRIDOU E, PUKKALA E, STORM H, TERRACINI B, VATTEN L. Clustering of childhood leukaemia: a European study in progress. Journal of Epidemiology and Biostatistics 1996; 1: 13-22.
18. ALTENBURG HP, AGUDO A, BERRINO F, BOSHUIZEN HC, BUENO-DE-MESQUITA HB, JANZON L, LE MARCHAND
L, LINSEISEN J, LUKANOVA A, RASMUSON T, VINEIS P, RIBOLI E, MILLER A. Using multiple imputation methods to estimate relative risks in small EPIC lung cancer subsets. IARC Sci Publ 2002; 156: 53-4.
19. AMMENDOLA A, SAMPAOLO S, AMBROSONE L, AMMENDOLA E, CICCONE G, MIGLIARESI S, DI IORIO G. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve 2005; 31: 382-5.
20. ANDREONI B, BERETTA G, BLENGINI C, CALISTRI D, CASCINU S, CIONINI L, COLUCCI G, COSIMELLI M,
CROSTA C, DI COSTANZO F, FRASSINETTI L, GARUFI C, GION M, LANZA G, LA VECCHIA C, LEO E, MEREGALLI M, NITTI D, OLMI P, PAGANELLI G, PARMIGIANI G, PIEROTTI M, PONZ DE LEON M, SEGNAN N, SENORE C, SOBRERO A. Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori del Colon-retto. Consiglio Nazionale delle Ricerche e Ministero dell'Istruzione, dell'Università e della Ricerca, 2004.
21. ANDREONI B, BERETTA G, BLENGINI C, CALISTRI D, CASCINU S, CIONINI L, COLUCCI G, COSIMELLI M,
CROSTA C, DI COSTANZO F, FRASSINETTI L, GARUFI C, GION M, LANZA G, LA VECCHIA C, LEO E, MEREGALLI M, NITTI D, OLMI P, PAGANELLI G, PARMIGIANI G, PIEROTTI M, PONZ DE LEON M, SEGNAN N, SENORE C, SOBRERO A. Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori del Colon-retto. Consiglio Nazionale delle Ricerche e Ministero dell'Istruzione, dell'Università e della Ricerca, 2004.
22. ANDREONI B, CROSTA C, BIANCHI PP, MONTORSI M, BIFFI R, CHIAPPA A, ANDREONI L, BATOLOMEI M, PAGANELLI G, SONZOGNI A, VIALE G, FORTI D, BISANTI L, SENORE C, SEGNAN N. La strategia del linfonodo sentinella nel trattamento dei polipi maligni del colon retto. In: Archivio ed atti della società italiana di chirurgia. Luigi Pozzi, Roma 2004.
23. ANDREONI B, CROSTA C, LOTTI M, CARLONI M, MARZONA L, BIFFI R, LUCA F, POZZI S, CENCIARELLI S,
SENORE C. Flexible sigmoidoscopy as a colorectal cancer screening test in the general population: recruitment phase results of a randomized controlled trial in Lombardia, Italy. Chir Ital 2000; 52: 257-62.
24. ANDREONI B, CROSTA C, PACE U, LOTTI M, CARLONI M, BISANTI L, ZOCCHETTI C, SEGNAN N. La prevenzione secondaria del carcinoma colorettale. Oncologia Europea 2000; 11: 35-8.
25. ANDRION A, FEYLES E, LANGE A, GIUDICI M, GRASSO G, AMORE M, BONDI A, CRISTOFORI E, PEZZOTTA
MG, BELLOMI A, ANGHINONI E, BARBAZZA R, MAGNANI C, CICCONE G. [Audit of histopathological activities in the laboratories of 7 general hospitals. 1. Types of resources and quantitative aspects of the workload] Pathologica 1996; 88: 18-24.
26. ANDRION A, GAGLIO A, LANGE A, GIUDICI M, GRASSO G, AMORE M, BONDI A, CRISTOFORI E, PEZZOTTA
MG, BELLOMI A, ANGHINONI E, BARBAZZA R, MAGNANI C, CICCONE G. [Audit of histopathology
2
activities at the pathology departments of 7 general hospitals. 2. Response time] Pathologica 1996; 88: 181-7.
27. ANDRION A, MAGNANI C, BETTA PG, DONNA A, MOLLO F, SCELSI M, BERNARDI P, BOTTA M, TERRACINI B. Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol 1995; 48: 85660.
28. ANGHINONI E, GONZALEZ G, CERESA M, ZAPPA M, GIORDANO L, Iniziative regionali per l’attuazione
di screening per i tumori femminili del collo dell’utero e della Mammella in Italia. In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 74-77.
29. ANTÒ J, BOLUMAR F, DEBERT-RIBEIRO M, FABIA J, KARMAUS W, LAST J, MERLETTI F, SCHOUTEN E. Epilex A
multilingual lexicon of epidemiological terms. Commission of the European Communities, Brussels-Luxembourg, 1993.
30. ANTTILA A, RONCO G, CLIFFORD G, BRAY F, HAKAMA M, ARBYN M, WEIDERPASS E. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004; 91: 93541.
31. APPIANO S, BERTETTO O, CICCONE G, DONNA G, GIANINO MM, MERLETTI F, MUSSA A, MONCHIERO G, NIEDDU S, SEGNAN N. La Rete oncologica piemontese. Politiche sanitarie 2002; 3: 185-90.
32. APPIANO S, MANCINI E, SEGNAN N. Gli Screening oncologici nella Regione Piemonte. ARESS, Anno 1, n°4, Dicembre 2001. Pag. 10-11.
33. AXELSON O, BALBUS JM, COHEN G, DAVIS D, DONNAY A, DOOLITTLE R, DURAN BM, EGILMAN D, EPSTEIN
SS, GOLDMAN L, GRANDJEAN P, HANSEN ES, HELTNE P, HUFF J, INFANTE P, JACOBSON MF, JOSHI TK, LADOU J, LANDRIGAN PJ, LEE PR, LOCKWOOD AH, MACGREGOR G, MELNICK R, MESSING K, NEEDLEMAN H, OZONOFF D, RAVANESI B, RICHTER ED, SASS J, SCHUBERT D, SUZUKI D, TEITELBAUM D, TEMPLE NJ, TERRACINI B, THOMPSON A, TICKNER J, TOMATIS L, UPTON AC, WHYATT RM, WIGMORE D, WILSON T, WING SB, SHARPE VA. Re: Regulatory Toxicology and Pharmacology.Int J Occup Environ Health 2003; 9: 386-9; 389-90.
34. AXELSON O, CASTLEMAN B, EPSTEIN S, FRANCO G, GIANNASI F, GRANDJEAN P, GREENBERG M, HOOPER K, HUFF J, JACOBSON M, JOSHI TK, KULKARNI GK, LADOU J, MAZAHERI M, MEKONNEN Y, MELNICK R, MIRABELLI D, OFRIN R, PARTANEN T, POTT F, SASS J, SOSKOLNE CL, SUPLIDO ML, TERRACINI B, TOMATIS L, UNGVARY G, WATTERSON A, WESSELING C, YASSI A. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels. Int J Occup Environ Health 2002; 8: 271- 3.
35. BALMA R, BIGGERI A, BUSETTO D, CARTABELLOTTA N, CELIN D, CISLAGHI C, CORREANI A, COSTA G,
DIRINDIN N, FANTINI.MP, GALANTI C, GEDDES DE FILICAIA M, GRILLI R, LUPO A, MONTAGUTI U, PACI E, PANICO S, PERUCCI C, SEGNAN N, SPINSANTI S, VINEIS P. Open letter to the Health Minister from a group of epidemiologists and experts in health programming. Epidemiol Prev 2001; 25: 501.
36. BARBERO M, PRETI M, MICHELETTI L, BERTINI U, CANNI' M, BOCCI F, BOCCI C, RONCO G, VOGLINO GF, GHIRINGHELLO B, MASSOBRIO M. Risk factors of recurrence in squamous cell carcinoma of the vulva: role of immunohistochemical parameters. Proceedings 1997 conference of the International society for the study of vulvovaginal disease.
37. BARCHIELLI A, FEDERICO M, DE LISI V, BUCCHI L, FERRETTI S, PACI E, PONTI A, BUIATTI E
FOR THE
SCREENREG WORKING GROUP (Segnan N, Ronco G, Patriarca S, Rosso S, Zanetti R, Frigerio A et al). In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer 2005,( in press).
38. BARONE-ADESI F, RICHIARDI L, MERLETTI F. Population attributable risk for occupational cancer in Italy. Int J Occup Environ Health 2005; 11: 23-31.
3
39. BARTSCH M, VINEIS P. et al. Smoking and bladder cancer: molecular dosimetry studies in
smokers of black and blond tobacco implicate aromatic amines. Eur J Cancer 1993; 29A: 1199-207.
40. BATTISTA RN, HODGE MJ, VINEIS P. Medicine, practice and guidelines: the uneasy juncture of science and art. J Clin Epidemiol 1995; 48: 875-80.
41. BAUSSANO I, CAZZADORI A, SCARDIGLI A, CONCIA E. Clinical and demographic aspects of
extrathoracic tuberculosis: experience of an Italian university hospital. Int J Tuberc Lung Dis 2004; 8: 486-92.
42. BAUSSANO I, TERRACINI B. Cosa può fare l’epidemiologia di fronte al terrorismo? Epidemiol Prev 2004; 28: 67-8.
43. BEGG CB, HUMMER A, MUJUMDAR U, ARMSTRONG BK, KRICKER A, MARRETT LD, MILLIKAN RC, GRUBER SB, ANTON-CULVER H, KLOTZ JB, ZANETTI R, GALLAGHER RP, DWYER T, REBBECK TR, BERWICK M; GEM STUDY GROUP. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004; 15: 957-65.
44. BELLONE G, CARBONE A, TIBAUDI D, MAURI F, FERRERO I, SMIRNE C, SUMAN F, RIVETTI C, MIGLIARETTI G, CAMANDONA M, PALESTRO G, EMANUELLI G, RODECK U. Differential expression of transforming growth factors-β1, β2 and β3 in human colon carcinoma. Eur J Cancer 2001; 37: 224-33.
45. BENA A, D’ERRICO A, MIRABELLI D, PASQUALINI O. Ambienti di lavoro. In: Morgagni S, Valpreda
M, Gnavi R, Costa G. eds, La salute in Piemonte 2000. Torino, Regione Piemonte, 2001. Pag. 113-30.
46. BENA A, D’ERRICO A, MIRABELLI D. Un sistema di rilevazione attiva dell’asma bronchiale professionale: i risultati di due anni di attività del programma PRiOR. Med Lav 1999; 90: 556-71.
47. BENELLI E, PALTRINIERI B, GIORDANO L, SEGNAN N.
Diagnasi precoce dei tumori femminili: Screening mammografici sulla stampa italiana. In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 104-111.
48. BERARDINO M, MORRONE O, SCIACCA PF, ROSATO R, CICCONE G, MASSARO F. Discharge criteria from intensive care unit in brain injured patients. Acta Neurochir (Wien) 2004; 146: 453-6.
49. BERRINO F, RICHIARDI L, BOFFETTA P, ESTEVE J, BELLETTI I, RAYMOND L, TROSCHEL L, PISANI P, ZUBIRI L,
ASCUNCE N, GUBERAN E, TUYNS A, TERRACINI B, MERLETTI F; MILAN JEM WORKING GROUP. Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 2003; 14: 213-23.
50. BERRINO F, RICHIARDI L, MERLETTI F. Occupational exposures, anatomic location, and geographic distribution of laryngeal cancer. Cancer Causes and Control 2004; 15: 429430.
51. BERTI G, MIGLIORE E, CICCONE G. Risultati descrittivi. Progetto SIDRIA II Torino. Scuole elementari. Aprile 2003.
52. BERWICK M, MATULLO G, SONG YS, GUARRERA S, DOMINGUEZ G, ORLOW I, WALKER M, VINEIS P.
Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma. J CLIN ONCOL 2004; 22: 3997-4001.
53. BERWICK M, VINEIS P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000; 92: 874-97.
54. BERWICK M, VINEIS P. Measuring DNA repair capacity: small steps. J Natl Cancer Inst 2005; 97: 84-5.
55. BERWICK M, VINEIS P. Response Re: Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000; 92: 1537.
4
56. BETTA PG, ANDRION A, DONNA A, MOLLO F, SCELSI M, ZAI G, TERRACINI B, MAGNANI C. Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis. Pathol Res Pract 1997; 193: 759-65.
57. BIANCHINI F, BOEING H, VINEIS P, ELMSTAHL S, MARTINEZ-GARCIA C, VAN KAPPEL AL, OHSHIMA H, RIBOLI E, KAAKS R. Alcohol consumption and oxidative damage. IARC Sci Publ 2002; 156: 163-4.
58. BIANCHINI F, JAECKEL A, VINEIS P, MARTINEZ-GARCIA C, ELMSTAHL S, VAN KAPPEL AL, BOEING H, OHSHIMA
H, RIBOLI E, KAAKS R. Inverse correlation between alcohol consumption and lymphocyte levels of 8-hydroxydeoxyguanosine in humans. Carcinogenesis 2001; 22: 885-90.
59. BIGGERI A, BACCINI M, BELLINI P, TERRACINI B. Meta-analysis of the Italian studies of short-term effects of air pollution (MISA), 1990-1999. Int J Occup Environ Health 2005; 11: 107-22.
60. BIGGERI A, BELLINI P, TERRACINI B. [Meta-analysis of the Italian studies on short-term effects of air pollution] Epidemiol Prev 2001; 25: 1-71.
61. BIGGERI A, STANGHELLINI E, MERLETTI F, MARCHI M. Latent class models for varying catchability
and correlation among sources in Capture-Recapture estimation of the size of a human population. Statistica Applicata – Italian J Applied Statistics 1999; 2: 563-76.
62. BIGI R, CORTIGIANI L, GREGORI D, DE CHIARA B, FIORENTINI C. Exercise versus recovery electrocardiography in predicting mortality in patients with uncomplicated myocardial infarction. Eur Heart J 2004; 25: 558-64.
63. BIGI R, CORTIGIANI L, GREGORI D, DE CHIARA B, PARODI O, FIORENTINI C. Exercise versus recovery
electrocardiography for predicting outcome in hypertensive patients with chest pain. J Hypertens 2004; 22: 2193-9.
64. BINGHAM SA, DAY NE, LUBEN R, FERRARI P, SLIMANI N, NORAT T, CLAVEL-CHAPELON F, KESSE E, NIETERS A, BOEING H, TJONNELAND A, OVERVAD K, MARTINEZ C, DORRONSORO M, GONZALEZ CA, KEY TJ, TRICHOPOULOU A, NASKA A, VINEIS P, TUMINO R, KROGH V, BUENO-DE-MESQUITA HB, PEETERS PH, BERGLUND G, HALLMANS G, LUND E, SKEIE G, KAAKS R, RIBOLI E; EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1496-501.
65. BISANTI L, MAGGINI M, RASCHETTI R, SPILA ALEGIANI S, MENNITI IPPOLITO F, CAFFARI B, SEGNAN N, PONTI A. Cancer mortality in ethylene oxide workers. Brit J Ind Med 1993; 50: 317-24.
66. BISANTI L, RUSSO A, BELLINI A, MANCINI E, PONTI A, SEGNAN N, ROSSELLI
DEL TURCO M, ZAPPA M. Caratterizzazione della popolazione afferente ai programmi di screening mammografico: risultati preliminari dello studio FRiCaM (Fattori di rischio per il Cancro della Mammella). In: Rosselli del Turco M, Zappa M, eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Terzo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2004, Pag. 144149.
67. BISANTI L, RUSSO A, BELLINI A, PACI E, PONTI A, ROSSELLI DEL TURCO M, SEGNAN N, ZAPPA M. Rischi e
benefici dell'ecografia di screening: lo studio Ribes. In: Rosselli del Turco M, Zappa M, eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Primo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2002, Pag. 86-91.
68. BISANTI L, RUSSO A, BELLINI A, PONTI A, ROSSELLI
DEL TURCO M, SEGNAN N, ZAPPA M. Stato di avanzamento degli studi Ribes e Fricam. In: Rosselli del Turco M., Zappa M., eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 114 - 7.
69. BLAMEY R, BLICHERT-TOFT M, CATALIOTTI L, COSTA A, GRECO M, HOLLAND R, KAUFMANN M, PERRY N, PONTI A, REDMOND K, SAINSBURY R. (EUSOMA Working Party). The requirements of a specialist breast unit. Eur J Cancer 2000; 36: 2288-93.
70. BO S, CAVALLO-PERIN P, CICCONE G, SCAGLIONE L, PAGANO G. The metabolic syndrome in twins: a consequence of low birth weight or of being a twin? Exp Clin Endocrinol Diabetes 2001; 109: 135-40.
5
71. BO S, CAVALLO-PERIN P, SCAGLIONE L, CICCONE G, PAGANO G. Low birthweight and metabolic abnormalities in twin with increased susceptibility to Type 2 diabetes mellitus. Diabet Med 2000; 17: 365-70.
72. BO S, CICCONE G, GRASSI G, GANCIA R, ROSATO R, MERLETTI F, PAGANO GF. Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004; 57: 1196-201.
73. BO S, CICCONE G, GRASSI G, GANCIA R, ROSATO R, MERLETTI F, PAGANO GF. Isolated systolic
hypertension in a cohort of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2004; 14: 157-61.
74. BO S, CICCONE G, ROSATO R, GANCIA R, GRASSI G, MERLETTI F, PAGANO GF. Renal damage in patients with Type 2 diabetes: a strong predictor of mortality. Diabet Med 2005; 22: 258-65.
75. BO S, CICCONE G, SCAGLIONE L, TALIANO C, PIOBBICI M, MERLETTI F, PAGANO G. Warfarin for nonvalvar atrial fibrillation: still underused in the 21st century? Heart 2003; 89: 553-4.
76. BO S, GENTILE L, CAVALLO-PERIN P, VINEIS P, GHIA V. Sex- and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol 1999; 36: 147-53.
77. BOCCADORO M, PALUMBO A, BRINGHEN S, MERLETTI F, CICCONE G, RICHIARDI L, RUS C, BERTOLA A,
GIACCONE L, OMEDE P, MUSTO P. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma. Haematologica 2002; 87: 846-50.
78. BOFFETTA P, AGUDO A, AHRENS W, BENHAMOU E, BENHAMOU S, DARBY SC, FORTES C, GONZALES CA, JOCKEL K-H, KRAUSS M, KREIENBROCK L, KREUZER M, MENDES A, MERLETTI F, NYBERG F, PERSHAGEN G, POHLABELN H, SIMONATO L, SCHMIDT G, WHITLEY E, WICHMANN H-E, WINCK C, ZAMBON P, SARACCI R. Multicenter case-control study of exposure to environmental tobacco smoke and risk of lung cancer in Europe. J Natl Cancer Inst 1998; 90: 1440-50.
79. BOFFETTA P, MERLETTI F, FAGGIANO F, MIGLIARETTI G, FERRO G, ZANETTI R, TERRACINI B. Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study. Am J Epidemiol 1997; 145: 1100-5.
80. BOFFETTA P, MERLETTI F, MAGNANI C, TERRACINI B. A population-based study of prognostic factors in oral and oropharyngeal cancer. Eur J Cancer B Oral Oncol 1994; 30B: 369-73.
81. BOFFETTA P, MERLETTI F, WINKELMANN R, MAGNANI C, CAPPA AP, TERRACINI B. Survival of breast cancer patients from Piedmont, Italy. Cancer Causes Control 1993; 4: 209-15.
82. BOFFETTA P, NYBERG F, AGUDO A, BENHAMOU E, JÖCKEL K-H, KREUZER M, MERLETTI F, PERSHAGEN G, POHLABELN H, SIMONATO L, WICHMANN H-E, SARACCI R. Risk of lung cancer from exposure to environmental tobacco smoke from cigars, cigarillos and pipes. Int J Cancer 1999; 83: 805-6.
83. BOFFETTA P, PERSHAGEN G, JÖCKEL KH, FORASTIERE F, GABORIEAU V, HEINRICH J, JAHN I, KREUZER M, MERLETTI F, NYBERG F, RÖSCH F, SIMONATO L. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 1999; 91: 697-701.
84. BOFFETTA P, RICHIARDI L, BERRINO F, ESTEVE J, PISANI P, CROSIGNANI P, RAYMOND L, ZUBIRI L, DEL MORAL
A, LEHMANN W, DONATO F, TERRACINI B, TUYNS A, MERLETTI F. Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 2003; 14: 203-12.
85. BOFFETTA P, SOUTAR A, CHERRIE JW, GRANATH F, ANDERSEN A, ANTTILA A, BLETTNER M, GABORIEAU V,
KLUG SJ, LANGARD S, LUCE D, MERLETTI F, MILLER B, MIRABELLI D, PUKKALA E, ADAMI HO, WEIDERPASS E. Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control 2004; 15: 697-706.
86. BOLDORINI R, VIGANÒ P, MONGA G, NEBULERI M, CARGNEL A, GUBERTINI G, MIGLIARETTI G, COSTANZI G. Hepatic histology of patients with HIV infection and chronic hepatitis C treated with interferon. J Clin Path 1997; 50: 735-40.
6
87. BOLOGNESI E, CIMINO G, DIVERIO D, RAPANOTTI MC, D’ALFONSO S, FLEISCHHAUER K, MIGLIARETTI G, MOMIGLIANO-RICHIARDI P. HLA class I in acute promyelocytic leukemia(APL): possible correlation with clinical outcome. Leukemia 2000; 14: 393-8.
88. BONELLI L, SCIALLERO S, ASTE H, ANDREONI B, GASPERONI S, FERRERO F, FERRARIS R, AGNOLUCCI A, ZAPPA
M, SEGNAN N. History of negative colorectal endoscopy and the risk of recto-sigmoid neoplasms at screening FS. Gastrenterology 2000; 118(4S).
89. BONGIOVANNI M, CASSONI P, DE GIULI P, VIBERTI L, CAPPIA S, IVALDI C, CHIUSA L, BUSSOLATI G. p27(kip1) immunoreactivity correlates with long-term survival in pleural malignant mesothelioma. Cancer 2001; 92: 1245-50.
90. BOSHUIZEN HC, BUENO-DE-MESQUITA HB, ALTENBURG HP, AGUDO A, LE MARCHAND L, BERRINO F, JANZON
L, RASMUSON T, VINEIS P, LUKANOVA A, LINSEISEN J, RIBOLI E, MILLER A. Adjustment for smoking in lung cancer analyses in the EPIC cohort. IARC Sci Publ 2002; 156: 59-61.
91. BOTTI C, COMBA P, PIRASTU R, VINEIS P. Causalità in epidemiologia: Popolazioni, individui e spiegazioni alternative. Epidemiol Prev 1999; 23: 260-7.
92. BOYLE P, VAINIO H, SMITH R, BENAMOUZIG R, LEE WC, SEGNAN N, TAKIMA K, TSUBONO Y. Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol 2005; 16: 25-30.
93. BRAGA M, CICCONE G, FAVERO L, IAPICHINO G, LORENZONI L, DA CAS R, NONIS M. Analisi dei transiti
in terapia intensiva per mezzo dei dati del flusso della scheda di dimissione ospedaliera e del sistema APR-DRG. In “Progetto di valutazione degli APR DRG su dati di attività ospedaliera italiana”. 3M Italia Spa, Segrate, 1999. Pag. 32-48.
94. BRENNAN P, BOGILLOT O, CORDIER S, GREISER E, SCHILL W, VINEIS P, LOPEZ-ABENTE G, TZONOU A, CHANG-
CLAUDE J, BOLM-AUDORFF U, JOCKEL KH, DONATO F, SERRA C, WAHRENDORF J, HOURS M, T'MANNETJE A, KOGEVINAS M, BOFFETTA P. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-94.
95. BRENNAN P, BOGILLOT O, GREISER E, CHANG-CLAUDE J, WAHRENDORF J, CORDIER S, JOCKEL K.H, LOPEZ-
ABENTE G, TZONOU A, VINEIS P, DONATO F, HOURS M, SERRA C, BOLM-AUDORFF U, SCHILL W, KOGEVINAS M, BOFFETTA P. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 2001; 12: 411-7.
96. BRENNAN P, BUFFLER PA, REYNOLDS P, WU AH, WICHMANN HE, AGUDO A, PERSHAGEN G, JOCKEL KH,
BENHAMOU S, GREENBERG RS, MERLETTI F, WINCK C, FONTHAM ET, KREUZER M, DARBY SC, FORASTIERE F, SIMONATO L, BOFFETTA P. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: A pooled analysis of two large studies. Int J Cancer 2004; 109: 12531.
97. BRETTI S, CASTAGNETO B, CASADIO C, BETTA PG, MAGNANI C, ZAI S. Il mesotelioma pleurico: esperienze integrate. Argomenti di Oncologia 1998; 19: 241-52.
98. BROEDERS M, SCHARPANTGEN A, ASCUNCE N, GAIRARD B, OLSEN AH, MANTELLINI P, CERDA MOTA T, VAN
LIMBERGEN E, SÉRADOUR B, PONTI A, SALAS TREJO L, NYSTRÖM L, FOR THE EUROPEAN BREAST CANCER NETWORK (EBCN) (SEGNAN N, DELMASTRO G, FRIGERIO A). Comparison of early performance indicators for screening projects within the European breast cancer network: 1989-2000, Eur J Cancer Prev 2005; 14: 107-116.
99. BRUNO G, BIGGERI A, LAPORTE RE, MCCARTY D, MERLETTI F, PAGANO G. National Diabetes Programs. Diabetes Care 1994; 17: 548-56.
100.BRUNO G, BIGGERI A, MERLETTI F, BARGERO G, FERRERO S, PAGANO G, PERIN PC. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes Care 2003; 26: 2353-8.
101.BRUNO G, BIGGERI A, MERLETTI F, PAGANO G. Temporal trends in incidence rates of Type I
diabetes in Germany: birth cohort and calendar period effects. Diabetologia 2000; 43: 1334-6.
7
102.BRUNO G, CERUTTI F, MERLETTI F, CAVALLO-PERIN P, GANDOLFO E, RIVETTI M, RUNZO C, PINACH S, PAGANO G. Piedmont Study Group for Diabetes Epidemiology. Residual beta-cell function and male/female ratio are higher in incident young adults than in children: the registry of type 1 diabetes of the province of Turin, Italy, 1984-2000. Diabetes Care 2005; 28: 312-7.
103.BRUNO G, MERLETTI F, BIGGERI A, BARGERO G, FERRERO S, PAGANO G, CAVALLO-PERIN P. Fibrinogen
and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2005; 48: 427-34.
104.BRUNO G, MERLETTI F, BIGGERI A, BARGERO G, FERRERO S, PAGANO G, PERIN PC. Progression to Overt
Nephropathy in Type 2 Diabetes: The Casale Monferrato Study. Diabetes Care 2003; 26: 2150-5.
105.BRUNO G, MERLETTI F, BIGGERI A, BARGERO G, FERRERO S, RUNZO C, PRINA CERAI S, PAGANO G, CAVALLO-PERIN P; Casale Monferrato Study. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004; 27: 2689-94.
106.BRUNO G, MERLETTI F, BIGGERI A, CERUTTI F, GROSSO N, DE SALVIA A, VITALI E, PAGANO G. Increasing
trend of type I diabetes in children and young adults in the province of Turin (Italy). Analysis of age, period and birth cohort effects in 1984 to 1996. Diabetologia 2001; 44: 225.
107.BRUNO G, MERLETTI F, BIGGERI A, PAGANO G. Data sources and validity of epidemiological studies on diabetes. Diabetes Nutr Metab 2003; 16: 189-91.
108.BRUNO G, MERLETTI F, BOFFETTA P, CAVALLO-PERIN P, BARGERO G, GALLONE G, PAGANO G. Impact of
glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 297-301.
109.BRUNO G, MERLETTI F, DE SALVIA A, LEZO A, ARCARI RK, PAGANO G. Comparison of incidence of
insulin-dependent diabetes mellitus in children and young adults in the province of Turin, Italy, 1984-91. Diabetic Medicine 1997; 14: 964-9.
110.BRUNO G, MERLETTI F, PAGANO G. Incidence of insulin-dependent diabetes among Sardinian migrants to northern Italy. Lancet 1996; 347: 193-4.
111.BRUNO G, MERLETTI F, VUOLO A, PISU E, GIORIO M, PAGANO G. Sex differences in incidence of IDDM in age-group 15-29 yr. Higher risk in males in Province of Turin, Italy. Diabetes Care 1993; 16: 133-6.
112.BRUNO G, PAGANO G, FAGGIANO F, DE SALVIA A, MERLETTI F. Effect of Sardinian heritage on risk and age at onset of type I diabetes: a demographic case-control study of Sardinian migrants. Int J Epidemiol 2000; 29: 532-5.
113.BRUZZI P, ROSSELLI DEL TURCO M, SEGNAN N, SANTI L. Gli screening di popolazione in oncologia. Le Scienze S.p.A. Editore. 1994, 98-108.
114.BUCCHI L, BARCHIELLI A, RAVAIOLI A, FEDERICO M, DE LISI V, FERRETTI S, PACI E, VETTORAZZI M, PATRIARCA
S, FRIGERIO A, BUIATTI E. Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 2004 Dec 14; [Epub ahead of print].
115.BUCCHI L, BARCHIELLI A, RAVAIOLI A, FEDERICO M, DE LISI V, FERRETTI S, PACI E, VETTORAZZI M, PATRIARCA
S, FRIGERIO A, BUIATTI E. Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al. Br J Cancer 2005 Apr 26; [Epub ahead of print].
116.BUCCHI L, BARCHIELLI A, RAVAIOLI A, FEDERICO M, DE LISI V, FERRETTI S, PACI E, VETTORAZZI M, PATRIARCA
S, FRIGERIO A, BUIATTI E; SCREENREG WORKING GROUP. Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 2005; 92: 156-61.
8
117.BUGIANI M, BORRACCINO A, MIGLIORE E, CAROSSO A, PICCIONI P, CAVALLERO M, CARIA E, SALAMINA G, AROSSA W. Tuberculin reactivity in adult BCG-vaccinated subjects: a cross-sectional study. Int J Tuberc Lung Dis 2003; 7: 320-6.
118.BUGIANI M, CAROSSO A, MIGLIORE E, PICCIONI P, CORSICO A, OLIVIERI M, FERRARI M, PIRINA P,
DE
MARCO R; ISAYA (ECRHS ITALY) STUDY GROUP. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy 2005; 60: 165-70.
119.BUIATTI E, BARCHIELLI A, BARTOLACCI S, BUCCHI L, DE LV, FEDERICO M, FERRETTI S, PACI E, VETTORAZZI M, ZANETTI R, & the SCREENREG Working group. Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy. Cancer Causes Control 2002; 13: 65-71.
120.BUIATTI E, BARCHIELLI A, BARTOLACCI S, FEDERICO M, DE LISI V, BUCCHI L, FERRETTI S, PACI E, SEGNAN N, TUMINO R; SCREENREG WORKING GROUP. The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. Eur J Cancer 2003; 39: 1776-82.
121.CADUM E, ARMITANO A, BERTI G, MIRABELLI D. Ambiente fisico e salute umana. In: Morgagni S, Valpreda M, Gnavi R, Costa G. eds, Piemonte, 2001. Pag. 79-111.
La salute in Piemonte 2000.
Torino, Regione
122.CADUM E, ROSSI G, MIRABELLI D, VIGOTTI MA, NATALE P et al. Inquinamento atmosferico e mortalità giornaliera a Torino, 1991-1996. Epidemiol Prev 1999; 23: 268-76.
123.CAMPOBASSO O, ANDRION A, RONCO G, et al. The value of the 1981 WHO histological
classification in inter-observer reproducibility and changing pattern of lung cancer. Int J Cancer 1993; 53: 205-8.
124.CANAVESE C, BERGAMO D, CICCONE G, BURDESE M, MADDALENA E, BARBIERI S, THEA A, FOP F. Low-
dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients. Nephrol Dial Transplant 2004; 19: 156470.
125.CANAVESE C, BERGAMO D, CICCONE G, LONGO F, FOP F, THEA A, MARTINA G, PIGA A. Validation of
serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int 2004; 65: 1091-8.
126.CANAVESE C, HOLLO Z, CICCONE G, GHISETTI V, BARBUI A, FOP F, MARTINA G, FORGNONE F, NOVO P, THEA A, GRILL A, MARCHIARO G. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients. J Nephrol 2000; 13: 352-9.
127.CANTELLO R, CIVARDI C, CAVALLI A, VARRASI C, TARLETTI R, MONACO F, MIGLIARETTI G. Cortical
excitability in criptogenic localization-related epilepsy: interictal transcranial magnetic stimulation studies. Epilepsia 2000; 41: 694-704.
128.CAPELLO D, FAIS F, VIVENZA D, MIGLIARETTI G, CHIORAZZI N, GAIDANO G, FERRARINI M. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes. Leukemia 2000; 14: 811-5.
129.CAPELLO D, VITOLO U, PASQUALUCCI L, QUATTRONE S, MIGLIARETTI G. et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95: 651-9.
130.CARBALLO F, TERRACINI B. Molecular epidemiology and informed consent. Epidemiol Prev 2002; 26: 211.
131.CARNINO F, FUDA G, CICCONE G, ISKRA L, GUERCIO E, DADONE D, CONTE PF. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 1997; 65: 467-472.
132.CAROZZI F, NOFERINI D, CONFORTINI M, CIATTO S, MADDAU C, RONCO G. The value of HPV testing in predicting the development of high grade lesions: a case control study. Atti de "27th European Congress of cytology" Lillehammer 16-19 sett. 2000. Pubblicato su Cytopathology 2000; 11: 363-467.
9
133.CAROZZI F, RONCO G, CONFORTINI M, NOFERINI D, MADDAU G, CIATTO S, SEGNAN N. Predcition of high grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer 2000; 83: 1462-7.
134.CERRUTI MAINARDI P, PASTORE G, ZWEIER C, RAUCH A. Mowat-Wilson syndrome and mutation in
the zinc finger homeo box 1B gene: a well defined clinical entity. J Med Genet. 2004; 41: 16.
135.CHANG ET, MONTGOMERY SM, RICHIARDI L, EHLIN A, EKBOM A, LAMBE M. Number of siblings and risk of Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 1236-43.
136.CHIÒ A, CICCONE G, CALVO A, VERCELLINO M, DI VITO N, GHIGLIONE P, MUTANI R. Validity of
hospital morbidity records for amyotrophic lateral sclerosis. A population-based study. J Clin Epidemiol 2002; 55: 723-7.
137.CHIO A, CUCATTO A, CALVO A, TERRENI AA, MAGNANI C, SCHIFFER D. Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. J Neurol 1999; 246: 175-80.
138.CHIÒ A, MAGNANI C, SCHIFFER D. Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy, 1957-1987; application to birth cohorts. Neuroepidemiol 1995; 14: 269-77.
139.CHIÒ A, MAGNANI C, SCHIFFER D. Prevalence of Parkinson’s disease in Northwestern Italy: Comparison of tracer methodology and clinical ascertainment of cases. Movement Disorders 1998; 13: 400-5.
140.CHIÒ A, MAGNANI C, SCHIFFER D. The increase of Parkinson's disease mortality could be due to a cohort effect. Acta Neurol Scand 1995; 92: 113-5.
141.CICCONE G, BERTERO D, BRUNO A, CANAVESE C, CICCARELLI E, IVALDI C, PACITTO A, ROSATO R, ARIONE
R. Qualità dei dati o qualità dell’assistenza? Confronto tra diversi metodi di standardizzazione per gravità clinica, basati sulla scheda di dimissione, nell’analisi della mortalità ospedaliera. Epidemiol Prev 1999; 23: 286-93.
142.CICCONE G, BOBBIO M, DI SUMMA M, POLETTI G, PANDOLFO G, PIOBBICI M, CENTOFANTI P, GRASSO E,
BUONO G, VERDECCHIA C, PANSINI S, CASTENETTO E, ROGGERO S, ARIONE R, MERLETTI F, TERRACINI B. Mortalità ospedaliera in una Unità di cardiochirurgia di Torino: confronti internazionali e andamento temporale. Epidemiol Prev 2004; 28: 34-40.
143.CICCONE G, BONVICINI R, ZANOLA S, BOMBONATO M, CERAMINIELLO A. Necrotizing fasciitis. A diagnostic and therapeutic challenge. Minerva Chir 1999; 54: 819-23.
144.CICCONE G, DALMASSO P, FATUR VOLANTE T, CAMERLENGO A, FAGGIANO F, MAGNANI C, NATALE P, PICCIONI P, BUGIANI M. SIDRIA: prevalenza di asma e malattie allergiche nella popolazione pediatrica a Torino. Informa SIAIC 1996; 1: 6-9.
145.CICCONE G, FAGGIANO F, FALASCA P. [SO2 air pollution and hospital admissions in Ravenna: a case-control study] Epidemiol Prev 1995; 19: 99-104.
146.CICCONE G, FORASTIERE F, AGABITI N, BIGGERI A, BISANTI L, CHELLINI E, CORBO G, DELL’ORCO V, DALMASSO P, FATUR VOLANTE T, GALASSI C, PIFFER S, RENZONI E, RUSCONI F, SESTINI P, VIEGI G, AND THE SIDRIA COLLABORATIVE GROUP. Road traffic and respiratory effects in children. Occup Environ Med 1998; 55: 771-8.
147.CICCONE G, GIORDANO L, MAGNANI C, MANCINI E, MERLETTI F, PASTORE G, PATRIARCA S, PONTI A, RONCO G, ROSSO S, SEGNAN N, SENORE C, ZANETTI R. Tumori. In: Morgagni S, Valpreda M, Gnavi R, Costa G. eds, La salute in Piemonte 2000. Torino, Regione Piemonte, 2001. Pag. 117234.
148.CICCONE G, IMAZIO M, MASSOBRIO N. Costi e benefici in cardiochirurgia. In: S. Bergerone, M. Morello (a cura di): Selezione di argomenti di cardiologia 2. Centro Scientifico Editore, Torino, 1997. Pag. 243-62.
149.CICCONE G, IVALDI C, CICCARELLI E, PIOBBICI M, ARIONE R. Indicatori di classe sociale e gravità clinica:
un’analisi dei ricoveri all’ospedale Molinette con APR-DRG.
10
In “Progetto di
valutazione degli APR DRG su dati di attività ospedaliera italiana”. 3M Italia Spa, Segrate, 1999. Pag. 60-66.
150.CICCONE G, LORENZONI L, IVALDI C, CICCARELLI E, PIOBBICI M, ARIONE R. Classe sociale, modalità di
ricovero, gravità clinica e mortalità ospedaliera: un’analisi con “All patient refined DRG” dei dimessi dall’ospedale Molinette di Torino. Epidemiol Prev 1999; 23: 188-96.
151.CICCONE G, MIGLIARETTI G, ROSATO R, MASSA A, EMANUELLI S, MERLETTI F. La mobilità sanitaria per
ricoveri oncologici nella Regione Piemonte con approfondimenti sul Polo di Novara (anno 1997). Novara, Lega Italiana per la Lotta contro i Tumori, 1999.
152.CICCONE G, MIRABELLI D, LEVIS A, GAVAROTTI P, REGE-CAMBRIN G, DAVICO L, VINEIS P. Myeloid Leukemias and Myelodysplastic Syndromes: Chemical Exposures, Histologic Subtype and Cytogenetics in a Case-Control Study. Cancer Genetics Cytogenetics 1993; 68: 135-9.
153.CICCONE G, PISCOPO M, ROSATO R, MERLETTI F. La mobilità sanitaria per ricoveri oncologici nella Regione Piemonte (anno 1999). Quaderni CPO-Piemonte N. 6. Torino, 2001.
154.CICCONE G, PRASTARO C, IVALDI C, GIACOMETTI R, VINEIS P. Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status. Oncol 2000; 11: 1201-4.
Ann
155.CICCONE G, ROSATO R, MIGLIARETTI G, MERLETTI F. La mobilità sanitaria per ricoveri oncologici nella Regione Piemonte (anno 1998). Quaderni CPO-Piemonte N. 5. Torino, 2001.
156.CICCONE G, VINEIS P. Salute e classi sociali: accesso alla prevenzione o accesso alle cure? Epidemiol Prev 1994; 18: 141-5.
157.CICCONE G. [Features of traffic near houses and respiratory damage in children: the results of the SIDRIA (Italian Study on Respiratory Problems in Childhood and the Environment)] Ann Ist Super Sanita 2000; 36: 305-9.
158.CICCONE G. Come iniziare una ricerca clinica. In: Ideare, pianificare, condurre e presentare una ricerca clinica. Centro Scientifico Editore, Torino, 2001. Pag 1-52.
159.COEBERGH JWW, CAPOCACCIA R, GATTA G, MAGNANI C, STILLER C.A. Childhood cancer survival in Europe, 1978-1992: the EUROCARE study. Eur J Cancer 2001; 37: 671-2.
160.COEBERGH JWW, PASTORE G, GATTA G, CORAZZIARI I, KAMPS W,
AND THE EUROCARE WORKING GROUP. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-1992: the EUROCARE study. Eur J Cancer 2001; 37: 687-94.
161.COLEMAN D, DAY N, DOUGLAS G, FARMERY E, LYNGE E, PHILIP J, SEGNAN N. European guidelines for
quality assurance in cervical cancer screening. Europe against cancer programme. Eur J Cancer 1993; 29A: S1- 38.
162.COMBA P, MAGNANI C, BOTTI C. Setting priorities for environmental protection from asbestos: ethical aspects. Epidemiol Prev 2000; 24: 85-6.
163.COMBA P, MAGNANI C, PIRASTU R. L’epidemiologo in tribunale: requisiti, standard professionali e considerazioni deontologiche. Epidemiol Prev 2001; 25: 77-80.
164.CONFORTINI M, CAROZZI F, DALLA PALMA P, GHIRINGHELLO B, PARISIO F, PRANDI S, RONCO G, CIATTO S,
MONTANARI G; GISCI WORKING GROUP FOR CERVICAL CYTOLOGY. Interlaboratory reproducibility of atypical squamous cells of undetermined significance report: a national survey. Cytopathology 2003; 14: 263-8.
165.CONSIGLIO NAZIONALE DELLE RICERCHE E ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO. Consenso
sugli screening in oncologia: indirizzo di ricerca e raccomandazioni al Servizio Sanitario Nazionale. Berrino F, Bruzzi P, Franceschi S, Maggino T, Marsoni S, Rosselli del Turco M, Segnan N. Eds. 1996, Roma.
166.CORTESINA G, GABRIELE P, GIORDANO C, MERLETTI F, MORRISON A, MUELLER HERMELINK HK, PALESTRO G, SANNAZZARI GL, SARTORIS A, SASCO A, SEGNAN N, STEINER W, SUCCO G, TERRACINI B, VALENTE G,
11
VERSHULST J. Report of an International Workshop on Perspectives on Secondary Prevention of Laryngeal Cancer. Eur J Cancer 1993; 29A: 1348-52.
167.COSTANTINI AS, MILIGI L, KRIEBEL D, RAMAZZOTTI V, RODELLA S, SCARPI E, STAGNARO E, TUMINO R, FONTANA A, MASALA G, VIGANO C, VINDIGNI C, CROSIGNANI P, BENVENUTI A, VINEIS P. A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology 2001; 12: 78-87.
168.CPO Piemonte – CSI Piemonte: Protocollo operativo dei programmi regionali di screening dei tumori della mammella e del collo dell’utero. Regione Piemonte – Assessorato alla Sanità. Ottobre 1998.
169.CRISPO A, BRENNAN P, JOCKEL KH, SCHAFFRATH-ROSARIO A, WICHMANN HE, NYBERG F, SIMONATO L,
MERLETTI F, FORASTIERE F, BOFFETTA P, DARBY S. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 2004; 91: 1280-6.
170.CROCETTI E, CAPOCACCIA R, CASELLA C, FERRETTI S, GUZZINATI S, ROSSO S, SACCHETTINI C, SPITALE A, STRACCI F, TUMINO R. Gli andamenti temporali della patologia oncologica in Italia: i dati dei registri tumori (1986-1997). Epidemiol Prev 2004; 28: 1-6.
171.CROCETTI E, CAPOCACCIA R, CASELLA C, GUZZINATI S, FERRETTI S, ROSSO S, SACCHETTINI C, SPITALE A, STRACCI F, TUMINO R; NETWORK OF THE ITALIAN CANCER REGISTRIES (AIRT). Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registries. Eur J Cancer Prev 2004; 13: 287-95.
172.CSERNI G, GREGORI D, MERLETTI F, SAPINO A, MANO MP, PONTI A, SANDRUCCI S, BALTAS B, BUSSOLATI G. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 2004; 91: 1245-52.
173.CUCCORESE C, MANO M.P, PONTI A, BORDON R, ARISIO R, MINGRONE K. Analysis of 47 breast lesions
screen detected treated by surgical biopsy: surgical margins status and presence of residual tumour at the surgical reexcision. Acts of the EORTC meeting, Marseille September 1998.
174.CUZICK J, EDWARDS R, SEGNAN N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997; 16: 1017-29.
175.DAL MASO L, FRANCESCHI S, POLESEL J, BRAGA C, PISELLI P, CROCETTI E, FALCINI F, GUZZINATI S, ZANETTI R, VERCELLI M, REZZA G; CANCER AND AIDS REGISTY LINKAGE STUDY. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003; 89: 94-100.
176.DAL MASO L, POLESEL J, ASCOLI V, ZAMBON P, BUDRONI M, FERRETTI S, TUMINO R, TAGLIABUE G, PATRIARCA S, FEDERICO M, VERCELLI M, GIACOMIN A, VICARIO G, BELLU F, FALCINI F, CROCETTI E, DE LISI V, VITARELLI S, PIFFER S, STRACCI F, SERRAINO D, REZZA G, FRANCESCHI S; CANCER AND AIDS REGISTRY LINKAGE STUDY. Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer 2005; 92: 188-93.
177.DAL MASO L, REZZA G, ZAMBON P, TAGLIABUE G, CROCETTI E, VERCELLI M, ZANETTI R, FALCINI F, TONINI G, MANGONE L, DE LISI V, FERRETTI S, TUMINO R, STANTA G, VITARELLI S, SERRAINO D, FRANCESCHI S. NonHodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer 2001; 93: 430-5.
178.DAL MASO L, ZANETTI R, ORENGO MA, TAGLIABUE G, GUZZINATI S, CAVALLIERI F, SERVENTI L, MANGONE L, FERRETTI S, MILANDRI C, PANNELLI F, BALZI D, TONINI G, GAFA' L, REZZA G, FRANCESCHI S. PER IL CANCER AIDS REGISTRY LINKAGE STUDY. Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy. Epidemiol Prev 2000; 24: 109-16.
AND
179.D'ALFONSO S, BARIZZONE N, GIORDANO M, CHIOCCHETTI A, MAGNANI C, CASTELLI L, INDELICATO M, GIACOPELLI F, MARCHINI M, SCORZA R, DANIELI MG, CAPPELLI M, MIGLIARESI S, BIGLIARDO B, SABBADINI MG, BALDISSERA E, GALEAZZI M, SEBASTIANI GD, MINISOLA G, RAVAZZOLO R, DIANZANI U, MOMIGLIANORICHIARDI P. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2005; 52: 539-47.
12
180.DAVICO L, SARCERDOTE C, CICCONE G, PEGORARO L, KERIM S, PONZIO G, VINEIS P. Chromosome 8, occupational exposures smoking and acute non-lymphocytic leukemias: a populationbased study. Cancer Epidemiol Biomarkers Prev 1998; 7: 1123-5.
181.DAVINI O, GARABELLO D, BERARDINO M, BERCHIO A, CICCONE G, LEOMBRUNI S, LUPARELLO V, MAO P, MASTROIANNI V, MOIRAGHI C. Evidence-based medicine and radiology: how to build a guideline. An attempt in minor head injury. Radiol Med 2002; 103: 319-31.
182.DEGIULI M, SASAKO M, CALGARO M, GARINO M, REBECCHI F, MINECCIA M, SCAGLIONE D, ANDREONE D, PONTI A, CALVO F. Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004; 30: 303-8.
183.DEGIULI M, SASAKO M, PONTI A, CALVO F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90: 1727-32.
184.DEGIULI M, SASAKO M, PONTI A, PONZETTO A, SOLDATI T, DANESE F, CALVO F. Morbidity and mortality
after D2 gastrectomy for gastric cancer: results of the italian gastric cancer study group prospective multicenter surgical study. J Clinical Onc 1998; 16: 1-6.
185.DEL PIANO M, BALLARE M, MONTINO F, TODESCO A, ORSELLO M, MAGNANI C, GARELLO E. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc 2005; 61: 421-6.
186.D'ERRICO A, MALATS N, VINEIS P, BOFFETTA P. Chapter 23. Review of studies of selected metabolic polymorphisms and cancer. IARC Sci Publ 1999; 148: 323-93.
187.D'ERRICO A, TAIOLI E, CHEN X, VINEIS P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1996; 1: 149-73.
188.DESIDERI A, FIORETTI PM, CORTIGIANI L, GREGORI D, COLETTA C, VIGNA C, TOTA F, RAMBALDI R, BAX J,
CELEGON L, BIGI R, PICANO E; COSTAMI (COST OF STRATEGIES AFTER MYOCARDIAL INFARCTION) TRIAL INVESTIGATORS. Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction. Eur Heart J 2003; 24: 1630-9.
189.DI LENARDA A, PINAMONTI B, MESTRONI L, SALVI A, SABBADINI G, GREGORI D, PERKAN A, ZECCHIN M, CARNIEL E, BUSSANI R, SILVESTRI F, MORGERA T, CAMERINI F, SINAGRA G; GRUPPO DI STUDIO SULLE MALATTIE MIOCARDIO. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste] Ital Heart J Suppl 2004; 5: 253-66.
DEL
190.DICKENSON D, VINEIS P. Evidence-based medicine and quality of care. Health Care Anal 2002; 10: 243-59.
191.DIKSHIT RP, BOFFETTA P, BOUCHARDY C, MERLETTI F, CROSIGNANI P, CUCHI T, ARDANAZ E, BRENNAN P. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 2005; [Epub ahead of print].
192.DISTANTE V, MANO MP, PONTI A, CATALIOTTI L, FILIPPINI L, GIORGI D, LAZZARETTI MG, MARCHESI C, PERFETTI E, SEGNAN N AND THE GISMA GROUP. Monitoring surgical treatment of screen-detected breast lesions in Italy. Eur J Cancer 2004; 40: 1006-12.
193.DISTANTE V, MANO MP, PONTI A, CATALIOTTI L, FILIPPINI L, GIORGI D, LAZZARETTI MG, MARCHESI C,
PERFETTI E, SEGNAN N. Monitoring surgical treatment of screen-detected breast lesions in Italy. Atti de "2nd European Breast Cancer Conference" Brussels 26-30 sett . 2000. Pubblicato su Eur J Cancer 2000; 36: S123 (abstract n° 396).
194.EKBOM A, RICHIARDI L, AKRE O, MONTGOMERY S, SPAREN P. Neither age at immigration nor duration of stay affects the risk of testicular cancer in Finnish immigrants in Seweden. J Natl Cancer Inst 2003; 95: 1238-40.
195.ENGEL LS, TAIOLI E, PFEIFFER R, GARCIA-CLOSAS M, MARCUS PM, LAN Q, BOFFETTA P, VINEIS P, AUTRUP H,
BELL DA, BRANCH RA, BROCKMOLLER J, DALY AK, HECKBERT SR, KALINA I, KANG D, KATOH T, LAFUENTE A, LIN HJ, ROMKES M, TAYLOR JA, ROTHMAN N. Pooled analysis and meta-analysis of glutathione Stransferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002; 156: 95-109.
13
196.ESTEVE A, SORLIE T, MARTEL-PLANCHE G, HOLLSTEIN M, KUSTERS I, LEWALTER J, VINEIS P, MONTESANO R. Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J Occup Environ Med 1995; 37: 59-68.
197.ESTEVE J, RIBOLI E, PEQUIGNOT G, TERRACINI B, MERLETTI F, CROSIGNANI P, ASCUNCE N, ZUBIRI L, BLANCHET F, RAYMOND L, REPETTO F, TUYNS AJ. Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in southwestern Europe. Cancer Causes Control 1996; 7: 240-52.
198.FABBRI S, PERFETTI E, COVONI D, BIANCHI S, BRANCATO B, PACI E AND GISMA WORKING GROUP (SEGNAN
N, GIORDANO L, PONTI A ET AL). Benign breast diseases in breast cancer screening programs in Italy (2000-2001). Tumori 2004; 90: 547-9.
199.FAGGIANO F, ZANETTI R, COSTA G. Cancer risk and social inequalities in Italy. J Epidemiol Community Health 1994; 48: 447-52.
200.FAGGIANO F, ZANETTI R, COSTA G. Le differenze sociali nell'incidenza dei tumori a Torino negli anni'80. L'Equita' nella Salute in Italia (a cura di G. Costa e F. Faggiano). 1994. 153-71.
201.FAGGIANO F, ZANETTI R, ROSSO S, COSTA G. Differenze sociali nell’incidenza, letalità e mortalità per tumori a Torino. Epidemiol Prev 1999; 23: 294-9.
202.FALCINI F, PACI E, LA ROSA P, MARANI E, DE LISI V, TONINI G, ZANETTI R, & GRUPPO AIRT. La rete italiana dei Registri Tumori. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
203.FALINI P, PACI E, DE LISI V, FALCINI F, FEDERICO M, FERRETTI S, PONTI A. Valutazione dell’impatto
dello screening mammografico: mortalità, stadiazione e uso di chirurgia conservativa. In: Rosselli del Turco M, Zappa M, eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Terzo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2004, Pag. 128131.
204.FERRANDO A, IVALDI C, BUTTIGLIERI A, PAGANO E, BONETTO C, ARIONE R, SCAGLIONE L, GELORMINO E, MERLETTI F, CICCONE G. Guidelines for preoperative assessment: impact on clinical practice and costs. Int J Qual Health Care 2005 Apr 14; [Epub ahead of print].
205.FERRARIS R, SENORE C, FRACCHIA M, SCIALLERO S, BONELLI L, ATKIN WS, SEGNAN N; SCORE WORKING
GROUP, ITALY. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population. Eur J Cancer 2004; 40: 245-52.
206.FERRETTI S, PATRIARCA S, ARTIOLI E, GIACOMIN A, GENTILINI M, BUDRONI M, & GRUPPO AIRT. Tecniche e problemi di registrazione. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
207.FILIPE JAN, MAULE M M. Effects of dispersal mechanisms on spatio-temporal development of epidemics. Journal of Theoretical Biology 2004; 226: 125-41.
208.FILIPE JAN, MAULE MM, GILLIGAN CA. On 'Analytical models for the patchy spread of plant disease'. Bull Math Biol 2004; 66: 1027-37.
209.FILIPE JAN, MAULE MM. Analytical methods for predicting the behaviour of population models with general spatial interactions. Mathematical Biosciences 2003; 183: 15-35.
210.FILIPE JAN, MAULE MM. Effects of dispersal mechanisms on spatio-temporal development of epidemics. Journal of Theoretical Biology 2004; 226: 125-41.
211.FONTANA A, PICOCO C, MASALA G, PRASTARO C, VINEIS P. Incidence rates of lymphomas and environmental measurements of phenoxy herbicides: ecological analysis and casecontrol study. Archiv Environ Health 1998; 53: 384-7.
14
212.FORASTIERE F, FRIGERIO A, RONCO G. [Financial law and tumor screening]. Epidemiol Prev 2001; 25: 2.
213.FORASTIERE F, PISTELLI R, SESTINI P, FORTES C, RENZONI E, RUSCONI F, DELL'ORCO V, CICCONE G, BISANTI L SIDRIA COLLABORATIVE GROUP, ITALY. Consumption of fresh fruit rich in vitamin C and wheezing symptoms in children. Thorax 2000; 55: 283-8.
AND THE
214.FORNENGO P, BRUNO A, GRASSI G, VINEIS P, PAGANO G. Concordance between American
Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care 1999; 22: 652-3.
215.FRANCESCHI S, DAL MASO L, ARNIANI S, CROSIGNANI P, VERCELLI M, SIMONATO L, FALCINI F, ZANETTI R,
BARCHIELLI A, SERRAINO D, REZZA G. Risk of cancer other than Kaposi’s sarcoma ad nonHodgkin’s lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 1998; 78: 966-70.
216.FRANCESCHI S, DAL MASO L, ARNIANI S, LO RE A, BARCHIELLI A, MILANDRI C, SIMONATO L, VERCELLI M, ZANETTI R, REZZA G. Linkage of AIDS and cancer registries in Italy. Int J Cancer 1998; 75: 83-4.
217.FRANCESCHI S, SEGNAN N. Valutazione dell'efficacia degli screening per i tumori dell'apparato digerente. Ann Ist Super Sanita' 1996; 32: 621-7.
218.FRANCO F, PAOLINELLI F, TERRACINI B, MAGNANI C. Studio Retrospettivo di coorte di mortalità tra i
dipendenti dell'ANIC -Rumianca di Carrara. Atti del Convegno "Aggiornamenti in tema di neoplasie di origine professionale". Siena, 19-21 Novembre 1991.
219.GABASSI PG, CERVAI S, ROZBOWSKY P, SEMERARO A, GREGORI D. Burnout syndrome in the helping professions. Psychol Rep 2002; 90: 309-14.
220.GALASSI C, BIGGERI A, CICCONE G, FORASTIERE F; SIDRIA PHASE 1 COLLABORATIVE GROUP. Environment and respiratory diseases in childhood: the Italian experience. Int J Occup Environ Health 2005; 11: 103-6.
221.GALASSI C, DE SARIO M. AND FORASTIERE F. (EDS). Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. SIDRIA-2 fase. Accepted for pubblication as Epid Prev Supplement, 2005.
222.GALLUS S, GIORDANO L, ALTIERI A, TALAMINI R, LA VECCHIA C. Cigarette smoking and risk of Hodgkin's disease. Eur J Cancer Prev 2004; 13: 143-4.
223.GANDOLFO S, RICHIARDI L, CARROZZO M, BROCCOLETTI R, CARBOME M, PAGANO M, VESTITA C, ROSSO S, MERLETTI F. Risk of oral squamous cell carcinoma with oral lichen planus: a follow-up study in an Italian population. Oral Oncology 2004; 40: 77-83.
224.GARTE S, BOFFETTA P, CAPORASO N, VINEIS P. Metabolic gene allele nomenclature. Cancer Epidemiol Biomarkers Prev 2001; 10: 1305-6.
225.GARTE S, GASPARI L, ALEXANDRIE AK, (VINEIS P) et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239-48.
226.GATTA G, BUIATTI E, CONTI E, DE LISI V FALCINI F, FEDERICO M, GAFÀ L, PONZ DE LEON M, VERCELLI M, ZANETTI R. Variation in the survival of adult cancer patients in Italy. Tumori 1997; 83: 497-504.
227.GATTA G, CORAZZIARI I, MAGNANI C, PERIS-BONET R, ROAZZI P, STILLER C AND THE EUROCARE WORKING GROUP.
Childhood Cancer Survival in Europe. Ann Oncol 2003; 14: v119-v127.
228.GEDDES M, FRANCESCHI S, BALZI D, ARNIANI S, GAFA’ L, ZANETTI R. Birthplace and classic Kaposi’s sarcoma in Italy. JNCI 1995; 87: 1015-7.
229.GEDDES M, FRANCESCHI S, BARCHIELLI A, FALCINI F, CARLI S, COCCONI G, CONTI E, CROSIGNANI P, GAFA' L,GIARELLI L, VERCELLI M, ZANETTI R. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994; 69: 333-6.
230.GELPI E, POSADA DE LA PAZ M, TERRACINI B, ABAITUA I, GOMEZ DE LA CAMARA A, KILBOURNE EM, LAHOZ
C, NEMERY B, PHILEN RM, SOLDEVILLA L, TARKOWSKI S. The Spanish Toxic Oil Syndrome 20 years
15
after its onset: a multidisciplinary review of scientific knowledge. Environ Health Perspect 2002; 110: 457-64.
231.GHISETTI V, FRANCESCHI S, SNIJDERS PFJ, GILLIO-TOS A, MARCHIARO G. MERLETTI F, SEGNAN N, RONCO G. Human Papilloma Virus testing in cervical cancer screening: results from a pilot experience in Italy. Proceedings XII Congress European Society of Clinical Microbiology Infectious Diseases. Milano 24-27 Apr 2002.
232.GIACHINO D,
VAN DUIST MM, REGAZZONI S, GREGORI D, BARDESSONO M, SALACONE P, SCAGLIONE N, SOSTEGNI R, SAPONE N, BRESSO F, SAMBATARO A, GAIA E, PERA A, ASTEGIANO M, DE MARCHI M. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 2004; 12: 206-12.
233.GION M, BARIOLI P, PONTI A, TORRI V, MIONE R, DITTADI R. How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitals. Tumour Biol 1998; 19: 269-74.
234.GION M, BARIOLI P, PONTI A, TORRI V, MIONE R, DITTADI R. How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals. Int J Biol Markers 1998; 13: 124-38.
235.GIORDANO L, CHARRIER L, COPPO A, D’ELIA P, DI STEFANO F, MOLINAR R, PICCINELLI C, SENORE C, SEGNAN N. Le attività di contrasto al fumo di tabacco nella Regione Piemonte. Quaderni CPO-Piemonte n°8, Torino gennaio 2005.
236.GIORDANO L, GIACCONE M. Il carcinoma ovarico: esistono i requisiti per una diagnosi
precoce? Atti del primo corso di aggiornamento su: Le neoplasie ovariche. Patologia e clinica. (pp. 19-25), Torino 1995.
237.GIORDANO L, GIORGI D, FASOLO G, SEGNAN N, ROSSELLI DEL TURCO M. Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMa). Tumori 1996; 82: 31-7.
238.GIORDANO L, GIORGI D, PICCINI P, SENORE C. Tend temporali di alcuni indicatori dei programmi
di screening mammografico in Italia. In: Rosselli del Turco M, Zappa M. eds, Osservatorio nazionale per la prevenzione dei tumori femminili. Primo rapporto. Lega Italiana per la Lotta contro i Tumori Roma, 2002. Pag. 22-31.
239.GIORDANO L, GIORGI D, PICCINI P, SENORE C. Trend temporali di alcuni indicatori dei
programmi di screening mammografico in Italia: 1996-2001. In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 24-35.
240.GIORDANO L, GIORGI D.
AND THE GISMA GROUP. Breast Cancer Screening: results of the italian programmes in the Italian Group for planning and evaluating breast cancer screening programmes (GISMa). XV International Scientific meeting of the International Epidemiological Association. Florence 146-4/9/1999.
241.GIORDANO L, ROWINSKI M, GAUDENZI G, SEGNAN N. What information do breast cancer screening programmes provide to Italian women? Eur J Public Health 2005; 15: 66-9.
242.GIORDANO L, SENORE C, PONTI A, SEGNAN N, VENTRIGLIA G. General Pratictioners' role in the Turin Screening Program "Prevenzione Serena". in: Pas L edt: General Practice and Cancer Prevention in Europe. The involvement of General Practitioners in cancer screening programs. The Hague, Mys & Breesch, 25-28, 1993.
243.GIORDANO L. Epidemiologia del carcinoma dell'endometrio. Possibilità di un intervento di
screening? Atti del corso di aggiornamento su 'Iperplasie e neoplasie dell'endometrio: patologia e clinica.’ p. 1-7. Torino, ottobre 1997.
244.GIORGI D, GIORDANO L, PACI E, ZAPPA M. Organizzazione e valutazione epidemiologica di un programma di screening mammografico. Attualità in Senologia Suppl N.1, 3-15, 1999.
245.GIORGI D, GIORDANO L, PICCINI P, PACI E, FRIGERIO A. Lo screening mammografico in Italia: dati
GISMa 2001. In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la
16
prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 14-23.
246.GIORGI D, GIORDANO L, SENORE C, MERLINO G, NEGRI R, CANCIAN M, LERDA M, SEGNAN N, ROSSELLI
DEL TURCO M. AND THE WORKING GROUP. General practitioners and mammographic screening uptake: influence of different modalities of GP participation. Tumori 2000; 86: 124-9.
247.GIWERCMAN A, RICHIARDI L, KAIJSER M, EKBOM A, AKRE O. Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: A population based case-control study. Int J Cancer 2005; [Epub ahead of print]
248.GOGLIANI F, CICCONE G, D'INCALCI T, RONCO G, TROIA B, VERNERO E, VINEIS P. Incidenti domestici
ed esposizione passiva a fumo di sigaretta: un'indagine sui bambini residenti nell'USL 25 (Rivoli). Epidemiol Prev 1993; 17: 223-7.
249.GOLDBERG M, KROMHOUT H, GUENEL P, FLETCHER AC, GERIN M, GLASS DC, HEEDERIK D, KAUPPINEN T, PONTI A. Job exposure matrices in industry. Int J Epidemiology 1993; 22,S2: 10-5.
250.GÓMEZ
DE LA CÁMARA A, POSADA DE LA PAZ M, ABAITUA BORDA I, BARAINCA OYAGÜE MT, ABRAIRA SANTOS V, RUIZ NAVARRO MD, TERRACINI B. Health status measurement in Toxic Oil Syndrome. J Clin Epidemiol 1998; 51: 867-73.
251.GOMEZ-LIRA M, LIGUORI M, MAGNANI C, BONAMINI D, SALVIATI A, LEONE M, ANDREOLI V, TROJANO M, VALENTINO P, SAVETTIERI G, QUATTRONE A, PIGNATTI PF, MOMIGLIANO-RICHIARDI P, GIORDANO M. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and metaanalysis) and new markers. J Neuroimmunol 2003; 140: 216-21.
252.GONTERO P, CASETTA G, ZITELLA A, BALLARIO R, PACCHIONI D, MAGNANI C, MUIR GH, TIZZANI A. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. Eur Urol 2000; 38: 287-96.
253.GONZALEZ CA, PERA G, AGUDO A, PALLI D, KROGH V, VINEIS P, TUMINO R, PANICO S, BERGLUND G,
SIMAN H, NYREN O, AGREN A, MARTINEZ C, DORRONSORO M, BARRICARTE A, TORMO MJ, QUIROS JR, ALLEN N, BINGHAM S, DAY N, MILLER A, NAGEL G, BOEING H, OVERVAD K, TJONNELAND A, BUENO-DEMESQUITA HB, BOSHUIZEN HC, PEETERS P, NUMANS M, CLAVEL-CHAPELON F, HELEN I, AGAPITOS E, LUND E, FAHEY M, SARACCI R, KAAKS R, RIBOLI E. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 2003; 107: 629-34.
254.GORMALLY E, HAINAUT P, CABOUX E, AIROLDI L, AUTRUP H, MALAVEILLE C, DUNNING A, GARTE S, MATULLO
G, OVERVAD K, TJONNELAND A, CLAVEL-CHAPELON F, BOFFETTA P, BOEING H, TRICHOPOULOU A, PALLI D, KROGH V, TUMINO R, PANICO S, BUENO-DE-MESQUITA HB, PEETERS PH, LUND E, GONZALEZ CA, MARTINEZ C, DORRONSORO M, BARRICARTE A, TORMO MJ, QUIROS JR, BERGLUND G, HALLMANS G, DAY NE, KEY TJ, VEGLIA F, PELUSO M, NORAT T, SARACCI R, KAAKS R, RIBOLI E, VINEIS P. Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer 2004; 111: 746-9.
255.GRAZZINI G, MANTELLINI P, CASTIGLIONE G, SENORE C. Lo screening per il carcinoma colorettale. Roma: 85-7; 1996. In: Lega Italiana per la Lotta contro i Tumori. Raccomandazioni per gli screening in Oncologia.
256.GRUPPO COLLABORATIVO SIDRIA (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C. MEMBERS OF THE GROUP). La frequenza dell'asma pediatrico in diverse aree italiane. Epidemiol Prev 1997; 21: 235-42.
257.GRUPPO COLLABORATIVO SIDRIA (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C. MEMBERS OF THE GROUP). La frequenza dei fattori di rischio per l'asma bronchiale in varie aree italiane. Epidemiol Prev 1997; 21: 243-51.
258.GRUPPO COLLABORATIVO SIDRIA (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C. MEMBERS OF THE GROUP). Abitudine al fumo di sigarette tra gli studenti di III media in diverse aree italiane. Epidemiol Prev 1998; 22: 155-64.
17
259.GRUPPO COLLABORATIVO SIDRIA (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C. MEMBERS OF THE GROUP). Impatto del fumo dei genitori su asma e sibili respiratori in bambini ed adolescenti. I risultati SIDRIA. Epidemiol Prev 1998; 22: 146-54.
260.GRUPPO COLLABORATIVO SIDRIA (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C. MEMBERS OF THE GROUP). Asthma and respiratory symptoms in 6-7 yr old Italian children: gender, latitude, urbanization and socioeconomic factors. Eur Respir J 1997; 10: 1780-6.
261.GRUPPO COLLABORATIVO SIDRIA (CICCONE G., DALMASSO P., FATUR VOLANTE T., MAGNANI C. MEMBERS
OF THE GROUP). Inquinamento da traffico e danni respiratori in bambini residenti in aree metropolitane. Epidemiol Prev 1998; 22: 242-7.
262.GRUPPO COLLABORATIVO SIDRIA. (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C.) Asma, disturbi respiratori e ambiente. Riv Ital Pediatr 1996; 22: 475-7.
263.GRUPPO COLLABORATIVO SIDRIA. (CICCONE G, DALMASSO P, FATUR VOLANTE T, MAGNANI C.) Studi Italiani sui Disturbi Respiratori nell’Infanzia e l’Ambiente. Epidemiol Prev 1995; 19: 76-8.
264.GRUPPO EBM-MOLINETTE. Valutazione del rischio e prevenzione delle complicanze cardiologiche perioperatorie (chirurgia non cardiaca).Ottobre 2004.
265.GUALA A, COZZI M, GUARINO R, CAMPRA D, PASTORE G. Back to sleep: a longitudinal report from an infant population based study in the Local Health Service 11, Piedmont, Italy. Minerva Pediatr 2005; 57(1): 52.
266.GUALA A, PAOLETTI R, PASTORE G, SINACCIO C, PAGANI L. Offering rubella vaccination to sexually active adolescents. Vaccine 2003; 21: 1561.
267.GUALA A, PASTORE G, GARIPOLI V, AGOSTI M, VITALI M, BONA G. The time of umbilical cord
separation in healthy full-term newborns: a controlled clinical trial of different cord care practices. Eur J Pediatr 2003; 162: 350-1.
268.GUENEL P, CYR D, SABROE S, LYNGE E, MERLETTI F, AHRENS W, BAUMGARDT-ELMS C, MENEGOZ F, OLSSON
H, PAULSEN S, SIMONATO L, WINGREN G. Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 2004; 15: 571-80.
269.GULINO G, ROSSO S, ZANETTI R. Melanoma cutaneo: effetto dei fattori prognostici clinici e
della classe sociale sulla sopravvivenza. Atti de "XXIII Réunion du Groupe pour l'Epidemiologie et l'Enregistrement du Cancer dans le Pays de Langue Latine" Funchal, 2122 maio 1998.
270.HAUPT R, VALSECCHI MG, SILVESTRI D, DE LORENZO P, NAPOLI S, MASERA G, TERRACINI B, JANKOVIC M. Early and late deaths after elective end of therapies for childhood cancer in Italy. Int J Cancer 2000; 86: 393-8.
271.IVALDI C, DALMASSO P, NESTI M, MAGNANI C. Il Registro dei Mesoteliomi maligni del Piemonte. Incidenza nel periodo 1990-1995. Epidemiol Prev 1999; 23: 308-15.
272.IVALDI C. Malattie genito-urinarie. In: Morgagni S, Valpreda M, Gnavi R, Costa G. eds, La salute in Piemonte 2000. Torino, Regione Piemonte, 2001. Pag. 265-76.
273.JACOBSON MF, SHARPE VA, ANGELL M, ASHFORD NA, BLUM A, CHARY LK, CHO M, COULL BC, DAVIS D,
DOOLITTLE RF, EGILMAN D, EPSTEIN SS, GREENBERG M, HOOPER K, HUFF J, JOSHI TK, KRIMSKY S, LADOU J, LEVENSTEIN C, MILES S, NEEDLEMAN H, PELLEGRINO ED, RAVANESI B, SASS J, SCHECTER A, SCHNEIDERMAN JS, SCHUBERT D, SOFFRITTI M, SUZUKI D, TAKARO TK, TEMPLE NJ, TERRACINI B, THOMPSON A, WALLINGA D, WING S. Editorial policies on financial disclosure. Nat Neurosci 2003; 6: 1001.
274.JANKOVIC M, FRASCHINI D, AMICI A, ARICÒ M, ARRIGHINI A, BASSO G, COLELLA R, DITULLIO MT, HAUPT
R, MACCHIA P, MAGRO S, MANCINI A, MANGANINI C, MELONI G, MINIERO R, ROSSO P, SARACCO P, TERRACINI B, MASERA G (AIEOP). Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. Eur J Cancer 1993; 29A: 1839-43.
18
275.JENAB M, FERRARI P, SLIMANI N, NORAT T, CASAGRANDE C, OVERAD K, OLSEN A, STRIPP C, TJONNELAND
A, BOUTRON-RUAULT MC, CLAVEL-CHAPELON F, KESSE E, NIETERS A, BERGMANN M, BOEING H, NASKA A, TRICHOPOULOU A, PALLI D, KROGH V, CELENTANO E, TUMINO R, SACERDOTE C, BUENO-DE-MESQUITA HB, OCKE MC, PEETERS PH, ENGESET D, QUIROS JR, GONZALEZ CA, MARTINEZ C, CHIRLAQUE MD, ARDANAZ E, DORRONSORO M, WALLSTROM P, PALMQVIST R, VAN GUELPEN B, BINGHAM S, SAN JOAQUIN MA, SARACCI R, KAAKS R, RIBOLI E. Association of nut and seed intake with colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2004; 13: 1595-603.
276.JORIS F, ROSSO S, ZANETTI R. Risk of basal and squamous cell carcinoma of the skin in Sion, Switzerland: a case-control study. Tumori 1999, 85: 435-442.
277.KAERLEV L, TEGLBJAERG PS, SABROE S, KOLSTAD HA, AHRENS W, ERIKSSON M, GUENEL P, HARDELL L, LAUNOY G, MERLER E, MERLETTI F, STANG A, OLSEN J. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multicenter case-control study. Cancer Causes Control 2000; 11: 791-7.
278.KAERLEV L, TEGLBJAERG PS, SABROE S, KOLSTAD HA, AHRENS W, ERIKSSON M, GONZALEZ AL, GUENEL P, HARDELL L, LAUNOY G, MERLER E, MERLETTI F, SUAREZ-VARELA MM, STANG A. Occupation and small bowel adenocarcinoma: a European case-control study. Occup Environ Med 2000; 57: 760-6.
279.KAERLEV L, TEGLBJAERG PS, SABROE S, KOLSTAD HA, AHRENS W, ERIKSSON M, GUENEL P, HARDELL L, LAUNOY G, MERLER E, MERLETTI F, STANG A. Medical risk factors for small-bowel adenocarcinoma with focus on Chron disease: a European population-based casecontrol study. Scand J Gastroenterol 2001; 36: 641-6.
280.KARAGAS MR, STUKEL TA, DYKES J, MIGLIONICO J, GREENE MA, CAREY M, ARMSTRONG B, ELWOOD JM, GALLAGHER RP, GREEN A, HOLLY EA, KIRKPATRICK CS, MACK T, OSTERLIND A, ROSSO S, SWERDLOW AJ. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer 2002; 86: 1085-92.
281.KAUPPINEN T, TOIKKANEN J, PEDERSEN D, YOUNG R, AHRENS W, BOFFETTA P, HANSEN J, KROMHOUT H,
MAQUEDA BLASCO J, MIRABELLI D, DE LA ORDEN-RIVERA V, PANNETT B, PLATO N, SAVELA A, VINCENT R, KOGEVINAS M. Occupational exposure to carcinogens in the European Union. Occup Environ Med 2000; 57: 10-8.
282.KEY TJ, ALLEN N, APPLEBY P, OVERVAD K, TJONNELAND A, MILLER A, BOEING H, KARALIS D, PSALTOPOULOU
T, BERRINO F, PALLI D, PANICO S, TUMINO R, VINEIS P, BUENO-DE-MESQUITA HB, KIEMENEY L, PEETERS PH, MARTINEZ C, DORRONSORO M, GONZALEZ CA, CHIRLAQUE MD, QUIROS JR, ARDANAZ E, BERGLUND G, EGEVAD L, HALLMANS G, STATTIN P, BINGHAM S, DAY N, GANN P, KAAKS R, FERRARI P, RIBOLI E; EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION (EPIC). Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004; 109: 119-24.
283.KRAMAROVA E, MANN JR, MAGNANI C, CORRAZIARI I, BERRINO F,
AND THE EUROCARE WORKING GROUP. Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe. Eur J Cancer 2001; 37: 750-9.
284.KREUZER M, BOFFETTA P, WHITLEY E, AHRENS W, GABORIEAU V, HEINRICH J, JÖCKEL KH, KREIENBROCK L, MALLONE S, MERLETTI F, ROESCH F, ZAMBON P, SIMONATO L. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000; 82: 227-33.
285.KURTZ JM, BARTELINK H, CATALIOTTI L, CUZICK J, DUNST J, EWERTZ M, FODOR J, FOURQUET A, GRECO M,
HAMMER J, JASSEM J, KUNKLER I, ORECCHIA R, PONTI A, ROMESTAING P, VAN LIMBERGEN E, YARNOLD J (EUSOMA WORKING PARTY). The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 2002 ; 38:1961-74.
286.LADETTO M, VALLET S, TROJAN A, DELL'AQUILA M, MONITILLO L, ROSATO R, SANTO L, DRANDI D, BERTOLA
A, FALCO P, CAVALLO F, RICCA I, DE MARCO F, MANTOAN B, BODE-LESNIEWSKA B, PAGLIANO G,
19
FRANCESE R, ROCCI A, ASTOLFI M, COMPAGNO M, MARIANI S, GODIO L, MARINO L, RUGGERI M, OMEDE P, PALUMBO A, BOCCADORO M. Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome. Blood 2005 Feb 24; [Epub ahead of print].
287.LAHMANN PH, HOFFMANN K, ALLEN N,
VAN GILS CH, KHAW KT, TEHARD B, BERRINO F, TJONNELAND A, BIGAARD J, OLSEN A, OVERVAD K, CLAVEL-CHAPELON F, NAGEL G, BOEING H, TRICHOPOULOS D, ECONOMOU G, BELLOS G, PALLI D, TUMINO R, PANICO S, SACERDOTE C, KROGH V, PEETERS PH, BUENO-DEMESQUITA HB, LUND E, ARDANAZ E, AMIANO P, PERA G, QUIROS JR, MARTINEZ C, TORMO MJ, WIRFALT E, BERGLUND G, HALLMANS G, KEY TJ, REEVES G, BINGHAM S, NORAT T, BIESSY C, KAAKS R, RIBOLI E. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111: 762-71.
288.LAURIOLA P, CISLAGHI C, BOTTI C, MAGNANI C, SATOLLI R, VINEIS P. Note preliminari per la definizione di alcune linee guida di etica in epidemiologia ambientale. Epidemiol Prev 1994; 18: 184-7.
289.LECLERC A, LUCE D, DEMERS PA, BOFFETTA P, KOGEVINAS M, BELLI S, BOLM-AUDORFF U, BRINTON LA, COLIN D, COMBA P, GÉRIN M, HARDELL L, HAYES RB, MAGNANI C, MERLER E, MORCET J-F, PRESTONMARTIN S, VAUGHAN TL, ZHENG W. Sinonasal cancer and occupation. Results from the reanalysis of twelve case-control studies. Am J Ind Med 1997; 31: 153-65.
290.LIBERATI A, VINEIS P. Introduction to the symposium: what evidence based medicine is and what it is not. J MED ETHICS 2004; 30: 120-1.
291.LUCE D, LECLERC A, BEGIN D, DEMERS PA, GERIN M, ORLOWSKI E, KOGEVINAS M, BELLI S, BUGEL I, BOLM-
AUDORFF U, BRINTON LA, COMBA P, HARDELL L, HAYES RB, MAGNANI C, MERLER E, PRESTON-MARTIN S, VAUGHAN TL, ZHENG W, BOFFETTA P. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 2002; 13: 147-57.
292.LYNGE E, AFONSO N, KAERLEV L, OLSEN J, SABROE S, AHRENS W, ERIKSSON M, GUENEL P, MERLETTI F, STENGREVICS A, SUAREZ-VARELA M, COSTA-PERERRA A, VYBERG M. European multi-centre casecontrol study on risk factors for rare cancers of unknown aetiology. Eur J Cancer . 2005; 41: 601-12.
293.MACFARLANE GJ, ZHENG T, MARSHALL JR, BOFFETTA P, NIU S, BRASURE J, MERLETTI F, BOYLE P. Alcohol,
tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Oral Oncol Eur J Cancer 1995; 31B: 181-7.
294.MAGGINO T, RONCO G, IOSSA A, SCARINCI M, NALDONI C, PILUTTI S, ZAPPA M. AND THE GISCI WORKING
GROUP ON ORGANISATION AND EVALUATION. Screening for cervical cancer in Italy. Atti de "Proceedings Eurogin 2000". Paris 5-9/4/2000.
295.MAGNANI C, AARELEID T, VISCOMI S, PASTORE G, BERRINO F,
AND THE EUROCARE WORKING GROUP. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. Eur J Cancer 2001; 37: 711-21.
296.MAGNANI C, AGUDO A, GONZALES CA, ANDRION A, CALLEJA A, CHELLINI E, DALMASSO P, ESCOLAR A, HERNANDEZ S, IVALDI C, MIRABELLI D, RAMIREZ J, TURUGUET D, USEL M, TERRACINI B. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 2000; 83: 104-11.
297.MAGNANI C, ANDRION A, BETTA PM, DONNA A, MOLLO F, SCELSI M, BOTTA M, TERRACINI B. Mesoteliomi ed esposizione ambientale ad amianto: epidemiologia e istopatologia. III Congresso Nazionale della FISAPEC. Pathologica 1993; 85: 144.
298.MAGNANI C, BELLIS D, BORGO G, BOTTA M, IVALDI C, MOLLO F, TERRACINI B. Incidence of mesothelioma among people environmentally exposed to asbestos. European Respiratory Review 1993; 3: 105-7.
299.MAGNANI C, CAPOCACCIA R, GATTA G, CORAZZIARI , KRAMAROVA E, PASTORE G, STILLER C, VISCOMI S. Childhood malignancies in the EUROCARE Study. The Data Base and the methods of survival analysis. Eur J Cancer 2001; 37: 678-86.
20
300.MAGNANI C, COMBA P, DI PAOLA M. Mesoteliomi pleurici nell'Oltrepò pavese: Mortalità, incidenza e correlazioni con un insediamento del cemento amianto. Med Lav 1994; 85: 157-60.
301.MAGNANI C, COMBA P, FERRARIS F, IVALDI C, MENEGHIN M, TERRACINI B. A case-control study of
carcinomas of the nose and paranasal sinuses in the woolen textile manufacturing industry. Arch Environ Health 1993; 48: 94-7.
302.MAGNANI C, DALMASSO P, BIGGERI A, IVALDI C, MIRABELLI D, TERRACINI B. Increased risk of
malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect 2001; 109: 915-9.
303.MAGNANI C, DALMASSO P, PASTORE G, TERRACINI B, MARTUZZI M, MOSSO ML, MERLETTI F. Increasing incidence of childhood leukemia in Northwest Italy, 1975-98. Int J Cancer 2003; 105: 552-7.
304.MAGNANI C, GATTA A, CORAZZIARI I, KRAMAROVA E, PASTORE G, VISCOMI S, STILLER C. Childhood
malignancies in the EUROCARE study: the database and the methods of survival analysis. Eur J Cancer 2001; 37: 678-86.
305.MAGNANI C, HAUPT R, ROMANENGO M. Ambiente e tumori infantili: i fattori di rischio accertati e quelli possibili. Prospettive in Pediatria 1997; 27: 129-40.
306.MAGNANI C, HAUPT R. Epidemiologia dei tumori infantili. Aggiornamenti di Fisiopatologia e Terapia in Pediatria 1998; 7: 31-43.
307.MAGNANI C, IVALDI C, BOTTA M, TERRACINI B. Pleural malignant mesothelioma and
environmental asbestos exposure in Casale Monferrato, Piedmont. Preliminary analysis of a case-control study. Med Lav 1997; 88: 302-9.
308.MAGNANI C, LEPORATI M. Mortality from lung cancer and population risk attributable to
asbestos in an asbestos cement manufacturing town in Italy. Occup Environ Med 1998; 55: 111-4.
309.MAGNANI C, MOLLO F, PAOLETTI L, BELLIS D, BERNARDI P, BETTA P, BOTTA M, FALCHI M, IVALDI C, PAVESI
M. Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study. Occup Environ Med 1998; 55: 840-6.
310.MAGNANI C, MOSSO ML, COLOMBO R, GIORDANO L, PASTORE G, ROSSO P, TERRACINI B. The Childhood Cancer Registry of Piedmont in: International Incidence of Childhood Cancer Vol. 2. IARC Publication, 1995.
311.MAGNANI C, MOSSO ML, PRASTARO C, TERRACINI B. Incidence and survival of intracranial
neoplasms of childhood: the experience of the Childhood Cancer Registry of Piedmont (RTI). Neuroepidemiology 1998; 17: 5.
312.MAGNANI C, PANNELLI F, GAFA’ L, PASTORE G, MOSCIATTI P, SCHILIRÒ G. I tumori infantili: dati dei
registri tumori infantili e dei registri tumori generali italiani. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
313.MAGNANI C, PANNELLI F, MOSCIATTI P, VISCOMI S, ROSSO S, SPITALE AB, PASTORE G. Analisi della
sopravvivenza per tumore infantile: i dati dai registri tumori italiani. Epidemiol Prev 2001; 25: 347-53.
314.MAGNANI C, PASTORE G,
AND THE ITACARE WORKING GROUP. Survival of childhood cancer patients in Italy, 1978-89. Tumori 1997; 83: 426-89.
315.MAGNANI C, PASTORE G, MOSSO ML, DALMASSO P, VISCOMI S, MERLETTI F, TERRACINI B. Frequenza e prognosi dei tumori infantili in Piemonte. Il Registro dei Tumori Infantili del Piemonte 196794. Quaderni CPO-Piemonte N. 4 . Torino 2001.
21
316.MAGNANI C, PAZÈ E, TERRACINI B, PASTORE G, MOSSO ML. Time trends in survival of children with acute lymphocytic leukemia in Piedmont, Italy: a report from the Population-Based Cancer Registry. Tumori 1995; 81: 164-8.
317.MAGNANI C, TERRACINI B, CORDERO DI MONTEZEMOLO L, GALLONE G, LUZZATTO L, MOSSO ML, PASTORE
G, ROSSO P. Incidence of second primary malignancies after a malignant tumor in childhood: a population-based survey in Piedmont (Italy). Int J Cancer 1996; 67: 6-10.
318.MAGNANI C, TERRACINI B, IVALDI C, BOTTA M, BUDEL P, MANCINI A, ZANETTI R. A cohort study on
mortality among wives of workers in the asbestos cement industry in Casale Monferrato, Italy. Br J Ind Med 1993; 50: 779-84.
319.MAGNANI C, TERRACINI B, IVALDI C, BOTTA M, MANCINI A, ANDRION A. Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy. Occup Environ Med 1995; 52: 362-7.
320.MAGNANI C, TERRACINI B, IVALDI C, MANCINI A, BOTTA M. Mortalità per tumori e altre cause tra i lavoratori del cemento-amianto a Casale Monferrato. Med Lav 1996; 87: 133-46.
321.MAGNANI C, VISCOMI S, DALMASSO P, IVALDI C, MIRABELLI D, TERRACINI B. Survival after pleural malignant mesothelioma: a population-based study in Italy. Tumori 2002; 88: 266-9.
322.MAGNANI C, ZANETTI R, SCHIAVO D, LEPORATI M, BOTTA M. Mortalità per tumore del polmone a Casale Monferrato e rischio attribuibile al lavoro nella produzione del cemento amianto. Epidemiol Prev 1995; 19: 338-41.
323.MAGNANI C. Pleural malignant mesothelioma and environmental exposure to asbestos
associated with asbestos cement production. The case of Casale Monferrato, Italy. The Can Mineral 2001; 5: 29-36.
324.MAGNANI C. Recenti indagini epidemiologiche sull'associazione tra campi elettromagnetici ELF e leucemie. Atti del Convegno Nazionale: Radiazioni non ionizzanti: effetti biologici, sanitari ed ambientali. Como 7-9 settembre 1994. Pag. 31-42.
325.MAGNANI C. Risk of childhood leukemia and environmental exposure to ELF electromagnetic fields. G Ital Med Lav Ergon 2003; 25: 373-5.
326.MALAVEILLE C, FIORINI L, BIANCHINI M, DAVICO L, BERTINETTI S, ALLEGRO G, HAUTEFEUILLE A, SACERDOTE C, VINEIS P. Randomized controlled trial of dietary intervention: association between level of urinary phenolics and anti-mutagenicity. Mutat Res 2004; 561: 83-90.
327.MALAVEILLE C, HAUTEFEUILLE A, PIGNATELLI B, TALASKA G, VINEIS P, BARTSCH H. Antimutagenic dietary phenolics as antigenotoxic substances in urothelium of smokers. Mutat Res 1998; 402: 21924.
328.MAMO C, MARINACCI C, DEMARIA M, MIRABELLI D, COSTA C. Factors other risks in the workplace as determinants of socioeconomic differences in health in Italy. Int J Occup Environ Health 2005 ; 11: 70-6.
329.MANCINI E, GIORDANO L, PONTI A, RONCO G, SENORE C, SEGNAN N. Screening dei tumori femminil.i In: Rapporto Osserva salute - Stato di salute e qualità dell'assistenza nelle regioni italiane. Vita e Pensiero, Roma 2004.
330.MANO MP, DISTANTE V, PONTI A, SEGNAN N, BORDON R, SIMONCINI R, CATALIOTTI L. Monitoraggio e Promozione della Qualità del Trattamento del carcinoma mammario nelle Unità di Senologia e nei programmi di screening in Italia. Attualità di Senologia 2001; supplemento 1.
331.MARCUS PM, HAYES RB, VINEIS P, GARCIA-CLOSAS M, CAPORASO NE, AUTRUP H, BRANCH RA, BROCKMOLLER J, ISHIZAKI T, KARAKAYA AE, LADERO JM, MOMMSEN S, OKKELS H, ROMKES M, ROOTS I, ROTHMAN N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000; 9: 461-7.
22
332.MARCUS PM, VINEIS P, ROTHMAN N. NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies Pharmacogenetics 2000; 10: 115-22.
conducted
in
the
general
population.
333.MARTIN-ARRIBAS MC, POSADA M, TERRACINI B, CARBALLO F, ABAITUA I. [Review of ethical aspects in biomedical research. The experience of the Ethics Committee of the Center for Toxic Oil Syndrome and Rare Diseases [CISATER]] Gac Sanit 2003; 17: 512-4.
334.MARTONE T, AIROLDI L, MAGAGNOTTI C, CODA R, RANDONE D, MALAVEILLE C, AVANZI G, MERLETTI F, HAUTEFEUILLE A, VINEIS P. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int J Cancer 1998; 75: 512-6.
335.MARTONE T, VINEIS P, MALAVEILLE C, TERRACINI B. Impact of polymorphisms in xeno(endo)biotic
metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 2000; 462: 303-9.
336.MARTUZZI M, MITIS F, BIGGERI A, TERRACINI B, BERTOLLINI R. [Environment and health status of the
population in areas with high risk of environmental crisis in Italy] Epidemiol Prev 2002; 26: suppl 1-53.
337.MASALA G, DI LOLLO S, PICOCO C, CROSIGNANI P, DEMICHELI V, FONTANA A, FUNTÒ I, MILIGI L, NANNI
O, PAPUCCI A, RAMAZZOTTI V, RODELLA S, STAGNARO E, TUMINO R, VIGANÒ C, VINDIGNI C, SENIORI COSTANTINI A, VINEIS P. Incidence rates of leukemias, lymphomas and myelomas in Italy: Geographic distribution and NHL histotypes. Int J Cancer 1996; 68: 156-9.
338.MASERA G, PESSION A, TERRACINI B. Childhood cancer mortality. Lancet 1996; 348. 473-4. 339.MATOS EL, LORIA DI, ZENGARINI N, FERNANDEZ MM, GUEVEL CG, MARCONI E, SPITALE A, ROSSO S. Atlas de mortalidad por Càncer: Argentina 1997-2001. Buenos Aires, 2003.
340.MATOS EL, VILENSKY M, MIRABELLI D, BOFFETTA P. Occupational exposures and lung cancer in Buenos Aires, Argentina. J Occup Environ Med 2000; 42: 653-9.
341.MATULLO G, BERWICK M, VINEIS P. Gene-environment interactions: how many false positives? J Natl Cancer Inst 2005; 97: 550-1.
342.MATULLO G, GUARRERA S, CARTURAN S, PELUSO M, MALAVEILLE C, DAVICO L, PIAZZA A, VINEIS P. DNA
repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001; 92: 562-7.
343.MATULLO G, PALLI D, PELUSO M, GUARRERA S, CARTURAN S, CELENTANO E, KROGH V, MUNNIA A, TUMINO
R, POLIDORO S, PIAZZA A, VINEIS P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22: 1437-45.
344.MATULLO G, PELUSO M, POLIDORO S, GUARRERA S, MUNNIA A, KROGH V, MASALA G, BERRINO F, PANICO
S, TUMINO R, VINEIS P, PALLI D. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003; 12: 674-7.
345.MAULE MM, & MIRABELLI D. Metodi bayesiani nell’analisi spaziale dei dati geografici. L’Osservatorio, 2004, pp 12-15.
346.MENCAGLIA E, ROSSO S, TAMBURINI M. TIQ. Therapy Impact Questionnaire. EdiSES, Napoli, 1993. 347.MERLER E, VINEIS P, ALHAIQUE D, MILIGI L. Occupational cancer in Italy. Environ Health Perspect 1999; 107: 259-71.
348.MERLER E, VINEIS P, MILIGI L. Occupational cancer in Italy. Epidemiol Prev 1998; 22: 12-25. 349.MERLETTI F, GELORMINO E, RICHIARDI L.
Medicina Palliativa e Cure Palliative: aspetti epidemiologici. In “Corso di Perfezionamento in Cure Palliative”. A cura di Vignotto F, De Luca A, Bertetto O, Ciuffreda L. Edizioni Scienza Medica, Torino, 2002. Pag. 37-49.
23
350.MERLETTI F, MIGLIARETTI G, CADUM E, CISLAGHI C, DAL CASON M, PISANI G. Atlante della Mortalità tumorale nelle Province di Novara e Verbano-Cusio-Ossola 1980-1991. Novara, Giugno 1999 (edito da AM grafica, Novara).
351.MERLETTI F, MIRABELLI D, RICHIARDI L. Occupational Epidemiology in “Hanbook of
Epidemiology”, Ahrens W, Pigeot I editors, Springer Berlin Heidelberg New York 2005, pp 917-49.
352.MERLETTI F, MIRABELLI D. Esposizioni occupazionali. In: AA.VV. "Strategie di prevenzione dei
tumori e prove di efficacia". Edito dalla Lega Italiana per la Lotta contro i Tumori, Roma, 2004. Vol. 1, 97-107.
353.MERLETTI F, MIRABELLI D. Intervention and Implementation Strategies and Activities for Occupational Exposures. UICC, Geneva 2004 (in corso di stampa). Il testo è in corso di pubblicazione anche in Italia (Lega Italiana per la lotta contro i Tumori).
354.MERLETTI F, MIRABELLI D. Les expositions professionnelles. In: AA.VV. "Prévention des cancers: Stratégies d’actions à l’usage des ONG européennes". UICC, Genéve, 2004. Vol. 1, 137149.
355.MERLETTI F, MIRABELLI D. Occupational exposures. In: AA.VV. "Evidence-based. Cancer Prevention: Strategies for NGOs". UICC, Geneva 2004. Vol. 1, 135-147.
356.MERLETTI F, RICHIARDI L, BOFFETTA P. Effetti per la salute del fumo passivo. Med Lav 1998; 89, 2: 149-63.
357.MERLETTI F, RICHIARDI L, BOFFETTA P. La proporzione di tumori polmonari attribuibili all'occupazione. Epidemiol Prev 1999; 23: 327-32.
358.MERLETTI F, SEGNAN N. I programmi di screening per i tumori. Medic 1997; 13: 40-3. 359.MERLETTI F, SOSKOLNE CL, VINEIS P. Epidemiological method applied to occupational health
and safety. In: “ILO Encyclopaedia of Occupational Health and Safety. Fourth Edition”. J.M. Stellman ed. International Labour Organization, Geneva, 1998, Vol. I. Pages 28.128.39.
360.MERLETTI F. Epidemiologia descrittiva e fattori di rischio per i tumori del colon retto. In: La Prevenzione del cancro. M Kreugli Ed. Lega Italiana per la lotta contro i tumori, Novara 1995 Pag. 12-22.
361.MERLETTI F. La grande obesità: epidemiologia, attesa di vita e incidenza di patologie associate. Minerva Gastroenterologica e Dietologica 1997; 43: 3-5.
362.MEZZA E, PICCOLI GB, PACITTI A, SORAGNA G, BERMOND F, BURDESE M, GAI M, MOTTA D, JEANTET A, MERLETTI F, VINEIS P, SEGOLONI GP; WORKING GROUP OF THE 5TH YEAR OF THE MEDICAL SCHOOL OF TORINO. EPO or not-EPO? An evidence based informed consent. Int J Artif Organs 2004; 27: 320-9.
363.MICHELETTI L, RONCO G, PRETI M, GHIRINGHELLO G, BARBERO M, BOCCI C, ZANOTTO-VALENTONO MC, MASSOBRIO M. Pronostic influence of metastatic patterns of groin lymph node positivity in squamous cell carcinoma of the vulva. Proceedings 1997 conference of the International society for the study of vulvovaginal disease.
364.MICHELI A, FRANCISCI S, KROGH V, GIORGIO ROSSI A, CROSIGNANI P,
AND THE ITAPREVAL WORKING GROUP. Cancer prevalence in italian cancer registry areas: the ITAPREVAL study. Tumori 1999; 85: 309-69.
365.MICHELI A, ZANETTI R. Incidenza e prevalenza dei tumori dell’apparato digerente: i dati dei registri tumori italiani. Ann Ist Super Sanità 1996; 32: 503-12.
366.MIGLIARETTI G, CADUM E, MIGLIORE E, CAVALLO F. Traffic air pollution and hospital admission for
asthma: a case-control approach in a Turin (Italy) population. Int Arch Occup Environ Health 2005; 78: 164-9.
24
367.MIGLIARETTI G, MAULE MM, BELLINI S, CASTELLA A, CHIÒ A, MIRABELLI D, MERLETTI F, CAVALLO F. Metodi bayesiani nello studio della mortalità per malattie del sistema nervoso centrale in Piemonte (1992-1997). Statistica Applicata 2004:16; 205-218.
368.MIGLIARETTI G, MAULE MM, BELLINI S, CASTELLA A, CHIÒ A, MIRABELLI D, MERLETTI F, CAVALLO F.
Mortalità per malattie del Sistema Nervoso Centrale in Piemonte nel periodo 1992-1997. Università degli studi di Torino, Dipartimento di Sanità Pubblica e Microbiologia. Torino 2004.
369.MIGLIORE E, BERTI G, CICCONE G. RISULTATI
DESCRITTIVI.
PROGETTO SIDRIA II TORINO. SCUOLE MEDIE.
APRILE 2003.
370.MILIGI L, COSTANTINI AS, BOLEJACK V, VERALDI A, BENVENUTI A, NANNI O, RAMAZZOTTI V, TUMINO R, STAGNARO E, RODELLA S, FONTANA A, VINDIGNI C, VINEIS P. Non-Hodgkin's lymphoma, leukemia, and exposures in agriculture: results from the Italian multicenter case-control study. Am J Ind Med 2003; 44: 627-36.
371.MILIGI L, SCARPELLI A, SENIORI-COSTANTINI A, ALBERGHINI-MALTONI S, ARFAIOLI C, BIANCHI A, GORI R, SOMMANI L, RONCO G. Comparison of methods of occupational exposure assessment in epidemiology: solvents in shoe and leather goods industries. Atti "Conference on retrospective assessment of occupational exposures in epidemiology". IARC Lyon 13-15 Apr. 1994. (Poster).
372.MILIGI L, SENIORI COSTANTINI A, CROSIGNANI P, FONTANA A, MASALA G, NANNI O, RAMAZZOTTI V,
RODELLA S, STAGNARO E, TUMINO R, VIGANO C, VINDIGNI C, VINEIS P. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 60-9.
373.MILIGI L, SETTIMI L, MASALA G, MAIOZZI P, ALBERGHINI MALTONI S, SENIORI COSTANTINI A, VINEIS P. Pesticide exposure assessment: a crop-exposure matrix. Int J Epidemiol 1993; 22: 42-5.
374.MILLER AB, ALTENBURG HP, BUENO-DE-MESQUITA B, BOSHUIZEN HC, AGUDO A, BERRINO F, GRAM IT,
JANSON L, LINSEISEN J, OVERVAD K, RASMUSON T, VINEIS P, LUKANOVA A, ALLEN N, AMIANO P, BARRICARTE A, BERGLUND G, BOEING H, CLAVEL-CHAPELON F, DAY NE, HALLMANS G, LUND E, MARTINEZ C, NAVARRO C, PALLI D, PANICO S, PEETERS PH, QUIROS JR, TJONNELAND A, TUMINO R, TRICHOPOULOU A, TRICHOPOULOS D, SLIMANI N, RIBOLI E. Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2004; 108: 269-76.
375.MINIERO R, SARACCO P, PASTORE G, ZURLO MG, TERRACINI B, ROSSO P, MASERA G. Relapse after first
cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology Oncology (AIEOP). Med Pediatr Oncol 1995; 24: 71-6.
376.MINOZZI S, SENORE C, CICCONE C, DE ANGELIS C. L’utilizzo dell’ecoendoscopia nella diagnosi e stadiazione dei tumori gastroenterici. Quaderni CPO-Piemonte n°10, Torino febbraio 2005.
377.MIRABELLI D, BENA A. et al. Sorveglianza epidemiologica sulla patologia professionale: un programma della regione Piemonte (PRiOR). Epidemiol Prev 1998; 22: 212-20.
378.MIRABELLI D, CADUM E. [Mortality among patients with pleural and peritoneal tumors in Alta Valle di Susa] Epidemiol Prev 2002; 26: 284-6.
379.MIRABELLI D, CHIUSOLO M, CALISTI R, MASSACESI S, RICHIARDI L, NESTI M, MERLETTI F. Database di
occupazioni ed attività industriali che comportano rischio di tumore del polmone. Epidemiol Prev 2001; 4-5: 215-21.
380.MIRABELLI D, MAGNANI C. Interaction between occupational and environmental exposure to asbestos. Epidemiologic survey. G Ital Med Lav Ergon 2003; 25: 402-4.
381.MIRABELLI D. [Carcinogens: destabilizing values] Epidemiol Prev 2000; 24: 52. 382.MIRABELLI D. Occupational exposures to carcinogens in Italy. Int J Occup Environ Health 2005 ; 11: 53-63.
25
383.MIRABELLI D. Quale sorveglianza sanitaria sui lavoratori? Epidemiol Prev 1993; 17: 187-90. 384.MIRABELLI D. Stima del numero di lavoratori esposti a cancerogeni in Italia, nel contesto dello studio europeo CAREX. Epidemiol Prev 1999; 23: 346-59.
385.MITIS F, MARTUZZI M, BIGGERI A, BERTOLLINI R, TERRACINI B. Industrial activities in sites at high environmental risk and their impact on the health of the population. Int J Occup Environ Health 2005; 11: 88-95.
386.MÖLLER TR, GARWICZ S, CORAZZIARI I, MAGNANI C. Survival of children with liver tumours in Europe 1978-1989. Eur J Cancer 2001; 37: 744-9.
387.MOLLO F, BELLIS D, MAGNANI C, DELSEDIME L, ANDRION A. Hyaline splenic and hepatic plaques. Correlation with cirrhosis, pulmonary tuberculosis, and asbestos exposure. Arch Pathol Lab Med 1993; 117: 1017-21.
388.MOLLO F, MAGNANI C, BO P, BURLO P, CRAVELLO M. The attribution of lung cancers to asbestos exposure: a pathologic study of 924 unselected cases. Am J Clin Pathol 2002; 117: 90-5.
389.MONGINI F, CICCONE G, DEREGIBUS A, FERRERO L, MONGINI T. Muscle tenderness in different headache types and its relation to anxiety and depression. Pain 2004; 112: 59-64.
390.MONGINI F, CICCONE G, IBERTIS F, NEGRO C. Personality characteristics and accompanying symptoms in temporomandibular joint dysfunction, headache, and facial pain. J Orofac Pain 2000; 14: 52-8.
391. MONTANARI G, BERARDENGO E, BRANCA M, CONFORTINI M, PARISIO F, RONCO G, SEGNAN N, VOLANTE R.: Quality control in cervicalvaginal cytology. An Italian experience. Proceedings 10th Conference International Federation of Colposcopy and Cervical Pathology. Buenos Aires Nov. 1999.
392.MONTANARI G, CONFORTINI M, BELLOMI A, COCCHI V, DALLA PALMA P, D'AMBROSIO E, GIOVAGNOLI
MR, NAVONE R, RONCO G; ITALIAN GROUP FOR CERVICAL CANCER SCREENING. Assessment of specimen adequacy reproducibility: an Italian experience. Diagn Cytopathol 2003; 28: 224-6.
393.MONTANARI G, RONCO G, CONFORTINI M, PARISIO F, BERARDENGO E, CRISTINA MV, ARNAUD S., CAMPIONE D, BALDINI D, MANCINI E, SEGNAN N. The effect on agreement of discussing cervical smears that were differently classified. Atti de "27th European Congress of cytology" Lillehammer 16-19 Sept 2000 Pubblicato su Cytopathology 2000; 11: 363-467 (abstract no 83).
394.MONTANARI G, RONCO G. Qual'e' lo stato dell'arte dello screening per la neoplasia cervicale uterina in Italia? Atti Convegno 1997 Societa' italiana Colposcopia e patologia cervicovaginale.
395.MORALES MM, OLSEN J, JOHANSEN P, KAERLEV L, GUENEL P, ARVEUX P, WINGREN G, HARDELL L, AHRENS
W, STANG A, LLOPIS A, MERLETTI F, VILLANUEVA MA. Viral infection, atopy and mycosis fungoides. A European multicentre case-control study. Eur J Cancer 2002; 39: 511-6.
396.MORALES MM, OLSEN J, JOHANSEN P, KAERLEV L, GUENEL P, ARVEUX P, WINGREN G, HARDELL L, AHRENS
W, STANG A, LLOPIS A, MERLETTI F, VILLANUEVA MA. Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. Eur J Cancer 2003; 39: 511-6.
397.MORALES SUAREZ-VARELA MM, OLSEN J, KAERLEV L, GUENEL P, ARVEUX P, WINGREN G, HARDELL L, AHRENS W, STANG A, LLOPIS-GONZALES A, MERLETTI F, GUILLEN-GRIMA F, JOHANSEN P. Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre casecontrol study. Eur J Cancer 2001; 37: 392-7.
398.MORALES-SUAREZ-VARELA MM, OLSEN J, JOHANSEN P, KAERLEV L, GUENEL P, ARVEUX P, WINGREN G, HARDELL L, AHRENS W, STANG A, LLOPIS A, MERLETTI F, AURREKOETXEA JJ, MASALA G. Occupational risk factors for mycosis fungoides: a European multicenter case-control study. J Occup Environ Med 2004; 46: 205-11.
26
399.MORTON LM, HARTGE P, HOLFORD TR, HOLLY EA, CHIU BC, VINEIS P, STAGNARO E, WILLETT EV,
FRANCESCHI S, LA VECCHIA C, HUGHES AM, COZEN W, DAVIS S, SEVERSON RK, BERNSTEIN L, MAYNE ST, DEE FR, CERHAN JR, ZHENG T. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925-33.
400.MOSSO ML, MAGNANI C, PASTORE G, TERRACINI B. Mortality of parents of children with cancer: a population-based study in Turin, Italy. Tumori 1999; 85: 443-8.
401.MOSSO ML, PASTORE G, CORDERO L, MAGNANI C, et al. Registro tumori infantili Regione Piemonte (RTI-Piemonte). Qualità di vita in pazienti lungosopravvissuti dopo diagnosi di tumore maligno in età pediatrica. Riv Ital Pediatr 1998; 24: 184.
402.MOSSO ML, PASTORE G, MAGNANI C, MADON E, BARISONE E, RICARDI U, TERRACINI B. Stato di salute
e inserimento sociale delle persone sopravvissute ad un tumore maligno diagnosticato in età pediatrica: uno studio del Registro Tumori Infantili del Piemonte. Riv Ital Pediatr 2000; 26: 813-20.
403.MUCCI N, TERRACINI B, CAMONI I. Evaluation of carcinogenicity of chemicals and productive
processes effected by the National Advisory Toxicological Committee. Med Lav 1998; 89: 78-83.
404.NOVARA R, CODA R, MARTONE T, VINEIS P. Exposure to aromatic amines and ras c-erbB-2 overexpression in bladder cancer. J Occup Environ Med 1996; 38: 390-3.
405.PACCHIONI D, MARTONE T, GHISOLFI G, BUSSOLATI G, TIZZANI A, CASETTA G, VINEIS P. Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer. Carcinogenesis 1997; 18: 165961.
406.PACI E, GIORGI D, GIORDANO L, KROGH V, SASSOLI P. Programmi di screening mammografico in Emilia Romagna, Piemonte e Toscana. Attualità in Senologia 1999; 24: 51-52.
407.PACI E, SEGNAN N. Salute della donna e Screening in Oncologia. Epidemiol Prev 1996; 20: 143-5.
408.PAGANO E, CICCONE G, GALASSI C, SEGNAN N, MERLETTI F,
E GRUPPO DI LAVORO RELAZIONE
EPIDEMIOLOGICA.
Relazione sanitaria sull’oncologia in Piemonte: aspetti epidemiologici. Torino, CPO-Piemonte, Regione Piemonte, Rete Oncologica, marzo 2005.
409.PAGANO E, CICCONE G, IACOMUSSI S, DIRINDIN N. La mobilità per motivi sanitari: criticità di
sistema o falso problema? In: Cooperazione e competizione nel servizio sanitario. A cura di: N. Dirindin. Il Mulino,Bologna. 2003.
410.PAGANO E, CICCONE G.
E GRUPPO DI LAVORO RELAZIONE EPIDEMIOLOGICA. Relazione sanitaria sull’oncologia in Piemonte: aspetti epidemiologici. Torino, CPO-Piemonte, Regione Piemonte, Rete Oncologica, novembre 2003.
411.PAGANO E, GUERRUCCI D. La formazione del conto economico consolidato delle Asl e delle aziende ospedaliere. Politiche Sanitarie 2001; 2: 57-67.
412.PAGANO E, PONTI A, GELORMINO E, MERLETTI F, MANO MP. An economic evaluation of the optimal workload in treating surgical patients in a breast unit. Eur J Cancer 2003; 39: 74854.
413.PAGANO E. Come è difficile trasformare le conoscenze scientifiche in azione politica. Epidemiol Prev 2004; 28: 2.
414.PALA V, BERRINO F, VINEIS P, PALLI D, CELENTANO E, TUMINO R, KROGH V. How vegetables are eaten in Italy EPIC centres: still setting a good example? IARC Sci Publ 2002; 156: 119-21.
415.PALLI D, KROGH V, RUSSO A, BERRINO F, PANICO S, TUMINO R, VINEIS P. EPIC-Italy. A molecular epidemiology project on diet and cancer. AdvExpMedBiol 1999; 472: 21-8.
27
416.PALLI D, MASALA G, PELUSO M, GASPARI L, KROGH V, MUNNIA A, PANICO S, SAIEVA C, TUMINO R, VINEIS P, GARTE S. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Carcinogenesis 2004; 25: 577-84.
417.PALLI D, MASALA G, VINEIS P, GARTE S, SAIEVA C, KROGH V, PANICO S, TUMINO R, MUNNIA A, RIBOLI E, PELUSO M. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults. Carcinogenesis 2003; 24: 739-46.
418.PALLI D, VINEIS P, RUSSO A, BERRINO F, KROGH V, MASALA G, MUNNIA A, PANICO S, TAIOLI E, TUMINO R, GARTE S, PELUSO M. Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy crosssectional study. Int J Cancer 2000; 87: 444-51.
419.PALUMBO A, BERTOLA A, FALCO P, ROSATO R, CAVALLO F, GIACCONE L, BRINGHEN S, MUSTO P, PREGNO
P, CARAVITA T, CICCONE G, BOCCADORO M. Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma. Hematol J 2004; 5: 318-24.
420.PALUMBO A, BRINGHEN S, PETRUCCI MT, MUSTO P, ROSSINI F, NUNZI M, LAUTA VM, BERGONZI C, BARBUI A, CARAVITA T, CAPALDI A, PREGNO P, GUGLIELMELLI T, GRASSO M, CALLEA V, BERTOLA A, CAVALLO F, FALCO P, RUS C, MASSAIA M, MANDELLI F, CARELLA AM, POGLIANI E, LIBERATI AM, DAMMACCO F, CICCONE G, BOCCADORO M. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 2004; 104: 3052-7.
421.PANICO S, CELENTANO E, GALASSO R, MATTIELLO A, MASALA G, PALLI D, SACERDOTE C, VINEIS P, TUMINO
R, SIERI S, BERRINO F, KROGH V. Dietary pattern and ischemic heart disease incidence in a female population of a Mediterranean Country: findings from the EPIC Italy collaboration. Circulation 2003; 108: 737.
422.PANNELLI F, MOSCIATTI P, FELICI L, MAGNANI C, PASCUCCI C, PASTORE G. Andamento nel tempo della sopravvivenza per tumori infantili in Italia nel periodo 1978-1994: primo rapporto dai registri italiani. Epidemiolo Prev 2001; 25: 354-75.
423.PARKIN DM (IARC, LYON); CLAYTON D (MRC BIOSTATITICS UNIT, CAMBRIDGE); BLACK RJ, MASUYER E
(IARC, LYON); FRIEDL HP (AUSTRIA); IVANOV E (BELARUS); SINNAEVE J (EC, BRUSSELS); TZVETANSKY CG (BULGARIA); GERYK E (CZECH REPUBLIC); STORM HH (DENMARK); RAHU M(ESTONIA); PUKKALA E (FINLAND); BERNARD JL, CARLI PM, L'HUILLIER MC, MENEGOZ F, SCHAFFER P, SCHRAUB S (FRANCE); KAATSCH P, MICHAELIS J (GERMANY); APJOK E, SCHULER D (HUNGARY); CROSIGNANI P, MAGNANI C, TERRACINI B (ITALY); STENGREVICS A (LATVIA); KRIAUCIUNAS R (LITHUANIA); COEBERGH JW (NETHERLANDS); LANGMARK F (NORWAY); ZATONSKI W (POLAND); TULBURE R (ROMANIA); BOUKHNY A, MERABISHVILI V (RUSSIAN FEDERATION); PLESKO I, KRAMAROVA E (SLOVAKIA); POMPE-KIRN V (SLOVENIA); BARLOW L (SWEDEN); ENDERLIN F, LEVI F, RAYMOND L, SCHULER G, TORHORST J (SWITZERLAND); STILLER CA, SHARP L (UNITED KINGDOM); BENNETT BG (UNSCEAR, VIENNA) Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer 1996; 73: 1006-12.
424.PARKIN DM, CARDIS E, MASUYER E (IARC); FRIEDL HP, HANSLUWKA H (AUSTRIA); BOBEV D (BULGARIA);
IVANOV E (BELARUS); SINNAEVE J (CEC, BRUSSELS); AUGUSTIN J, PLESKO I (CZECHOSLOVAKIA); STORM HH. (DENMARK); RAHU M (ESTONIA); KARJALAINEN S (FINLAND); BERNARD JL, CARLI PM, L'HUILLIER MC, LUTZ JM, SCHAFFER P, SCHRAUB S (FRANCE); MICHAELIS J, MÖHNER M STANECZEK W (GERMANY); VARGHA M (HUNGARY); CROSIGNANI P MAGNANI C, TERRACINI B (ITALY); KRIAUCIUNAS R (LITHUANIA); COEBERGH JW (NETHERLANDS); LANGMARK F (NORWAY); ZATONSKI W (POLAND); MERABISHVILI V (RUSSIAN FEDERATION); POMPE-KIRN V (SLOVENIA); BARLOW L (SWEDEN); RAYMOND L (SWITZERLAND); BLACK R, STILLER CA (UNITED KINGDOM); BENNETT BG (UNSCEAR, VIENNA) Childhood leukaemia following the Chernobyl accident: the European childhood leukaemia-lymphoma incidence study (ECLIS). Eur J Cancer 1993; 29A: 87-95.
425.PARKIN DM, WHELAN SL, FERLAY J, RAYMOND L, YOUNG J. eds.: Cancer incidence in five continents. Vol. VII. IARC Scientific Publications N. 143. Lyon, 1997.
426.PASCHE B, KOLACHANA P, NAFA K, SATAGOPAN J, CHEN YG, LO R.S, BRENER D, YANG D, KIRSTEIN L, ODDOUX C, OSTRER H, VINEIS P, VARESCO L, JHANWAR S, LUZZATTO L, MASSAGUE J, OFFIT K. TbetaRI(6A) is a candidate tumor susceptibility allele. Cancer Res 1999; 59: 5678-82.
28
427.PASSARINO G, BURLO P, CICCONE G, COMINO A, CRAVELLO M, IANNICELLI P, MOLLO F. Prevalence of myocarditis at autopsy in Turin, Italy. Arch Pathol Lab Med 1997; 121: 619-22.
428.PASTORE G, GUALA A, ZAFFARONI M. Back to sleep: risk factors for SIDS as targets for public health campaigns. J Pediatr 2003; 142: 453-4.
429.PASTORE G, MAGNANI C, MOSSO ML, VISCOMI S, TERRACINI B, MERLETTI F. Marriage and offspring in
adult long-term survivors of childhood cancer: a study from the childhood cancer registry of the Piedmont region (Italy). Ital J Pediatr 2002; 28: 121-7.
430.PASTORE G, MAGNANI C, VERDECCHIA A, PESSION A, VISCOMI S, COEBERGH JWW, AND THE EUROCARE
WORKING GROUP. Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study. Eur J Cancer 2001; 37: 703-10.
431.PASTORE G, MOSSO ML, CARNEVALE F, CORDERO DI MONTEZEMOLO L, FORNI M, MADON E, RICARDI U, TERRACINI B, MAGNANI C. Survival trends of childhood cancer diagnosed during 1970-94 in Piedmont, Italy: a report from the childhood cancer registry. Med Pediatr Oncol 2001; 36: 481-8.
432.PASTORE G, MOSSO ML, CORDERO
DI MONTEZEMOLO L, MADON E, TERRACINI B, MAGNANI C. Variazione della sopravvivenza dei bambini affetti da tumore maligno in Piemonte 197094: uno studio del Registro dei Tumori Infantili del Piemonte. Riv Ital Pediatr 2001; 27: 337-44.
433.PASTORE G, MOSSO ML, DALMASSO P, MAGNANI C. Il Registro dei Tumori Infantili del Piemonte.
Epidemiologia descrittiva dei tumori maligni in età pediatrica in Piemonte, 1967-1994. Epidemiol Prev 1999; 23: 360-8.
434.PASTORE G, MOSSO ML, MAGNANI C, LUZZATTO L, BIANCHI M, TERRACINI B. Physical impairment and
social life among adult long term survivors of childhood cancer: a population-based study from the Childhood Cancer Registry of Piedmont-Italy. Tumori 2001; 87: 372-8.
435.PASTORE G, MOSSO ML, MAGNANI C, MADON E, BARISONE E, TERRACINI B. Stato di salute ed
inserimento sociale delle persone sopravvissute ad un tumore maligno diagnosticato in età pediatrica. Uno studio del Registro dei Tumori Infantili del Piemonte. Riv Ital Ped 2000; 26: 813-20.
436.PASTORE G, VISCOMI S, GEROV GL, TERRACINI B, MADON E, MAGNANI C. Population-based survival
after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998-a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Cancer 2003; 39: 952-60.
437.PASTORE G, VISCOMI S, MOSSO, ML, MAULE MM, TERRACINI B, MAGNANI C, MERLETTI F. Early deaths
from childhood cancer. A report from the Childhood Cancer Registry of Piedmont, Italy, 1967-98. Eur J Pediatr 2004; 163: 313-9.
438.PATRIARCA S, GAFA’ L, FERRETTI S, VITARELLI S, CESARACCIO R, CROCETTI E, FERRANTE MC, ROLLO P, TAGLIABUE G. Coding criteria of bladder cancer: effects on estimating survival. Epidemiol Prev 2001; 25: 42-7.
439.PELUSO M, AIROLDI L, ARMELLE M, MARTONE T, CODA R, MALAVEILLE C, GIACOMELLI G, TERRONE C, CASETTA G, VINEIS P. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study. Cancer Epidemiology Biomarkers and Prevention 1998; 7: 341-6.
440.PELUSO M, AIROLDI L, MAGAGNOTTI C, FIORINI L, MUNNIA A, HAUTEFEUILLE A, MALAVEILLE C, VINEIS P.
White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis 2000; 21: 183-7.
441.PELUSO M, VINEIS P. “Mediterranean diet” and DNA adducts. Eur J Cancer Prevention 2000; 9: 71-2.
442.PENNA A, LABATE C, D’ALFONSO A, BALLINI L, NANTE N, CICCONE G. Utilità e limiti delle linee guida: il progetto TRiPSS2 in quattro ospedali del Piemonte. QA 2004; 15: 190-201.
29
443.PENNANZIO M, SENORE C, FERRARIS R, ARRIGONI A, BERTONE A, COPPOLA F, FRACCHIA M, GEMME C, SPANDRE M, PERA A, ROSSINI FP, SEGNAN N. Association of duration of the test with yield and miss rate of polyps at screening sigmoidoscopy Gastrointestinal Endoscopy 2000; 51: A6871.
444.PENNAZIO M, SENORE C, SCIALLERO S, ASTE H, COPPOLA F, ARRIGONI A, GEMME C, SEGNAN N. Predictive value of the characteristcs of distal adenomas for advanced proximal lesions. Gastrointestinal Endoscopy 1999; 49: AB67.
445.PERA A, SENORE C, DIPLACIDO R,
FERRARI A, FERRARIS R, RECCHIA S, REPICI A, RIZZETTO M, ROSSINI FP, SPANDRE M, TURCO D, SEGNAN N. Comparing yield of FOBT and FS in a screening population. Gastrointestinal Endoscopy 2002; 55: AB218.
446.PEREA-MILLA LOPEZ E, MINARRO-DEL MORAL RM, MARTINEZ-GARCIA C, ZANETTI R, ROSSO S, SERRANO S, ANEIROS JF, JIMENEZ-PUENTE A, REDONDO M. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer 2003; 88: 1702-7.
447.PESSION A, RONDELLI R, HAUPT R, MAGNANI C, PASTORE G, TERRACINI B, DE ROSA M, RAGO S, PAOLUCCI
G. Sistema di rilevazione dei casi di tumore maligno in età pediatrica in Italia su base ospedaliera. Riv Ital Pediatr 2000; 26: 333-41.
448.PESSION A, RONDELLI R, PAOLUCCI P, PASTORE G, DINI G, BONETTI F, MADON E, MANDELLI F, ZANESCO L, UDERZO C, PRETE A, RABUSIN M, UGAZIO A, DI BARTOLOMEO P, FAVRE C, BOJDFAULKNER L, POGGI V, LUKSCH R, DONFRANCESCO A, ARGIOLU F, LA NASA G, AMICI A, LOCATELLI F. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Haematologica 2000; 85: 638-46.
449.PETRELLI G, SIEPI G, MILIGI L, VINEIS P. Solvents in Pesticides. Scand J Work Environ Health 1993; 19: 63-5.
450.PETTERSSON A, KAIJSER M, RICHIARDI L, ASKLING J, EKBOM A, AKRE O. Women smoking and testicular cancer: one epidemic causing another? Int J Cancer 2004; 109: 941-4.
451.PINAMONTI B, PERKAN A, DI LENARDA A, GREGORI D, SINAGRA G. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail 2002; 4: 49-61.
452.POHLABELN H, BOFFETTA P., AHRENS W, MERLETTI F, AGUDO A, BENHAMOU E, BENHAMOU S, BRÜSKE-
HOHLFELD I, FERRO G, FORTES C, KREUZER M, MENDES A, NYBERG F, PERSHAGEN G, SARACCI R, SCHMID G, SIEMIATYCKI J, SIMONATO L, WHITLEY E, WICHMANN H-E, WINCK C, ZAMBON P, JÖCKEL K-H. Occupational risks for lung cancer among nonsmokers. Epidemiology 2000; 11: 532-8.
453.PONTI A, BOSIA S, SEGNAN N, RONCO G, PICCIONI P, LUCCOLI L, DE COCK J, PAVAN I, PIRA E, CIGNETTI
A, GREMO F, NOVELLO V, PERUCCA M, RENOSIO G, RONCO C, ROSEO P, SCAPIN I. Comparison of methods of occupational exposure assessment in epidemiology: Pesticides in winegrowing. Atti "Conference on retrospective assessment of occupational exposures in epidemiology". IARC Lyon 13-15 Apr. 1994. (Poster).
454.PONTI A, DALMASSO M, DELMASTRO G, MANO MP, BORDON R, CATALIOTTI L, COLUCCIA C, DISTANTE V, FALLI F, SCHNAPPER G, SIMONCINI R, TOMATIS A, SEGNAN N. SQTM 2.2: Scheda computerizzata per il monitoraggio della Qualità del Trattamento del carcinoma Mammario. Manuale d’uso. Dossier CPO n. 13, Torino luglio 1998.
455.PONTI A, DALMASSO M, DELMASTRO G, MANO MP, BORDON R, CATALIOTTI L, COLUCCIA C, DISTANTE V, FALLI F, SCHNAPPER G, SIMONCINI R, TOMATIS A, SEGNAN N. QT 2.3: Audit System on Quality of Breast Cancer Treatment. User’s Manual. Dossier CPO n. 14, Torino, ottobre 1998.
456.PONTI A, DALMASSO M, DELMASTRO G, MANO MP, BORDON R, CATALIOTTI L, COLUCCIA C, DISTANTE V, FALLI F, SCHNAPPER G, SIMONCINI R, TOMATIS A, SEGNAN N. SQTM 2.3: Scheda computerizzata per il monitoraggio della Qualità del Trattamento del carcinoma Mammario. Manuale d’uso. Dossier CPO n. 15, Torino, ottobre 1998.
30
457.PONTI A, DISTANTE V, MANO MP, BLAMEY RW, CODD M, GIORGI D, GOREY T, LINOS DA, SAINSBURY JRC, SEGNAN N. AND THE EAC PROJECT WORKING GROUP. Monitoring surgical treatment of screendetected breast lesions in four European countries. Atti de "2nd European Breast Cancer Conference" Brussels 26-30 sett . 2000. Pubblicato su European Journal of Cancer 2000; 36: S123 (abstract n° 395).
458.PONTI A, DISTANTE V, MANO MP, CATALIOTTI L. Qualità del trattamento chirurgico nello screening. Attualità in Senologia 2001; 31: 13-5.
459.PONTI A, FAGGIANO F. La distribuzione sociale dei fattori di rischio di malattia: il caso del fumo di tabacco. Equita' nella salute in Italia (a cura di G. Costa e F. Faggiano). 1994. 18198.
460.PONTI A, GIORDANO L. Lo "screening genetico" per il cancro della mammella. Epidemiol Prev 1999; 23: 369-71.
461.PONTI A, MANO MP, DISTANTE V, BORDON R, CATALIOTTI L, NALDONI C, TAFFURELLI M, SEGNAN N. Il
progetto SQTM sulla qualità della diagnosi e della terapia entro i programmi di screening: risultati degli indicatori chirurgici (anno 2002). In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 54-61.
462.PONTI A, MANO MP, COLUCCIA C, GIANI R, SCHNAPPER G, FRIGERIO A, SEGNAN N. Quality of
treatment of screen-detected breast cancer cases. XXème Rèunion du Groupe pour l’Epidémiologie et l’Enregistrement des Cancers dans les pays de langue latine. Lyon 25 et 26 mai 1995.
463.PONTI A, MANO MP, DISTANTE V, BORDON R, CATALIOTTI L, FEDERICI A, NALDONI C, PITARELLA S, ROSSELLI DEL TURCO M, TAFFURELLI M, TOMATIS M, VETTORAZZI, SEGNAN N. Il progetto SQTM sulla qualità della diagnosi e della terapia entro i programmi di screening: risultati degli indicatori 2003. In: Rosselli del Turco M, Zappa M, eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Terzo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2004, pag. 60-73.
464.PONTI A, MANO MP, SEGNAN N, DISTANTE V, CATALIOTTI L. Il progetto SQTM sulla qualità della diagnosi e della terapia entro i programmi di screening: risultati preliminari degli indicatori chirurgici. In: Rosselli del Turco M., Zappa M., eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Primo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2002, Pag. 86-91.
465.PONTI A, SEGNAN N, BLAMEY R, BORDON R, CATALIOTTI L, CODD M, DISTANTE V, GIORGI D, GOREY T, LINOS A, LINOS DA, MANO MP, SAINSBURY R. Data Collection on Treatment of Screen-Detected lesions. In Perry N, Broeders M, de Wolf C, Tornberg S, Schouten J, eds. European Guidelines for Quality Assurance in Mammography Screening, 3rd Edition. European Commission, Europe Against Cancer Programme, Luxembourg, 2001.
466.PONTI A, VERGINI V, CALLEGARI T, BRANCATO B, FALINI F, FRIGERIO A, NALDONI C, PACI E, SENORE C,
SERAFINI M, VITALI B, SEGNAN N. “European Screening Evaluation Database (SEED): potenziale utilizzo di un comune archivio di dati individuali per la valutazione dello screening mammografico a livello regionale e nazionale. In: Rosselli del Turco M., Zappa M., eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Terzo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2004, pag. 132-135.
467.PONZETTO M, MAERO B, MAINA P, ROSATO R, CICCONE G, MERLETTI F, RUBENSTEIN LZ, FABRIS F. Risk
factors for early and late mortality in hospitalized older patients: the continuing importance of functional status. J Gerontol A Biol Sci Med Sci 2003; 58: 1049-54.
468.POSADA
DE LA PAZ M, ABAITUA I, TERRACINI B, GIMÉNEZ O, SÁNCHEZ PORRO P, GÓMEZ MERA C. Late deaths among young women affected by the toxic oil syndrome in Spain. Epidemiology 1999; 10: 345.
31
469.PRETI M, MICHELETTI L, BARBERO M, GHIRINGHELLO B, ZANOTTO-VALENTINO MC, NICOLACI P, CANNI' M, BORGNO G, SEGNAN N, RONCO G. Histological parameters of vulvar invasive carcinoma and lymph-node metastases. J Reprod Med 1993; 38: 28-32.
470.PRETI M, RONCO G, GHIRINGHELLO B., MICHELETTI L. Reccurent squamous cell carcinoma of the
vulva: clinico-pathological determinants identifying low-risk patients. Cancer 2000; 88: 1869-76.
471.PRETI M, RONCO G, MICHELETTI L, BARBERO M, BOCCI C, GHIRINGHELLO B, MASSOBRIO M. Recurrent squamous cell carcinoma of the vulva: a multivariate analysis of clinical and pathological determinants. Proceedings 1997 conference of the International society for the study of vulvovaginal disease.
472.RAMENGHI U, BONISSONI S, MIGLIARETTI G, DEFRANCO S, BOTTAREL F, GAMBARUTO C, DIFRANCO D, PRIORI
R, CONTI F, DIANZANI I, VALESINI G, MERLETTI F, DIANZANI U. Deficiency of the fas apoptosis pathway without fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood 2000; 95: 3176-82.
473.RANZI A, GAMBINI M, SPATTINI A, GALASSI C, SESTI D, BEDESCHI M, MESSORI A, BARONI A, CAVAGNI G, LAURIOLA P. Air pollution and respiratory status in asthmatic children: hints for a locally based preventive strategy. AIRE study. Eur J Epidemiol 2004; 19: 567-76.
474.RENZONI E, FORASTIERE F, BIGGERI A, VIEGI G, BISANTI L, CHELLINI E, CICCONE G, CORBO G, GALASSI C, RUSCONI F, SESTINI P. AND SIDRIA COLLABORATIVE GROUP. Differences in parental- and self-report of asthma, rhinitis and eczema among Italian adolescents. Eur Respir J 1999; 14: 597-604.
475.RESEGOTTI A, ASTEGIANO M, FARINA EC, CICCONE G, AVAGNINA G, GIUSTETTO A, CAMPRA D, FRONDA
GR. Side-to-Side Stapled Anastomosis Strongly Reduces Anastomotic Leak Rates in Crohn's Disease Surgery. Dis Colon Rectum 2005 Feb 17; [Epub ahead of print].
476.RIBOLI E, HALEY NJ, TREDANIEL J, SARACCI R, PRESTON- MARTIN S, TRICHOPOULOS D, BECHER H, BURCH JD, FONTHAM ETH, GAO Y-T, JINDAL SK, KOO LC, LE MARCHAND L, SEGNAN N, SHIMIZU H, STANTA G, WUWILLIAMS AH, ZATONSKI W. Do the nonsmoking daughters of smokers tend to marry smokers? Implications for epidemiological research on environmental tobacco smoke: the AIRC collaborative study. Cancer Epidemiology, Biomarkers & Prevention 1995; 4: 821-4.
477.RIBOLI E, HUNT KJ, SLIMANI N, FERRARI P, NORAT T, FAHEY M, CHARRONDIERE UR, HEMON B, CASAGRANDE
C, VIGNAT J, OVERVAD K, TJONNELAND A, CLAVEL-CHAPELON F, THIEBAUT A, WAHRENDORF J, BOEING H, TRICHOPOULOS D, TRICHOPOULOU A, VINEIS P, PALLI D, BUENO-DE-MESQUITA HB, PEETERS PH, LUND E, ENGESET D, GONZALEZ CA, BARRICARTE A, BERGLUND G, HALLMANS G, DAY NE, KEY TJ, KAAKS R, SARACCI R. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
478.RICHIARDI L, AKRE O, BELLOCCO R, EKBOM A. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 2002; 87: 545-50.
479.RICHIARDI L, AKRE O, LAMBE M, GRANATH F, MONTGOMERY SM, EKBOM A. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 2004; 15: 323-9.
480.RICHIARDI L, AKRE O, MONTGOMERY SM, LAMBE M, KVIST U, EKBOM A. Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J Natl Cancer Inst 2004; 96: 145-7.
481.RICHIARDI L, ASKLING J, GRANATH F, AKRE O. Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 669-73.
482.RICHIARDI L, BELLOCCO R, ADAMI HO, TORRANG A, BARLOW L, HAKULINEN T, RAHU M, STENGREVICS A, STORM H, TRETLI S, KURTINAITIS J, TYCZYNSKI JE, AKRE O. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004; 13: 2157-66.
483.RICHIARDI L, BOFFETTA P, MERLETTI F. Analysis of nonresponse bias in a population-based casecontrol study on lung cancer. J Clin Epidemiol 2002; 55: 1033-40.
32
484.RICHIARDI L, BOFFETTA P, SIMONATO L, FORASTIERE F, ZAMBON P, FORTES C, GABORIEAU V, MERLETTI F. Occupational risk factors for lung cancer in men and women: a population-based casecontrol study in Italy. Cancer Causes Control 2004; 15: 285-94.
485.RICHIARDI L, FORASTIERE F, BOFFETTA P, SIMONATO L, MERLETTI F. Effect of different approaches to treatment of smoking as a potential confounder in a case-control study on occupational exposures. Occup Environ Med 2005; 62: 101-4.
486.RICHIARDI L, FORASTIERE F, BOFFETTA P, SIMONATO L, MERLETTI F. Effect of different approaches to treatment of smoking as a potential confounder in a case-control study on occupational exposures. Occup Environ Med 2005; 62: 101-4.
487.RICHIARDI L, MERLETTI F. Epidemiologia del tumore del polmone.
In: C.F. Donner, C.M. Sanguinetti eds. Trattato Italiano di Pneumlogia. Vol. III”. Edi-Aipo Scientifica, Pisa, 2001.
488.RICHIARDI L, MERLETTI F. Stima della distorsione da non-rispondenza. Epidemiol Prev 2001; 25: 40-1.
489.RODELLA S, CICCONE G, REGE-CAMBRIN G, VINEIS P, AND THE WORKING GROUP ON THE EPIDEMIOLOGY OF
HEMATOLYMPHOPOIETIC MALIGNANCIES IN ITALY. Cytogenetics and occupational exposures in acute nonlymphocytic leukemia and myelodysplastic syndrome. Scand J Work Environ Health 1993; 19: 369-74.
490.RONCO G, BERARDENGO E, CRISTINA MV, PARISIO F, SENORE C, GIORDANO L, SEGNAN N, MONTANARI G, VOLANTE R. Frequenza di prelievi inadeguati e di patologia cervico-vaginale nelle donne anziane: dati dal programma di screening "Prevenzione Serena" a Torino. Atti del convegno "La prevenzione dei tumori: utopia, illusione, realta'." Trento 11/10/1993.
491.RONCO G, BIGGERI A. Estimating sensitivity and specificity when repeated tests are performed on the same subject. J Epidemiol Biostatistics 1999; 4: 329-36.
492.RONCO G, GHISETTI V, SEGNAN N, SNIJDERS PJ, GILLIO-TOS A, MEIJER CJ, MERLETTI F, FRANCESCHI S. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005; 41: 297-305.
493.RONCO G, IOSSA A, NALDONI C, PILUTTI S, ANGHINONI E, ZAPPA M, DALLA PALMA P, CIATTO S, SEGNAN
N. A first survey of organised cervical cancer screening programmes in Italy. Tumori 1998; 84: 624-30.
494.RONCO G, MONTANARI G, AIMONE V, PARISIO F, SEGNAN N, VALLE A, VOLANTE R. Estimating the sensitivity of cervical cytology: errors of interpretation and test limitations. Cytopathology 1996; 7: 151-8.
495.RONCO G, MONTANARI G, CONFORTINI M, PARISIO F, BERARDENGO E, DELPIANO AM, ARNAUD S, CAMPIONE D, BALDINI D, POLL P, LYNGE E, MANCINI E, SEGNAN N. Effect of circulation and discussion of cervical smears on agreement between laboratories. Cytopathology 2003; 14: 115-20.
496.RONCO G, PILUTTI S, NALDONI C, VETTORAZZI M, SCARINCI M, SCALISI A, DALLA PALMA P, IOSSA A, SEGNAN N, ZAPPA M. Stato dello screening cervicale in Italia. In “Osservatorio Nazionale per la prevenzione dei tumori femminili. Primo rapporto” Roma, 2002.
497.RONCO G, RICCIARDI V, NALDONI C. et al Livello di attivazione ed indicatori di processo dei
programmi organizzati di screening cervicale in Italia. In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 36-51.
498.RONCO G, SEGNAN N, GIORDANO L, PILUTTI S, SENORE C, PONTI A, VOLANTE R. Interaction of
spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer 1997; 33: 1262-7.
499.RONCO G, SENORE C, GIORDANO L, QUADRINO S, PONTI A, SEGNAN N. Who has Pap-tests: effect of
a call programme on coverage and determinants of compliance. Epidemiol Prev 1994; 18: 218-23.
33
500.RONCO G, VINEIS P, MONTANARI G, ORLASSINO R, PARISIO F, ARNAUD S, BERARDENGO E, FABBRINI T,
SEGNAN N. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis. Cancer 2003; 99: 83-8.
501.RONCO G, ZAPPA M, NALDONI C, BERRINO F, IOSSA A, ANGHINONI E, DALLA PALMA P, MAGGINO T,
SEGNAN N, PER GISCI. Indicatori e standard per la valutazione di processo di programmi di screening del cancro del collo dell'utero - manuale operativo. Prima versione Maggio 1997, seconda versione Novembre 1998.
502.RONCO G, ZAPPA M, NALDONI C, IOSSA A, BERRINO F, ANGHINONI E, DALLA PALMA P, MAGGINO T,
VETOTRAZZI M, SEGNAN N. GISCi. Indicatori e standard per la valutazione di processo di programmi di screening del cancro del collo dell'utero - manuale operativo. Supplemento ad Epidemiol Prev 1999; 23: 1-32.
503.RONCO G. La ricerca del papillomavirus come test primario per lo screening cervicale In:
Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 118-119.
504.RONCO G. La ricerca del papillomavirus come test primario per lo screening cervicale. In “Osservatorio Nazionale per la prevenzione dei tumori femminili. Primo rapporto” Roma, 2002.
505.RONCO G. Utilizzo della ricerca molecolare del virus del papilloma umano (HPV) come test di screening del cancro del collo dell’utero: una revisione. Epidemiol Prev 1999; 23: 372-7.
506.ROSATO R, BALDI I, DI CUONZO D, PAGANO E, MERLETTI F, CICCONE G. La mobilità sanitaria per
ricoveri oncologici nella Regione Piemonte (anni 1997-2001). Quaderni CPO-Piemonte N. 7. Torino, 2003.
507.ROSATO R, CICCONE G, FARINA EC, GELORMINO E, PAGANO E, SENORE C, MERLETTI F. Valutazione di
qualità dell’assistenza attraverso la scheda di dimissione ospedaliera: un esempio sulla chirurgia dei tumori del retto. Epidemiol Prev 2003; 27: 207-14.
508.ROSATO R, GREGORI D, BO S, GRASSI G, CICCONE G, MERLETTI F, PAGANO GF. L’analisi delle
ospedalizzazioni ripetute di una coorte di pazienti diabetici. In: Pagano A, Vittadini G ed., Qualità e valutazione delle strutture sanitarie. Milano, Etas 2004, 313-22.
509.ROSATO R, GREGORI D. Rischio competitivo e catene di Markov: una breve nota sul modello additivo. Epidemiol Prev 2003; 27: 186-9.
510.ROSSO P, TERRACINI B, FEARS TR, JANKOVIC M, FOSSATI BELLANI F, ARRIGHINI A, CARLI M, CORDERO
DI
MONTEZEMOLO L, GARRÉ ML, GUAZZELLI C, IZZI GC, LOIACONO G, MANCINI A, TAMARO P, TESTI AM, MASERA G, HAUPT R. Second malignant tumors after elective end of therapy for a first cancer in childhood. A multicenter study in Italy. Int J Cancer 1994; 59: 451-6.
511.ROSSO S, BUDRONI M. Skin cancers: melanoma, non-melanoma cancers and Kaposi's sarcoma. Epidemiol Prev 2004; 28: 57-63.
512.ROSSO S, CASELLA C, CROCETTI E, FERRETTI S, GUZZINATI S. Sopravvivenza dei casi di tumore in Italia negli anni novanta: i dati dei Registri Tumori. Epidemiol Prev 2001; 25: (suppl) 1-375.
513.ROSSO S, FAGGIANO F, ZANETTI R, COSTA G. Social class and cancer survival in Turin (Italy). J Epidemiol Commun Health 1997; 51: 30-4.
514.ROSSO S, GUZZINATI S, STRACCI P, PUPPO A, MICCINESI G, ANTONINI S, & GRUPPO AIRT. Indicatori, popolazioni e presentazione dei risultati. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
515.ROSSO S, JORIS F, ZANETTI R. Risk of basal and squamous cell carcinoma of the skin in Sion, Switzerland: a case-control study. Tumori, 1999; 85: 435-42.
34
516.ROSSO S, MACKIE R, ZANETTI R. Sun exposure, UVA lamps and risk of skin cancer. Epidemiological Studies. Eur J Cancer 1994; 30A: 550-2.
517.ROSSO S, MICCINESI G, CROSIGNANI P, LA ROSA F, ROSCIONI S. [Selection criteria, methods of analysis and results presentation issues.] Epidemiol Prev 2001; 25: 21-7.
518.ROSSO S, MINARRO R, SCHRAUB S, TUMINO R, FRANCESCHI S, ZANETTI R. Reproducibility of skin
characteristic measurements and reported sun exposure history. Int J Epidemiol 2002; 31: 439-46.
519.ROSSO S, PATRIARCA S, VICARI P, ZANETTI R. Cancer incidence in Turin: the effect of migration. Tumori. 1993; 79: 304-10.
520.Rosso S, Spitale A, Balzi D, Franceschi S, Zanetti R. Stima dell’incidenza dei tumori nelle regioni italiane nel Epidemiol Prev 2004; 28: 247-57.
521.ROSSO S, ZANETTI R, MARTINEZ C, TORMO MJ, SCHRAUB S, SANCHO-GARNIER H, FRANCESCHI S, GAFÀ L, PEREA E, NAVARRO C, LAURENT R, SCHRAMECK C, TALAMINI R, TUMINO R, WECHSLER J. The multicentre south-european study "HELIOS": II. Different sun exposure patterns in the etiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1447-54.
522.ROSSO S, ZANETTI R, PIPPIONE M, SANCHO-GARNIER H. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Mel Res 1998; 8: 573-83.
523.ROSSO S, ZANETTI R. [Geographical estimates and prediction of cancer occurrences: fashion or necessity] Epidemiol Prev 2002; 26: 254-6.
524.ROSSO S. Misurazione dei parametri "soft". Quaderni di cure palliative 1994; 3: 199-202. 525.ROZEN P, BLANCHARD J, CAMPBELL D, CARLSEN E, LAMBERT R, MARBET U, PETERSON K, REGULA J, SEGNAN
N, SUCHANEK S, VAN GOSSUM A. Implementing Colorectal Cancer Screening: Group 2 Report ESGE/UEGF Colorectal Cancer - Public Awareness CampaignThe Public/Professional Interface WorkshopOslo, Norway, June 20 - 22, 2003 -. Endoscopi 2004; 36: 354-8.
526.ROZEN P, BLANCHARD J, CAMPBELL D, CARLSEN E, LAMBERT R, MARBET U, PETERSON K, REGULA J, SEGNAN
N, SUCHANEK S, VAN GOSSUM A. Implementing Colorectal Cancer Screening: Group 2 Report - ESGE/UEGF Colorectal Cancer - Public Awareness CampaignThe Public/Professional Interface WorkshopOslo, Norway, June 20-22, 2003 -. Endoscopy. 2004; 36(4): 354-8.
527.RU G, TERRACINI B, GLICKMAN LT. Host related risk factors for canine osteosarcoma. Vet J 1998; 156: 31-9.
528.RUSCONI F, FORASTIERE F, AGABITI N, BIGGERI A, CICCONE G. Frequenza di asma bronchiale in diverse aree Italiane. Riv Ital Pediatr 1997; 23: 245-53.
529.RUSCONI F, GALASSI C, CORBO GM, FORASTIERE F, BIGGERI A, CICCONE G, RENZONI E.
AND SIDRIA COLLABORATIVE GROUP. Risk factors for early, persistent, and late-onset wheezing in young children. Am J Respir Crit Care Med 1999; 160: 1617-22.
530.RUTGERS EJT, BARTELINK H, BLAMEY R, LICHERT-TOFT M, CATALIOTTI L, FOURQUET A, GRECO M, HOLLAND R,
JAKESZ R, JULIEN JP, ROUEN N, O'HIGGINS N, PETERSE JL, PETIT JY, PONTI A, SAINSBURY R, VAN DE VELDE CJH, (EUSOMA Working Party). Quality Control in the Locoregional Treatment of Breast Cancer. Eur J Cancer 2001; 37: 447-53.
531.SACERDOTE C, FIORINI L, DALMASSO M, VINEIS P. Alimentazione e rischi di cancro: indagine su un
campione di 10.054 volontari residenti nell'area torinese. Quaderni CPO-Piemonte n°3, Torino 2000.
532.SACERDOTE C, PELUSO M, MUNNIA A, MALAVEILLE C, VINEIS P. The choice of controls in a case-
control study on WBC-DNA adducts and metabolic polymorphisms. Biomarkers 2000; 5: 307-13.
533.SALA M, CORDIER S, CHANG-CLAUDE J, DONATO F, ESCOLAR-PUJOLAR A, FERNANDEZ F, GONZALEZ CA,
GREISER E, JOCKEL KH, LYNGE E, MANNETJE A, POHLABELN H, PORRU S, SERRA C, TZONOU A, VINEIS P, WAHRENDORF J, BOFFETTA P, KOGEVINA M. Coffee consumption and bladder cancer in
35
nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control 2000; 11: 925-31.
534.SALVAN A, PONS O, ROLETTI S, ERNA M, LIGUORI F, CICCOLALLO L, GALASSI C, MILIGI L, POGGI A, CANNIZZARO S, TUMINO R, BORTOT P, POLICHETTI A, VECCHIA P, MAGNANI C FOR THE SETIL WORKGROUP. A pilot study of residential exposure to extremely low frequency magnetic fields for the Italian epidemiologic study of risk factors for childhood cancer (SETIL). In Kostarakis P and Stavroulakis P, eds. Proceedings of the Millennium Workshop on Biological Effects of Electromagnetic Fields, Heraklion, Greece, 17 - 20 October 2000, pp 424-431. Book with peer review of papers.
535.SALVINI S, SAIEVA C, SIERI S, VINEIS P, PANICO S, TUMINO R, PALLI D. Physical activity in the EPIC cohort in Italy. IARC Sci Publ 2002; 156: 267-9.
536.SANT M, GATTA G, VALENTE F, BARCHIELLI A, RAMAZZOTTI V, SERVENTI L, ROSSO S. The ITACARE study. Tumori 1997; 83: 17-24.
537. SAPINO A, BIANCHI S, ARISIO R, BERARDENGO E, PONTI A, RU G, GIORGI D, MORRONE D, MARRA V, VEZZOSI V, BONGIOANNI M, FRIGERIO A, ROSSELLI DEL TURCO M, MANO M.P, COLUCCIA C, GIANI R, DISTANTE V, SIMONCINI R, CARDONAG, SEGNAN N. Results of diagnostic examinations and pathological grade in screen-detected ductal carcinoma in situ of the breast (DCIS). European Society of Mastology Abstracts. The Breast, 1997; 6: 327-8.
538.SARACCO G, CIANCIO A, OLIVERO A, SMEDILE A, ROFFI L, CROCE G, COLLETTA C, CARITI G, ANDREONI
M, BIGLINO A, CALLERI G, MAGGI G, TAPPERO GF, ORSI PG, TERRENI N, MACOR A, DI NAPOLI A, RINALDI E, CICCONE G, RIZZETTO M. A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology 2001; 34: 133-8.
539.SARACCO G, OLIVERO A, CIANCIO A, CARENZI S, SMEDILE A, CARITI G, ANDREONI M, ORSI PG, BIGLINO
A, TABONE M, ROFFI L, CROCE G, MANCA A, TAPPERO G, CICCONE G, RIZZETTO M. A randomized 4arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy. Hepatology 2002; 36: 959-66.
540.SARACCO P, BERTORELLO N, FARINASSO L, EINAUDI S, BARISONE E, ALTARE F, PASTORE G. Steroid
withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase. J Pediatr Hematol Oncol 2005; 27: 141-4.
541.SCAGLIONE L, PIOBBICI M, PAGANO E, BALLINI L, TAMPONI G, CICCONE G. Implementing a venous thromboembolism prophylaxis guideline in a large Italian teaching hospital: lights and shadows. Haematologica 2005.
542.SCIALLERO S, GHEZZI P, ZAPPA M, MALFITANA G, BONELLI L, ANDREONI B, CARDELLI A, ROSSINI FP, FERRARIS R, SEGNAN N, AND THE SCORE WORKGROUP. Multicentre randomized controlled trial of “onceonly” flexible sigmoidoscopy screening in Italy (SCORE): interim report. National meeting of digestive diseases. Milan November 14-18, 1998.
543.SEGNAN N, ANDREONI B, BISANTI L, CASTIGLIONE G, FERRARI A, GASPERONI S, MALFITANA A, PERA A, RECCHIA S, RIZZETTO M, RASSINI FP, SENORE C, TURCO P. Comparing different strategies for colorectal cancer. Gastrenterology 2002; 122: 1572.
544.SEGNAN N, APPIANO S, FRIGERIO A, GIORDANO L, MANCINI E, PONTI A, RONCO G, SENORE C, VOLANTE
R. Il monitoraggio di alcuni indicatori di qualita' dei programmi di screening nella Regione Piemonte. In: Rosselli del Turco M, Zappa M. eds, Osservatorio nazionale per la prevenzione dei tumori femminili. Primo rapporto. Lega Italiana per la Lotta contro i Tumori Roma, 2002. Pag. 72-79.
545.SEGNAN N, ARMAROLI P. “Compliance”, partecipazione consapevole e consenso informato nei programmi di screening dei tumori. Epidemiol Prev 1999; 23: 387-91.
36
546.SEGNAN N, ARMAROLI P.
E SANCHO-GARNIER H. Screening in AA.VV. "Prevenzione dei tumori: strategie ad uso delle organizzazioni non governative europee". Edito dalla Lega Italiana per la Lotta contro i Tumori, Roma, 2004.
547.SEGNAN N, ARMAROLI P.
E SANCHO-GARNIER H. Screening. In: AA.VV. "Strategie di prevenzione dei tumori e prove di efficacia". Edito dalla Lega Italiana per la Lotta contro i Tumori, Roma, 2004. Vol. 1, 131-140.
548.SEGNAN N, ARMAROLI P. Lo screening: cautele metodologiche e attenzioni organizzative in
Tendenze Nuove - Ruolo e contributo dell'organizzazione nell'attuazione del SSN e nella trasformazione e sviluppo del sistema sanitario. Il Mulino, Bologna 2004.
549.SEGNAN N, ARMAROLI P. Nuovi ponti da costruire. Epidemiol Prev 2003; 6: 323-7. 550.SEGNAN N, FRIGERIO A, PONTI A. Programma di screening del carcinoma mammario "Prevenzione Serena". Minerva Chirurgica. 1995; 50: 13.
551.SEGNAN N, GIORDANO L, PONTI A, RONCO G, SENORE C. Il programma torinese di screening del carcinoma della mammella e del collo dell'utero. Professione - Sanità Pubblica e Medicina Pratica 1999; 7: 8-11.
552.SEGNAN N, GIORDANO L, PONTI A, RONCO G. Metalmeccanica. In: "Mortalita' per professioni in
Italia negli anni '80". A cura di Costa G, Faggiano F, Lagorio S. Collana quaderni ISPESL, Roma, 1995.
553.SEGNAN N, GIORDANO L. Screening. Enciclopedia Medica Italiana. USES Edizioni Scientifiche Firenze 1993.
554.SEGNAN N, MANCINI E, SABBADINI L, RONCO G, FRIGERIO A. Pap test e mammografia in Italia
attraverso i risultati dell’indagine Multiscopo dell’anno 2000: diseguaglianze da ridurre e risorse riallocare.In: Rosselli del Turco M, Zappa M. eds, Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. Lega Italiana per la Lotta contro i Tumori, Roma, 2003, Pag. 70-73.
555.SEGNAN N, PONTI A, RONCO G, KROMHOUT H, HEEDERIK D, DE COCK J, BOSIA S, LUCCOLI L, PICCIONI P, SENIORI-COSTANTINI A, MILIGI L, SCARPELLI A, MARIOTTI M, SCARNATO C, MORISI L. Comparison of methods of for assessing the probability of exposure in metal plating, shoe and leather goods manufacture and wine growing. Occupational Hygiene 1996; 3: 199-208.
556.SEGNAN N, RONCO G, CIATTO S. Cervical cancer screening in Italy. Eur J Cancer 2000; 36: 2235-9.
557.SEGNAN N, RONCO G. Lo screening della cervice uterina mediante pap-test. "Raccomandazioni per gli screening in oncologia" a cura della Lega Italiana per la Lotta contro i Tumori. Bonelli L, Rosselli del Turco M, Segnan N. eds. 1996, Roma.
558.SEGNAN N, SENORE C, ANDREONI B, ARRIGONI A, BISANTI L, CARDELLI A, CASTIGLIONE G, CROSTA C,
DIPLACIDO R, FERRARI A, FERRARIS R, FERRERO F, FRACCHIA M, GASPERONI S, MALFITANA G, RECCHIA S, RISIO M, RIZZETTO M, SARACCO G, SPANDRE M, TURCO D, TURCO P, ZAPPA M; SCORE2 WORKING GROUP-ITALY. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005; 97: 347-57.
559.SEGNAN N, SENORE C, ANDREONI B, ASTE H, BONELLI L, CROSTA C, FERRARIS R, GASPERONI S, PENNA A, RISIO M, ROSSINI FP, SCIALLERO S, ZAPPA M, ATKIN WS. AND THE SCORE WORKING GROUP. Baseline Findings of the Italian Multicenter Randomized Controlled Trial of "Once-Only Sigmoidoscopy"-SCORE. J Natl Cancer Inst 2002; 94: 1763-72.
560.SEGNAN N, SENORE C, GIORDANO L, PONTI A, RONCO G. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998; 84: 348-53.
561.SEGNAN N. [Arguments against the distinction between primary and secondary prevention and prevention and treatment] Epidemiol Prev 2002; 26: 266-8.
37
562.SEGNAN N. Cervical Cancer Screening. Human benefits and human costs in the evaluation of screening programmes. Eur J Cancer 1994; 30A: 873-5.
563.SEGNAN N. Il parere dell'epidemiologo sulla diagnosi precoce del tumore alla mammella. Torino Medica, settembre 2004.
564.SEGNAN N. in AA.VV. Research in the behavioural and social sciences to improve cancer
control and care. A strategy for development. A report of an expert group. IARCPress, Lyon, 2003.
565.SEGNAN N. La mammografia come test di screening prima dei 50 anni. Epidemiol Prev 1997; 21: 86-7.
566.SEGNAN N. Migliorare la diagnosi precoce: questa è la sfida. Epidemiol Prev 2001; 25: 235. 567.SEGNAN N. Parsimonia e prevenzione secondaria dei tumori. Epidemiol Prev 1995; 19: 293-6. 568.SEGNAN N. Socioeconomic status and cancer screening. "Social Inequalities and Cancer" IARC Publications. Kogevinas M, Pearce N, Susser M, Boffetta P. eds. 1997; 138: 369-76.
569.SENIORI COSTANTINI A, MILIGI L, VINEIS P, AND WORKING GROUP ON HEMATOLYMPHOPOIETIC MALIGNANCIES IN ITALY
(WILL). Studio caso-controllo multicentrico italiano sulle neoplasie maligne del sistema emolinfopoietico. Ipotesi in studio e risultati preliminari sui rischi associati alle attività lavorative. Med Lav 1998; 89: 164-76.
570.SENORE C, BATTISTA RN, PONTI A, SEGNAN N, SHAPIRO SH, ROSSO S, AIMAR D. Comparing
participants and nonparticipants in a smoking cessation trial: selction factors associated with general practitioner recruitment activity. J Clin Epidemiol 1999; 1: 83-9.
571. SENORE C, BATTISTA RN, SHAPIRO SH, SEGNAN N, PONTI A, ROSSO S, AIMAR D. Predictors of smoking cessation following physicians' counselling. Prev Med 1998; 27: 412-21.
572.SENORE C, BERTONE A, CAVALLERO M, FORLAI MP, FRACCHIA M, SPANDRE M, SEGNAN N. Comparing miss-rate of colonoscopy and sigmoidoscopy. Gastrointestinal Endoscopy 1999; 49: AB68.
573.SENORE C, CICCONE G. Uso inappropriato dell’ospedale: dimensioni del problema e possibili determinanti. Professione 1998; 11: 9-12.
574.SENORE C, PENNANZIO M, ASTE H, SCIALLERO S, ANDREONI B, LOTTI M, GASPERONI S, GIULIANI O, FERRERO
F, AGNOLUCCI A, ZAPPA M, SEGNAN N. Predictive value for distal colorectal cancer and advanced distal adenomas of rectal bleeding in a screening population. Gastrenterology 2000; 118(4S).
575.SENORE C, PONTI A, COLOMBO A, MENGHI S, AIMAR D, SEGNAN N. Cotinina urinaria come indicatore di esposizione a fumo passivo. Epidemiol Prev 1999; 23: 392-8.
576.SENORE C, SEGNAN N, BONELLI L, SCIALLERO S, PENNAZIO M, ANGIOLI D, CROSTA C, GASPERONI S, MALFITANA G; SCORE WORKING GROUP. Predicting proximal advanced neoplasms at screening sigmoidoscopy. Dis Colon Rectum 2004; 47(8): 1331-40.
577.SENORE C, SEGNAN N, ROSSINI FP, FERRARIS R, CAVALLERO M, COPPOLA F, PENNANZIO M, ATKIN WS.
Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 1996; 3: 72-8.
578.SETTIMI L, COMBA P, CARRIERI P, BOFFETTA P, MAGNANI C, TERRACINI B, ANDRION A, BOSIA S, CIAPINI C, DE SANTIS M, DESIDERI E, FEDI A, LUCCOLI L, MAIOZZI P, MASINA A, PERAZZO PL, AXELSON O. Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med 1999; 36: 135-41.
579.SETTIMI L, RONCO G, CAVONE D, MERLO F, MUSTI M, COMBA P. Agricoltura. In: "Mortalita' per
professioni in Italia negli anni '80". A cura di Costa G, Faggiano F, Lagorio S. Collana quaderni ISPESL, Roma, 1995.
38
580.SILVESTRI L, MILANESE M, OBLACH L, FONTANA F, GREGORI D, GUERRA R,
VAN SAENE HK. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002; 30: 391-9.
581.SILVESTRI L, SARGINSON RE, HUGHES J, MILANESE M, GREGORI D, VAN SAENE HK. Most nosocomial
pneumonias are not due to nosocomial bacteria in ventilated patients. Evaluation of the accuracy of the 48 h time cut-off using carriage as the gold standard. Anaesth Intensive Care 2002; 30: 275-82.
582.SILVESTRI L,
VAN SAENE HK, MILANESE M, FONTANA F, GREGORI D, OBLACH L, PIACENTE N, BLAZIC M. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 2004; 23: 921-6.
583.SILVESTRI S, MAGNANI C, CALISTI R, BRUNO C. The experience of the Balangero chrysotile
asbestos mine in Italy. Health effects among workers mining and milling asbestos and the health experience of persons living nearby. Can Mineral 2001; 5: 177-86.
584.SIMONATO L, AGUDO A, AHRENS W, BENHAMOU E, BENHAMOU S, BOFFETTA P, BRENNAN P, DARBY SC,
FORASTIERE F, FORTES C, GABORIEAU V, GERKEN M, GONZALES CA, JÖCKEL K-H, KREUZER M, MERLETTI F, NYBERG F, PERSHAGEN G, POHLABELN H, RÖSCH F, WHITLEY E, WICHMANN H-E, ZAMBON P. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of intercountry heterogeneity. Int J Cancer 2001; 91: 876-87.
585.SISMONDI P, FRIGERIO A, MANO MP, PONTI A, SEGNAN N. Lo screening mammografico: dalla ricerca alla pratica. Doctor Ginecologia 1994: 21-38.
586.SITHISARANKUL P, VINEIS P, KANG D, ROTHMAN N, CAPORASO N, STRICKLAND P. Association of 1-
hydroxypyrene-glucuronide in human urine with cigarette smoking and broiler or roasted meat consumption. Biomarkers 1997; 2: 217-22.
587.SMITS KM, BENHAMOU S, GARTE S, WEIJENBERG MP, ALAMANOS Y, AMBROSONE C, AUTRUP H, AUTRUP JL,
BARANOVA H, BATHUM L, BOFFETTA P, BOUCHARDY C, BROCKMOLLER J, BUTKIEWICZ D, CASCORBI I, CLAPPER ML, COUTELLE C, DALY AK, MUZI G, DOLZAN V, DUZHAK TG, FARKER K, GOLKA K, HAUGEN A, HEIN DW, HILDESHEIM A, HIRVONEN A, HSIEH LL, INGELMAN-SUNDBERG M, KALINA I, KANG D, KATOH T, KIHARA M, ONO-KIHARA M, KIM H, KIYOHARA C, KREMERS P, LAZARUS P, LE MARCHAND L, LECHNER MC, LONDON S, MANNI JJ, MAUGARD CM, MORGAN GJ, MORITA S, NAZAR-STEWART V, KRISTENSEN VN, ODA Y, PARL FF, PETERS WH, RANNUG A, REBBECK T, PINTO LF, RISCH A, ROMKES M, SALAGOVIC J, SCHOKET B, SEIDEGARD J, SHIELDS PG, SIM E, SINNETT D, STRANGE RC, STUCKER I, SUGIMURA H, TO-FIGUERAS J, VINEIS P, YU MC, ZHENG W, PEDOTTI P, TAIOLI E. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. INT J CANCER 2004; 110: 266-70.
588.SPIX C, AARELEID T, STILLER C, MAGNANI C, KAATSCH P, MICHAELIS J. Survival of children with neuroblastoma: time trends and regional differences in Europe, 1978-1992. Eur J Cancer 2001; 37: 722-9.
589.STAGNARO E, RAMAZZOTTI V, CROSIGNANI P, FONTANA A, MASALA G, MILIGI L, NANNI O, NERI M, RODELLA S, COSTANTINI AS, TUMINO R, VIGANO C, VINDIGNI C, VINEIS P. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12: 325-34.
590.STAGNARO E, TUMINO R, PARODI S, CROSIGNANI P, FONTANA A, MASALA G, MILIGI L, NANNI O, RAMAZZOTTI V, RODELLA S, SENOIRI CONSTANTINI A, VIGANO C, VINDIGNI C, VINEIS P. Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004; 13: 4317.
591.STILLER CA, STEVENS MCG, MAGNANI C, CORAZZIARI I, AND THE EUROCARE WORKING GROUP. Survival
of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer 2001; 37: 767-74.
592.STRATTA P, BERMOND F, GUARRERA S, CANAVESE C, CARTURAN S, DALL'OMO A, CICCONE G, BERTOLA L, MAZZOLA G, FASANO E, MATULLO G. Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant 2004; 19: 587-95.
39
593.STRATTA P, CANAVESE C, CICCONE G, BAROLO S, DALL’OMO AM, FASANO ME, MAZZOLA G, BERUTTI S, FOP F, CURTONI ES, PICCOLI G. Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population. Am J Kidney Dis 1999; 33: 1071-9.
594.STRATTA P, CANAVESE C, CICCONE G, SANTI S, QUAGLIA M, GHISETTI V, MARCHIARO G, BARBUI A, FOP F, CAVALLO R, PICCOLI G. Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 1999; 82: 145-54.
595.STRATTA P, CANAVESE C, SANDRI L, CICCONE G, SANTI S, BAROLO S, MESSUEROTTI A, QUAGLIA M, MAZZUCCO G, FOP F, SEGOLONI GP, PICCOLI G. The concept of “glomerulonephritis”. The fascinating history of evolution and emergence of a specialist’s nosology focus on Italy and Torino. Am J Nephrol 1999; 19: 83-91.
596.STRATTA P, CANAVESE C, SANTI S, CICCONE G, ROSSO S. Systemic lupus erythematosus. Lancet 2001; 358: 586-7.
597.SUCCO G, BRAMARDI F, AIROLDI M, RIVA F, MOLETTO M, ROSSO S, CAIAZZO A, SARTORIS A. La qualità della vita post-trattamento nei pazienti Otorhinolaryngol Ital 1997, 17: 32-44.
affetti
da
carcinoma
laringeo.
Acta
598.'T MANNETJE A, KOGEVINAS M, CHANG-CLAUDE J, CORDIER S, GONZALEZ CA, HOURS M, JOCKEL KH, BOLM-AUDORFF U, LYNGE E, PORRU S, DONATO F, RANFT U, SERRA C, TZONOU A, VINEIS P, WAHRENDORF J, BOFFETTA P. Occupation and bladder cancer in European women. Cancer Causes Control 1999; 10: 209-17.
599.'T MANNETJE A, KOGEVINAS M, CHANG-CLAUDE J, CORDIER S, GONZALEZ CA, HOURS M, JOCKEL KH, BOLM-AUDORFF U, LYNGE E, PORRU S, DONATO F, RANFT U, SERRA C, TZONOU A, VINEIS P, WAHRENDORF J, BOFFETTA P. Smoking as a confounder in case-control studies of occupational bladder cancer in women. Am J Ind Med 1999; 36: 75-82.
600.'T MANNETJE A, KOGEVINAS M, LUCE D, DEMERS PA, BEGIN D, BOLM-AUDORFF U, COMBA P, GÉRIN M,
HARDELL L, HAYES RB, LECLERC A, MAGNANI C, MERLER E, TOBIAS A, BOFFETTA P. Sinonasal cancer, occupation and smoking in European women and men. Am J Ind Med 1999; 36: 101-7.
601.TALASKA G, SCHAMER M, CASETTA G, TIZZANI A, VINEIS P. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise. Cancer Letters 1994; 84: 93-7.
602.TAMBURINI M, BRUNELLI C, ROSSO S, VENTAFRIDDA V. Prognostic value of quality of life scores in terminal patients. J Pain Symptom Manage 1996; 1: 32-41.
603.TARELLA C, CARACCIOLO D, GAVAROTTI P, ARGENTINO C, ZALLIO F, CORRADINI P, NOVERO D, MAGNANI
C, PILERI A. Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 2000; 26: 1185-91.
604.TARELLA C, CUTTICA A, VITOLO U, LIBERATI M, DI NICOLA M, CORTELAZZO S, ROSATO R, ROSANELLI C, DI
RENZO N, MUSSO M, PAVONE E, SANTINI G, PESCAROLLO A, DE CRESCENZO A, FEDERICO M, GALLAMINI A, PREGNO P, ROMANO R, COSER P, GALLO E, BOCCADORO M, BARBUI T, PILERI A, GIANNI AM, LEVIS A. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Cancer 2003; 97: 2748-59.
605.TAVANI A, BOSETTI C, DAL MASO L, GIORDANO L, FRANCESCHI S, LA VECCHIA C. Influence of selected
hormonal and lifestyle factors on familial propensity to ovarian cancer. Gynecol Oncol 2004; 92: 922-6.
606.TERRACINI B, CARRA L. Preventive strategies and environmental risks. Epidemiol Prev 2002; 26: 163-4.
607.TERRACINI B, COEBERGH J-W, GATTA G, MAGNANI C, STILLER C, VERDECCHIA A, ZAPPONE A. Childhood cancer survival in Europe an overview. Eur J Cancer 2001; 37: 810-6.
40
608.TERRACINI B, DI TANNO N. Ambiente urbano e sanità. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris). AKOS Enciclopedia Pratica di Medicina, 7-0956, 2001, 4 p.
609.TERRACINI B, MARTIN-ARRIBAS C. Ethical and Social aspects in Toxic Oil Syndrome: Ten Years of
Progress World Health Organization Europe, Instituto de Salud Carlos III ISBN 92 890 1063 0, Copenhagen 2004, pp 85-94.
610.TERRACINI B, MOSSO ML, GIORDANO L, MAGNANI C. Epidemiologia dei tumori infantili. Riv Ital Pediatr 1993; 19: 6-10.
611.TERRACINI B, ZANETTI R. A short history of pathology registries, with emphasis on cancer registries. Soz Praventivmed 2003; 48: 3-10.
612.TERRACINI B. ["Epidemiologia e Prevenzione" and the multinationals of tobacco] Epidemiol Prev 2000; 24: 99-100.
613.TERRACINI B. [Has the world forgotten Seveso?] Epidemiol Prev 2001; 25: 11. 614.TERRACINI B. [International Congress on Asbestos: Past, present, and future, Osasco, September 17-20, 2000] Epidemiol Prev 2000; 24: 205-6.
615.TERRACINI B. [Research on pesticides is never excessive] Epidemiol Prev 2000; 24: 160. 616.TERRACINI B. [The WTO and asbestos: commerce above all] Epidemiol Prev 2000; 24: 245-6. 617.TERRACINI B. [Waste disposal, triangles and 'hot' areas] Epidemiol Prev 2004; 28: 299-300. 618.TERRACINI B. [What is hiding behind the classification of fibers?] Epidemiol Prev 2002; 26: 302. 619.TERRACINI B. Asbestos. In: Environmental Epidemiology. Exposure and disease. Bertollini R, Lebowitz MD, Saracci R, Savitz DA. (eds). Lewis Publishers, 1996. Pages 37-47.
620.TERRACINI B. Cancer hazard identification and qualitative risk assessment. The Science of the Total Environment 1996; 184: 91-5.
621.TERRACINI B. Carcinogenicity of pesticides: is everything under control? Int J Occup Environ Health 2002; 8: 73-5.
622.TERRACINI B. Development of environmental epidemiology in Latin America: scope, methodological issues, priorities. Int J Epidemiol 2005; 34: 485-7. Epub 2004 May 20.
623.TERRACINI B. Environmental and occupational epidemiology in Italy. Int J Occup Environ Health 2005; 11: 1-5.
624.TERRACINI B. Epidemiologia descrittiva dei tumori in Italia. In: Tumori. Enciclopedia medica italiana. Aggiornamento 1993. USES Edizioni Scientifiche Firenze. Pag. 7352-63.
625.TERRACINI B. Esperienze e prospettive dell’epidemiologia occupazionale in Italia. Med Lav 1994; 85: 55-67.
626.TERRACINI B. Il genoma dei palestinesi e l'editoria scientifica Epidemiol Prev 2003; 27: 203-4. 627.TERRACINI B. Introduction in: Toxic Oil Syndrome: Ten Years of Progress
World Health Organization Europe, Instituto de Salud Carlos III ISBN 92 890 1063 0, Copenhagen 2004, pp 1-3.
628.TERRACINI B. Limiti di velocità. Lettera al ministro Lunari Epidemiol Prev 2002; 26: 2. 629.TERRACINI B. Prevenzione dei rischi di cancerogenicità nell’ambiente di lavoro. Med Lav 1998; 89: 98-101.
630.TERRACINI B. The limits of epidemiology and the Spanish Toxic Oil Syndrome. Int J Epidemiol 2004; 33: 443-4.
631.TERRACINI B. The role of primary prevention. Epidemiol Prev 2004; 28: 102-12. 632.TERRACINI B. What kind of health surveillance for those exposed to carcinogens? Med Lav 2003; 94: 331.
41
633.TERRACINI B. When and why can an environmental epidemiologist legitimately refuse to
undertake survey requested by public authorities (or other representatives of the population) on the ground that the proposal is insufficiently justified? Rev Epidemiol Santé Publique 1999; 47: 201-3.
634.TIBALDI C, TOVO PA, ZIARATI N, PALOMBA E, SALASSA B, SCIANDRA M, D’AMBROSIO R, PONTI A, SINICCO
A. Asymptomatic women at high risk of vertical HIV-1 trasmission to their fetuses. Br J Obs Gynaec 1993; 100: 334-7.
635.TIMEUS F, CRESCENZIO N, DORIA A, FOGLIA L, LINARI A, GIACCONE M, PASTORE G, DI MONTEZEMOLO LC, RAMENGHI U, SARACCO P. Flow cytometric evaluation of circulating CD34(+) cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia. Exp Hematol 2005; 33: 597-604.
636.TJONNELAND AM, OVERVAD K, BINGHAM SA, DAY NE, LUBEN R, FERRARI P, SLIMANI N, NORAT T, CLAVEL-
CHAPELON F, KESSE E, NIETERS A, BOEING H, MARTINEZ C, DORRONSORO M, GONZALEZ CA, KEY TJ, TRICHOPOULOU A, NASKA A, VINEIS P, TUMINO R, KROGH V, BUENO-DE-MESQUITA HB, PEETERS PH, BERGLUND G, HALLMANS G, LUND E, SKEIE G, KAAKS R, RIBOLI E. [Dietary fibers in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study] Ugeskr Laeger 2004; 166: 2458-60.
637.TODROS T, RONCO G, FIANCHINO O, ROSSO S, GABRIELLI S, VALSECCHI L, SPAGNOLO D, ACANFORA L, BIOLCATI M, SEGNAN N, PILU G. Accuracy of the umbilical arteries Doppler flow velocity waveforms in detecting adverse perinatal outcomes in a high risk population. Acta Obstet Gynecol Scand 1996; 75: 113-9.
638.TORAASON M, ALBERTINI R, BAYARD S, BIGBEE W, BLAIR A, BOFFETTA P, BONASSI S, CHANOCK S, CHRISTIANI
D, EASTMOND D, HANASH S, HENRY C, KADLUBAR F, MIRER F, NEBERT D, RAPPORT S, REST K, ROTHMAN N, RUDER A, SAVAGE R, SCHULTE P, SIEMIATYCKI J, SHIELDS P, SMITH M, TOLBERT P, VERMEULEN R, VINEIS P, WACHOLDER S, WARD E, WATERS M, WESTON A. Applying new biotechnologies to the study of occupational cancer--a workshop summary. Environ Health Perspect 2004; 112: 413-6.
639.TORCHIO P, LEPORE AR, CORRAO G, COMBA P, SETTIMI L, BELLI S, MAGNANI C, DI ORIO F. Mortality study on a cohort of Italian licensed pesticide users. Sci Total Environ 1994; 149: 183-91.
640.TORNBERG S, CODD M, RODRIGUES V, SEGNAN N, PONTI A. Ascertainement and evaluation of interval cancers in population-based mammography screening programmes: collaborative study in four European centres. J Med Screen 2005; 12: 43-49.
a
641.TORTONE C, MIGLIARETTI G. Fumo. In: Morgagni S, Valpreda M, Gnavi R, Costa G. eds, La salute in Piemonte 2000. Torino, Regione Piemonte, 2001. Pag. 23-32.
642.TRICHOPOULOU A, ORFANOS P, NORAT T, BUENO-DE-MESQUITA B, OCKE MC, PEETERS PH,
VAN DER
SCHOUW YT, BOEING H, HOFFMANN K, BOFFETTA P, NAGEL G, MASALA G, KROGH V, PANICO S, TUMINO R, VINEIS P, BAMIA C, NASKA A, BENETOU V, FERRARI P, SLIMANI N, PERA G, MARTINEZ-GARCIA C, NAVARRO C, RODRIGUEZ-BARRANCO M, DORRONSORO M, SPENCER EA, KEY TJ, BINGHAM S, KHAW KT, KESSE E, CLAVEL-CHAPELON F, BOUTRON-RUAULT MC, BERGLUND G, WIRFALT E, HALLMANS G, JOHANSSON I, TJONNELAND A, OLSEN A, OVERVAD K, HUNDBORG HH, RIBOLI E, TRICHOPOULOS D. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005; 330: 991.
643.VAN BALLEGOOIJEN M, VAN DEN AKKER-VAN MARLE E, PATNICK J, LYNGE E, ARBYN M, ANTTILA A,
RONCO G, HABBEMA DJF. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000; 36: 2177-88.
644.VAN DAMME K, VINEIS P, SORSO M, CASTELEYN L. Ethical issues in genetic screening and genetic monitoring of employees. Ann NY Acad Sci 1997; 837: 554-65.
645.VAN DAMME K, VINEIS P. et al. Individual susceptibility and prevention of occupational diseases: scientific and ethical issues. J Occup Environ Med 1995; 37: 91-9.
42
646.VAN GILS CH, PEETERS PH, BUENO-DE-MESQUITA HB, BOSHUIZEN HC, LAHMANN PH, CLAVEL-CHAPELON F, THIEBAUT A, KESSE E, SIERI S, PALLI D, TUMINO R, PANICO S, VINEIS P, GONZALEZ CA, ARDANAZ E, SANCHEZ MJ, AMIANO P, NAVARRO C, QUIROS JR, KEY TJ, ALLEN N, KHAW KT, BINGHAM SA, PSALTOPOULOU T, KOLIVA M, TRICHOPOULOU A, NAGEL G, LINSEISEN J, BOEING H, BERGLUND G, WIRFALT E, HALLMANS G, LENNER P, OVERVAD K, TJONNELAND A, OLSEN A, LUND E, ENGESET D, ALSAKER E, NORAT T, KAAKS R, SLIMANI N, RIBOLI E. Consumption of vegetables and fruits and risk of breast cancer. JAMA 2005; 293: 183-93.
647.VANARA F, PONTI A, FRIGERIO A, SEGNAN N. Analisi dei costi di un programma di screening mammografico. Epidemiol Prev 1995; 19: 318-29.
648.VANARA F, SENORE C, SEGNAN N. Evidenze di efficacia e valutazione dei costi dello screening del cancro colorettale in Tendenze Nuove - Il Mulino, Bologna, gennaio-febbraio 2005.
649.VANARA F, SENORE C, SEGNAN N. Screening del cancro colorettale. Quaderni CPO-Piemonte n°9, Torino gennaio 2005.
650.VANARA F, ZAPPA M, ROSSELLI DEL TURCO M, SEGNAN N, PACI E, PONTI A. Analisi costo-efficacia di
un programma di screening mammografico esteso a tutto il territorio nazionale. Epidemiol Prev 1997; 21: 118-28.
651.VEGLIA F, MATULLO G, VINEIS P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003; 12: 157-60.
652.VERCELLI M, QUAGLIA A, PARODI S, CROSIGNANI P,
AND THE
ITAPREVAL WORKING GROUP. Cancer
prevalence in the elderly. Tumori 1999; 85: 391-9.
653.VERLATO G, CORSICO A, VILLANI S, CERVERI I, MIGLIORE E, ACCORDINI S, CAROLEI A, PICCIONI P, BUGIANI
M, LO CASCIO V, MARINONI A, POLI A, DE MARCO R. Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol 2003; 111: 1232-8.
654.VIEGI G, SIMONI M, LOMBARDI E, RUSCONI F, BERTI G, GALASSI C, FORASTIERE F,
AND THE SIDRIA-2 COLLABORATIVE GROUP. Indoor Exposure To Moulds And Respiratory Disorders Among Italian Children (SIDRIA-2° Phase Study). Proceedings of the Sixteenth Conference of the International Society for Environmental Epidemiology (ISEE), New York, 2004. Epidemiology 2004; 15: S185.
655.VINEIS P, AIROLDI L, VEGLIA P, OLGIATI L, PASTORELLI R, AUTRUP H, DUNNING A, GARTE S, GORMALLY E,
HAINAUT P, MALAVEILLE C, MATULLO G, PELUSO M, OVERVAD K, TJONNELAND A, CLAVEL-CHAPELON F, BOEING H, KROGH V, PALLI D, PANICO S, TUMINO R, BUENO-DE-MESQUITA B, PEETERS P, BERGLUND G, HALLMANS G, SARACCI R, RIBOLI E. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005; 330: 277.
656.VINEIS P, ALAVANJA M, BUFFLER P, FONTHAM E, FRANCESCHI S, GAO YT, GUPTA PC, HACKSHAW A, MATOS
E, SAMET J, SITAS F, SMITH J, STAYNER L, STRAIF K, THUN MJ, WICHMANN HE, WU AH, ZARIDZE D, PETO R, DOLL R. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96: 99-106.
657.VINEIS P, ALAVANJA M, GARTE S. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int J Cancer 2004; 108: 2-7.
658.VINEIS P, AND THE WORKING GROUP ON THE EPIDEMIOLOGY OF HEMATOLYMPHOPOIETIC MALIGNANCIES IN
ITALY. Incidence and time trends for lymphomas, leukemias and myelomas: hypothesis generation. Leukemia Research 1996; 20: 285-90.
659.VINEIS P, BARTSCH H, CAPORASO N, HARRINGTON AM, KADLUBAR FF, LANDI MT, MALAVEILLE C, SHIELDS
PG, SKIPPER P, TALASKA G, TANNENBAUM SR. Genetically based N-acetyltransferase metabolic polymorphism and low - level environmental exposure to carcinogens. Nature 1994; 369: 154-6.
660.VINEIS P, BERRINO F, TERRACINI B. Le nuove frontiere dell'epidemiologia dei tumori. In: "Il cancro, ricerca e applicazioni cliniche". Le Scienze editore, 1994.
43
661.VINEIS P, BRANDT-RAUF P. Mechanisms of carcinogenesis: chemical exposure and molecular changes. Eur J Cancer 1993; 29A: 1344-7.
662.VINEIS P, CANTOR K, GONZALES C, LYNGE E, VALLYATHAN V. Occupational cancer in developed and developing countries. Int J Cancer 1995; 62: 655-60.
663.VINEIS P, CAPORASO N. Tobacco and cancer: Epidemiology and the Laboratory? Environ Health Perspect 1995; 103: 156-60.
664.VINEIS P, CHRISTIANI DC. Genetic testing for sale. Epidemiology 2004; 15: 3-5. 665.VINEIS P, CICCONE G, MAGNINO A. Asbestos exposure, physical activity and colon cancer: a case-control study. Tumori 1993; 79: 301-3.
666.VINEIS P, CROSIGNANI P, SACERDOTE C, FONTANA A, MASALA G, MILIGI L, NANNI O, RAMAZZOTTI V, RODELLA S, STAGNARO E, TUMINO R, VIGANÒ C, VINDIGNI C, SENIORI COSTANTINI A. Haematopoietic cancer and peptic ulcer: a multicenter case-control study. Carcinogenesis 1999; 20: 145964.
667.VINEIS P, CROSIGNANI P, SACERDOTE C, FONTANA A, MASALA G, MILIGI L, NANNI O, RAMAZZOTTI V, RODELLA S, STAGNARO E, TUMINO R, VIGANÒ C, VINDIGNI C, SENIORI COSTANTINI A. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000; 54: 431-6.
668.VINEIS P, CROSIGNANI P, VIGANO C, FONTANA A, MASALA G, STAGNARO E, MILIGI L, COSTANTINI AS, NANNI O, RAMAZZOTTI V, RODELLA S, TUMINO R, VINDIGNI C. Lymphomas and multiple sclerosis in a multicenter case-control study. Epidemiology 2001; 12: 134-5.
669.VINEIS P, D'ERRICO A, MALATS N, BOFFETTA P. Chapter 25. Overall evaluation and research perspectives. IARC Sci Publ 1999; 148: 403-8.
670.VINEIS P, FORASTIERE F, HOEK G, LIPSETT M. Outdoor air pollution and lung cancer: recent epidemiologic evidence. Int J Cancer 2004; 111: 647-52.
671.VINEIS P, FORNERO G, MAGNINO A, GIACOMETTI R, CICCONE G. Diagnostic delay, clinical stage, and social class: a hospital-based study. J Epidemiol Comm Health 1993; 47: 229-31.
672.VINEIS P, KOGEVINAS M, SIMONATO L, BRENNAN P, BOFFETTA P. Levelling-off of the risk of lung and
bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000; 463: 103-10.
673.VINEIS P, MALATS N, BOFFETTA P. Chapter 1. Why study metabolic susceptibility to cancer? IARC Sci Publ 1999; 148: 1-3.
674.VINEIS P, MALATS N, PORTA M, REAL FX. Human cancer, carcinogenic exposures and mutation spectra. Mutat Res 1999; 436: 185-94.
675.VINEIS P, MALATS N. Chapter 6. Strategic issues in the design and interpretation of studies on metabolic polymorphisms and cancer. IARC Sci Publ 1999; 148: 51-61.
676.VINEIS P, MARINELLI D, AUTRUP H, BROCKMOLLER J, CASCORBI I, DALY AK, GOLKA K, OKKELS H, RISCH A,
ROTHMAN N, SIM E, TAIOLI E. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001; 10: 1249-52.
677.VINEIS P, MARTONE T. Genetic-environment interactions and low-level exposure to carcinogens. Epidemiology 1995; 6: 455-7.
678.VINEIS P, MARTONE T. La misurazione delle esposizioni ad agenti patogeni: dai questionari alle indagini di laboratorio. Prospettive in Pediatria 1994; 24: 235-40.
679.VINEIS P, MARTONE T. Molecular epidemiology of bladder cancer. Ann Ist Super Sanità 1996; 32: 21-7.
44
680.VINEIS P, MARTONE T. The role of genetically-based metabolic polymorphisms in human cancer: An ecological study of bladder cancer and N-Acetyltransferase in 23 Populations. Biotherapy 1998; 11: 201-4.
681.VINEIS P, MASALA G, SENIORI COSTANTINI A. &
THE WORKING GROUP FOR THE EPIDEMIOLOGY OF HEMATOLYMPHOPOIETIC MALIGNANCIES IN ITALY. Does a gene in the Xq28 region increase the risk of non-Hodgkin’s lymphomas? Ann Oncol 1999; 10: 471-3.
682.VINEIS P, MATULLO G, MANUGUERRA M. An evolutionary paradigm for carcinogenesis? J Epidemiol Community Health 2003; 57: 89-95.
683.VINEIS P, MCMICHAEL A. Interplay between heterocyclic amines in cooked meat and
metabolic phenotype in the etiology of colon cancer. Cancer Causes and Controls 1996; 7: 479-86.
684.VINEIS P, MCMICHAEL J. Bias and confounding in molecular epidemiological studies: Special considerations. Carcinogenesis 1998; 19: 2063-7.
685.VINEIS P, MILIGI L, CROSIGNANI P, DAVICO L, FONTANA A, MASALA G, NANNI O, RAMAZZOTTI V, RODELLA
S, STAGNARO E, TUMINO R, VIGANO C, VINDIGNI C, COSTANTINI AS. Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case-control study. Br J Cancer 2003; 88: 47-9.
686.VINEIS P, MILIGI L, CROSIGNANI P, FONTANA A, MASALA G, NANNI O, RAMAZZOTTI V, RODELLA S, STAGNARO E, TUMINO R, VIGANÒ C, VINDIGNI C, SENIORI COSTANTINI A. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000; 54: 907-11.
687.VINEIS P, PACI E. Epidemiology and the Italian National Health Service. J Epidemiol Commun Health 1995; 49: 559-62.
688.VINEIS P, PERERA F. Mini Review: DNA adducts as markers of exposure to carcinogens and risk of cancer. Int J Cancer 2000; 88: 325-8.
689.VINEIS P, PIRASTU R. Aromatic amines and cancer. Cancer Causes Control 1997; 8: 346-55. 690.VINEIS P, PORTA M. Causal thinking, biomarkers and mechanisms of carcinogenesis. J Clin Epidemiol 1996; 49: 951-6.
691.VINEIS P, RONCO G, CICCONE G, GOGLIANI F. Home injuries in children: a population-based intervention trial. Epidemiology 1994; 5: 349-51.
692.VINEIS P, RONCO G, CICCONE G, VERNERO E, TROIA B, D'INCALCI T, GOGLIANI F. Prevention of
Environmental Tobacco Smoke: effectiveness of an educational program. Tumori 1993; 79: 183-6.
693.VINEIS P, SCHULTE P, MCMICHAEL AJ.
Misconceptions on the use of genetic tests in populations. The Lancet 2001; 357: 709-12.
694.VINEIS P, SCHULTE PA, CARREON T, BAILER AJ, MEDVEDOVIC M. Issues of design and analysis in studies of gene-environment interactions. IARC Sci Publ 2004; 157: 417-35.
695.VINEIS P, SCHULTE PA. Scientific and ethical aspects of genetic screening of workers for
cancer risk: the case of the N-acetyltransferase phenotype. J Clin Epidemiol 1995; 48: 18997.
696.VINEIS P, SOSKOLNE CL. Cancer risk assessment and management. J Occup Med 1993; 35: 902-8.
697.VINEIS P, TALASKA G, MALAVEILLE C, BARTSCH H, MARTONE T, SITHISARANKUL P, STRICKLAND P. DNA
adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996; 65: 314-6.
698.VINEIS P, TERRACINI B, PACI E, PERUCCI C, TOMATIS L. Italy's environment (letter). Science 1994; 266: 956.
45
699.VINEIS P, VEGLIA F, BENHAMOU S, BUTKIEWICZ D, CASCORBI I, CLAPPER ML, DOLZAN V, HAUGEN A, HIRVONEN A, INGELMAN-SUNDBERG M, KIHARA M, KIYOHARA C, KREMERS P, LE MARCHAND L, OHSHIMA S, PASTORELLI R, RANNUG A, ROMKES M, SCHOKET B, SHIELDS P, STRANGE RC, STUCKER I, SUGIMURA H, GARTE S, GASPARI L, TAIOLI E. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003; 104: 650-7.
700.VINEIS P, VEGLIA F. Selection and validation of biomarkers for chemoprevention: the contribution of epidemiology - Review. IARC Sci Publ 2001; 154: 57-68.
701.VINEIS P. History of bias. Soz Praventivmed 2002; 47: 156-61. 702.VINEIS P. A self-fulfilling prophecy: are we underestimating the role of the environment in gene-environment interaction research? Int J Epidemiol 2004; 33: 945-6.
703.VINEIS P. Aspetti scientifici, pratici ed etici dello screening genetico. In: Tamburini M. e Santosuosso A. “Malati di rischio”. Masson Editore, Milano , 1999.
704.VINEIS P. Biomarkers, low-dose carcinogenesis and dietary exposures. Eur J Cancer Prevention 1997; 6: 147-51.
705.VINEIS P. Cancer as an evolutionary process at the cell level: an epidemiological perspective. Carcinogenesis 2003; 24: 1-6.
706.VINEIS P. Causality in epidemiology. Soz Praventivmed 2003; 48: 80-7. 707.VINEIS
P. Cause e meccanismi nell'insorgenza dell'epidemiologia. Arco di Giano 1995; 6: 141-9.
delle
malattie:
la
prospettiva
708.VINEIS P. Cosa si nasconde dietro la doppia verità. Epidemiol Prev 2004; 28: 137. 709.VINEIS P. Definition and classification of cancer: monothetic or polythetic? Theoretical Medicine 1993; 14: 249-56.
710.VINEIS P. Diet, genetic susceptibility and carcinogenesis. Public Health Nutr 2001; 4: 485-91. 711.VINEIS P. DNA adducts and the protective role of fruits and vegetables. IARC Sci Publ 2002; 156: 469-74.
712.VINEIS P. Environmental risks: scientific concepts and social perception. Theoret Med 1995; 16: 153-69.
713.VINEIS P. Epidemiologia e psichiatria: considerazioni di metodo. Epidemiologia e psichiatria sociale 1995; 4: 23-6.
714.VINEIS P. Epidemiology between social and natural sciences. J Epidemiol Community Health 1998; 52: 616-7.
715.VINEIS P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 1994; 102: 7-10.
716.VINEIS P. Ethical issues in genetic screening for cancer. Annals of Oncology 1997; 8: 945-9. 717.VINEIS P. Evidence-based medicine and ethics: a practical approach. J Med Ethics 2004; 30: 126-30.
718.VINEIS P. Evidence-based primary prevention? Scand J Work Environ Health 2000; 26: 443-8. 719.VINEIS P. Exposures, mutations and the history of causality. J Epidemiol Community Health 2000; 54: 652-3.
720.VINEIS P. Hypothesis: Coffee consumption, N-acetyltransferase phenotype and cancer. J Natl Cancer Inst 1993; 85: 1004-5.
721.VINEIS P. Individual susceptibility to carcinogens. Oncogene 2004; 23): 6477-83. 722.VINEIS P. Interaction between genetic susceptibility and chemical exposures in carcinogenesis: the example of tobacco. Acta Med Rom 1997; 35: 610-6.
46
723.VINEIS P. Interazioni tra genetica e ambiente. Med Lav 1998; 89: 117-23. 724.VINEIS P. La malattia in Italia. IRES-CGIL, Torino, 1993. 725.VINEIS P. La promozione dell'epidemiologia clinica per la razionalizzazione delle decisioni sanitarie. Arco di Giano 1994; 5: 147-56.
726.VINEIS P. La prova in medicina. Quaderni Storici 85; a. XXIX n. 1: 75- 90, aprile 1994. 727.VINEIS P. L'epidemiologia clinica nella formazione del medico. La Formazione del Medico 1993; 8: 56-60.
728.VINEIS P. Molecular epidemiology: a provisional evaluation. Epidemiol Prev 2003; 27: 3-4. 729.VINEIS P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 1997; 71: 1-3.
730.VINEIS P. Occupational factors for sarcoma subtypes. Epidemiology 1999; 10: 788. 731.VINEIS P. Proof in observational medicine. J Epidemiol Community Health 1997; 51: 9-13. 732.VINEIS P. ras Mutations and a cup of coffee: cause, confounder, effect modifier, or what else? J Epidemiol Community Health 1999; 53: 685.
733.VINEIS P. Rischi ambientali: concetti scientifici e percezione sociale. In: "Ambiente,
razionalità, costituzioni" Seminario Fondazione Olivetti (a cura di S. Scamuzzi). Bollati Boringhieri, 1994.
734.VINEIS P. The number needed to treat is value-laden. J Clin Epidemiol 2002; 55: 102-3. 735.VINEIS P. The randomized controlled trial in studies using biomarkers. Biomarkers 2003; 8: 1332.
736.VINEIS P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 2002; 181-182: 457-62.
737.VINEIS P. Tobacco and cancer: an update. Critical Reviews in Oncology/Hematology 1995; 18: 103-10.
738.VINEIS P. Use of biomarkers in epidemiology. The example of metabolic susceptibility to cancer. Toxicol Letters 1995; 77: 163-8.
739.VINEIS P. Uses of biochemical markers in environmental epidemiology. In: Bertollini R. et al. (Eds.) Environmental Epidemiology, CR Press, 1995.
740.VINEIS P. Verso un codice deontologico per gli epidemiologi. Ann Ist Super Sanità 1998; 34: 251-4.
741.VISCOMI S, PASTORE G, DAMA E, MERLETTI F, MAGNANI C. Attesa di vita come indicatore di outcome. Epidemiol Prev 2004; 28: 174-7.
742.VISCOMI S, PASTORE G, MOSSO ML, TERRACINI B, MADON E, MAGNANI C, MERLETTI F; CHILDHOOD
CANCER REGISTRY OF PIEDMONT, ITALY. Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. Haematologica 2003; 88: 974-82.
743.WECHSLER J, ZANETTI R, SCHRAMECK C, ROSSO S, PIPPIONE M, LINARES J, LAURENT R, ORTUNO G, BOI S,
GAFA L, JORIS F, SPATZ A, BARNEON G, SACERDOTE C, SANCHO-GARNIER H. Reproducibility of histopathologic diagnosis and classification of non-melanocytic skin cancer: a panel exercise in the framework of the multicenter southern European study HELIOS. Tumori 2001; 87: 95-100.
744.WÜNSCH-FILHO V, MONCAU JE, MIRABELLI D, BOFFETTA P. Occupational risk factors of lung cancer in São Paulo, Brazil. Scand J Work Environ Health 1998; 24: 118-24.
47
745.ZAMBELLI S, ZANIN A, GAGLIO A, ZAI G, BOSCO E, ANDRION A, MAGNANI C. Ki-67 scores and AgNor
counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value. Arch It Urol 1993; LXV: 665-70.
746.ZANETTI R, BUIATTI E, FEDERICO M, MICHELI A. Fatti e cifre dei tumori in Italia. Il pensiero Scientifico Editore. Roma 1998.
747.ZANETTI R, CROSIGNANI P, ROSSO S. Il Cancro in Italia. I dati di incidenza dei Registri Tumori: 1988-1992. Il Pensiero Scientifico Editore, 1997.
748.ZANETTI R, FALCINI F, SIMONATO L, VERCELLI M. [Survival of cancer patients in Italy in the nineties: the importance of population based data.] Epidemiol Prev 2001; 25: 1-8.
749.ZANETTI R, FERRETTI S, FUSCO M, BELLU’ F, RAMAZZOTTI V, CROSIGNANI P, & GRUPPO AIRT. L’incidenza
del cancro in Italia alla metà degli anni ‘90. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
750.ZANETTI R, GAFÀ L, FRANCESCHI S, ROSSO S. Stima della proporzione di tumori cutanei attribuibili all'esposizione solare in tre popolazioni italiane. Epidemiol Prev 1999; 23: 416-22.
751.ZANETTI R, GAFA’ L, PANNELLI F, CONTI E, ROSSO S. Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Il Pensiero Scientifico Editore, Roma 2002.
752.ZANETTI R, GIACOMIN A. Urinary tract cancers: kidney and urinary bladder. Epidemiol Prev 2004; 28: 82-7.
753.ZANETTI R, MICHELI A, ROSSO S, SANT M. The prevalence of cancer: a review of the available data. Tumori 1999; 85: 408-13.
754.ZANETTI R, PROTA G, NAPOLITANO A, MARTINEZ C, SANCHO-GARNIER H, OSTERLIND A, SACERDOTE C, ROSSO S. Development of an integrated method of skin phenotype measurement using the melanins. Melanoma Res 2001; 11: 551-7.
755.ZANETTI R, ROSSO S, MARTINEZ C, NAVARRO C, SCHRAUB S, SANCHO-GARNIER H, FRANCESCHI S, GAFÀ L, PEREA E, TORMO MJ, LAURENT R, SCHRAMECK C, CRISTOFOLINI M, TUMINO R, WECHSLER J. The multicentre south-european study "HELIOS": I. Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1440-6.
756.ZANETTI R, ROSSO S, NAVARRO C, SANCHO-GARNIER H, MARTINEZ C, SCHRAUB S, FRANCESCHI S, GAFA' L, WECHSLER J. The multicentre south european study "Helios" Different exposure pattern between basal-cell carcinoma and squamous-cell carcinoma of the skin. Atti de "XVIII Réunion du Groupe pour l'Epidemiologie et l'Enregistrement du Cancer dans le Pays de Langue Latine. Dijon". IARC Technical Report N° 20, Lyon, 1993.
757.ZANETTI R, ROSSO S, PROTA G, NAPOLITANO A, SNACHO-GARNIER H, MARTINEZ C, ØSTERLIND A, KOLOMOETS E. Prevention of melanoma and non-melanocytic skin cancer development of a new method for high risk groups detection. Pilot phase: final report. Europe Against Cancer Programme: Technical Report.
758.ZANETTI R, ROSSO S, VICARI P, FOGGETTI R, PATRIARCA S, PRANDI R, GREMO F. Cancer incidence in
Italy, Torino, 1988-91. In: Parkin D.M., Whelan S.L., Ferlay J., Raymond L., Young J. (eds), Cancer incidence in Five Continents, Volume VII. IARC Scientific Publications No 143, Lyon, IARC 1997.
759.ZANETTI R, ROSSO S. [Will epidemiology succeed in saving the tumor registries?] Epidemiol Prev 2002; 26: 198-202.
760.ZANETTI R, ROSSO S. Fatti e cifre dei tumori in Italia. Seconda Edizione. Roma, Il Pensiero Scientifico Editore, 2003.
761.ZANETTI R, TUMINO R. Ultraviolet radiation and skin tumours. Med Lav 1998; 89: 142-8. 762.ZANETTI R. L’incidenza del cancro in 183 popolazioni di 50 paesi in 5 continenti. Epidemiol Prev 1998; 22: 111-5.
48
763.ZANETTI R. Primi dati italiani sull'evoluzione nel tempo dell'incidenza di tumori. Epidemiol Prev 1993; 17: 180-2.
764.ZANOLIN ME, PATTARO C, CORSICO A, BUGIANI M, CARROZZI L, CASALI L, DALLARI R, FERRARI M, MARINONI A, MIGLIORE E, OLIVIERI M, PIRINA P, VERLATO G, VILLANI S, MARCO R; ISAYA STUDY GROUP. The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. Allergy 2004; 59: 306-14.
765.ZOCCOLA M, MOSSOTTI R, INNOCENTI R, LORIA DI, ROSSO S, ZANETTI R. Near infrared spectroscopy as a tool for the determination of eumelanin in human hair. Pigment Cell Res 2004; 17: 37985.
766.ZUCCOLO L, PASTORE G, MAULE M, GREGORI D, TERRACINI B, MERLETTI F, MAGNANI C. Time trends of
childhood cancer mortality rates: a report from the Childhood Cancer Registry of Piedmont, Italy, 1971-1998. Pediatr Blood Cancer 2004; 43: 788-91.
Eventuali richieste di estratti possono essere indirizzate al primo autore.
49